<?xml version="1.0" encoding="US-ASCII"?>  
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->     
<!-- Created: Wed Nov 07 11:47:35 EST 2018 -->  
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:compsci="http://compsciresources.com" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:usrm="http://www.bioheartinc.com/20180930" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"> 
  <link:schemaRef xlink:type="simple" xlink:href="usrm-20180930.xsd"/> 
  <context id="c0_AsOf30Sep2018">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c1_AsOf31Dec2017">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c2_AsOf30Sep2018_NoteAndCapitalLeasePayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:NoteAndCapitalLeasePayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c3_AsOf31Dec2017_NoteAndCapitalLeasePayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:NoteAndCapitalLeasePayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c4_AsOf30Sep2018_NotesPayableOtherPayablesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c5_AsOf31Dec2017_NotesPayableOtherPayablesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c6_AsOf30Sep2018_NoteAndCapitalLeasePayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">usrm:NoteAndCapitalLeasePayablesMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c7_AsOf31Dec2017_NoteAndCapitalLeasePayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">usrm:NoteAndCapitalLeasePayablesMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c8_From1Jul2018To30Sep2018_ProductMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c9_From1Jul2017To30Sep2017_ProductMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c10_From1Jan2018To30Sep2018_ProductMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c11_From1Jan2017To30Sep2017_ProductMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c12_From1Jul2018To30Sep2018_ServicesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usrm:ServicesMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c13_From1Jul2017To30Sep2017_ServicesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usrm:ServicesMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c14_From1Jan2018To30Sep2018_ServicesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usrm:ServicesMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c15_From1Jan2017To30Sep2017_ServicesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usrm:ServicesMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c16_From1Jul2018To30Sep2018">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c17_From1Jul2017To30Sep2017">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c18_From1Jan2018To30Sep2018">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c19_From1Jan2017To30Sep2017">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c20_AsOf31Dec2017_CommonStockMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c21_AsOf31Dec2017_AdditionalPaidInCapitalMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c22_AsOf31Dec2017_RetainedEarningsMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c23_From1Jan2018To30Sep2018_CommonStockMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c25_From1Jan2018To30Sep2018_RetainedEarningsMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c26_AsOf30Sep2018_CommonStockMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c27_AsOf30Sep2018_AdditionalPaidInCapitalMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c28_AsOf30Sep2018_RetainedEarningsMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c29_AsOf31Dec2016">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2016-12-31</instant> 
    </period>    
  </context>   
  <context id="c30_AsOf30Sep2017">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2017-09-30</instant> 
    </period>    
  </context>   
  <context id="c31_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfNotesPayableMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfNotesPayableMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c32_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfNotesPayableMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfNotesPayableMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c33_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfAccountsPayableMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c34_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfAccountsPayableMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfAccountsPayableMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c35_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c36_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c37_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfGuarantorFeesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfGuarantorFeesMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c38_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfGuarantorFeesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfGuarantorFeesMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c39_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfLegalFeesMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfLegalFeesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c40_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfLegalFeesMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:OtherSignificantNoncashTransactionsByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfLegalFeesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c41_AsOf7Nov2018">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2018-11-07</instant> 
    </period>    
  </context>   
  <context id="c42_AsOf30Sep2018_RoyaltyArrangementMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:RoyaltyArrangementMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c43_AsOf31Dec2017_RoyaltyArrangementMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">us-gaap:RoyaltyArrangementMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c44_AsOf30Sep2018_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c45_AsOf30Sep2018_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c46_AsOf30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c47_From1Jan2018To30Sep2018_MinimumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c48_From1Jan2018To30Sep2018_MaximumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c49_From1Jan2018To30Sep2018_AssetsHeldUnderCapitalLeasesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c50_From1Jan2018To30Sep2018_CustomerOneMember_AccountsReceivableMember_CreditConcentrationRiskMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c51_From1Jan2018To30Sep2018_CustomerTwoMember_AccountsReceivableMember_CreditConcentrationRiskMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerTwoMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c52_From1Jan2018To30Sep2018_CustomerThreeMember_AccountsReceivableMember_CreditConcentrationRiskMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerThreeMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c53_From1Jan2018To30Sep2018_AccountsReceivableMember_CreditConcentrationRiskMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c54_From1Jan2017To31Dec2017_CustomerOneMember_AccountsReceivableMember_CreditConcentrationRiskMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c55_From1Jan2017To31Dec2017_CustomerTwoMember_AccountsReceivableMember_CreditConcentrationRiskMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerTwoMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c56_From1Jan2017To31Dec2017_CustomerThreeMember_AccountsReceivableMember_CreditConcentrationRiskMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerThreeMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c57_From1Jan2017To31Dec2017_AccountsReceivableMember_CreditConcentrationRiskMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c58_From1Jul2018To30Sep2018_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerTwoMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c59_From1Jul2018To30Sep2018_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c60_From1Jul2018To30Sep2018_CustomerThreeMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerThreeMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c61_From1Jul2017To30Sep2017_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c62_From1Jan2018To30Sep2018_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c63_From1Jan2018To30Sep2018_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerTwoMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c64_From1Jan2017To30Sep2017_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerTwoMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c65_From1Jan2017To30Sep2017_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerOneMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c66_From1Jan2017To30Sep2017_CustomerThreeMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">usrm:CustomerThreeMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c67_From3Mar2017To3Mar2017">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2017-03-03</startDate>     
      <endDate>2017-03-03</endDate> 
    </period>    
  </context>   
  <context id="c68_From1Jan2018To30Sep2018_EmployeeStockOptionMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c69_From1Jan2017To30Sep2017_EmployeeStockOptionMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c70_From1Jan2018To30Sep2018_WarrantMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c71_From1Jan2017To30Sep2017_WarrantMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c72_From1Jul2018To30Sep2018_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c73_From1Jan2018To30Sep2018_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c74_From1Jul2017To30Sep2017_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c75_From1Jan2017To30Sep2017_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c76_From1Aug1999To30Jun2018_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>1999-08-01</startDate>     
      <endDate>2018-06-30</endDate> 
    </period>    
  </context>   
  <context id="c77_From1Aug1999To30Sep2018_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>1999-08-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c78_AsOf31Dec2017_USStemCellClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c79_From1Jan2017To31Dec2017_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c80_From1Jan2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c81_AsOf31Dec2017_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c82_From1Jul2018To30Sep2018_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c83_From1Jan2018To30Sep2018_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c84_From1Jan2017To31Dec2017_RegenerativeWellnessClinicLLCMember_OtherIncomeMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c85_From1Jul2017To30Sep2017_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-07-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c86_From1Jan2017To30Sep2017_RegenerativeWellnessClinicLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:RegenerativeWellnessClinicLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-09-30</endDate> 
    </period>    
  </context>   
  <context id="c87_From30Jan2018To30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-30</startDate>     
      <endDate>2018-01-30</endDate> 
    </period>    
  </context>   
  <context id="c88_From30Jan2018To30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember_UtilizedForFromationOfLLCMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">usrm:UtilizedForFromationOfLLCMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-30</startDate>     
      <endDate>2018-01-30</endDate> 
    </period>    
  </context>   
  <context id="c89_AsOf30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-01-30</instant> 
    </period>    
  </context>   
  <context id="c90_From1Jul2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">usrm:USStemCellClinicOfTheVillageLLCtheLLCMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c91_AsOf3Mar2017">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2017-03-03</instant> 
    </period>    
  </context>   
  <context id="c92_AsOf30Sep2018_AssetsHeldUnderCapitalLeasesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c93_AsOf31Dec2017_AssetsHeldUnderCapitalLeasesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c94_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAccruedExpensesAndAccruedInterestMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:EquityTransactionAxis">usrm:CommonStockIssuedInSettlementOfAccountsPayableAccruedExpensesAndAccruedInterestMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c95_AsOf25Oct2010_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:SeasideNationalBankAndTrustMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2010-10-25</instant> 
    </period>    
  </context>   
  <context id="c96_From1Jan2018To31Mar2018_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:SeasideNationalBankAndTrustMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-03-31</endDate> 
    </period>    
  </context>   
  <context id="c97_AsOf31Dec2016_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2016-12-31</instant> 
    </period>    
  </context>   
  <context id="c98_AsOf31Dec2016_HuntonWilliamsNote1Member_NotesPayableOtherPayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNote1Member</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2016-12-31</instant> 
    </period>    
  </context>   
  <context id="c99_AsOf31Dec2016_HuntonWilliamsNote2Member_NotesPayableOtherPayablesMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNote2Member</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2016-12-31</instant> 
    </period>    
  </context>   
  <context id="c100_From1Jan2016To31Dec2016_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2016-01-01</startDate>     
      <endDate>2016-12-31</endDate> 
    </period>    
  </context>   
  <context id="c101_From31Aug2017To31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-08-31</startDate>     
      <endDate>2017-08-31</endDate> 
    </period>    
  </context>   
  <context id="c102_AsOf31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-08-31</instant> 
    </period>    
  </context>   
  <context id="c103_From1Jul2018To30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c104_From1Jan2018To30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c105_AsOf30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c106_From12Sep2017To12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-09-12</startDate>     
      <endDate>2017-09-12</endDate> 
    </period>    
  </context>   
  <context id="c107_AsOf12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-09-12</instant> 
    </period>    
  </context>   
  <context id="c108_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-02</startDate>     
      <endDate>2018-01-02</endDate> 
    </period>    
  </context>   
  <context id="c109_AsOf2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-01-02</instant> 
    </period>    
  </context>   
  <context id="c110_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_EmbeddedDerivativeFinancialInstrumentsMember_ConvertibleDebtMember_RevenueBasedFactoringAgreementMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-02</startDate>     
      <endDate>2018-01-02</endDate> 
    </period>    
  </context>   
  <context id="c111_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-05-29</startDate>     
      <endDate>2018-05-29</endDate> 
    </period>    
  </context>   
  <context id="c112_AsOf29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-05-29</instant> 
    </period>    
  </context>   
  <context id="c113_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_EmbeddedDerivativeFinancialInstrumentsMember_ConvertibleDebtMember_RevenueBasedFactoringAgreementMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usrm:RevenueBasedFactoringAgreementMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-05-29</startDate>     
      <endDate>2018-05-29</endDate> 
    </period>    
  </context>   
  <context id="c114_AsOf30Sep2018_PowerUpLendingGroupNotesPayableMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c115_AsOf3Mar2017_CapitalLeaseObligationsMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-03-03</instant> 
    </period>    
  </context>   
  <context id="c116_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-03</startDate>     
      <endDate>2017-03-03</endDate> 
    </period>    
  </context>   
  <context id="c117_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearOneMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">usrm:RevenuePrecentageYearOneMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-03</startDate>     
      <endDate>2017-03-03</endDate> 
    </period>    
  </context>   
  <context id="c118_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearTwoMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">usrm:RevenuePrecentageYearTwoMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-03</startDate>     
      <endDate>2017-03-03</endDate> 
    </period>    
  </context>   
  <context id="c119_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearThreeMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">usrm:RevenuePrecentageYearThreeMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-03</startDate>     
      <endDate>2017-03-03</endDate> 
    </period>    
  </context>   
  <context id="c120_AsOf1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2015-06-01</instant> 
    </period>    
  </context>   
  <context id="c121_From1Jun2015To1Jun2015_PrincipalMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:PrincipalMember</xbrldi:explicitMember>    
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-06-01</startDate>     
      <endDate>2015-06-01</endDate> 
    </period>    
  </context>   
  <context id="c122_From1Jun2015To1Jun2015_InterestMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-06-01</startDate>     
      <endDate>2015-06-01</endDate> 
    </period>    
  </context>   
  <context id="c123_From1Jun2015To1Jun2015_UnpaidGuarantorFeesMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:UnpaidGuarantorFeesMember</xbrldi:explicitMember>    
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-06-01</startDate>     
      <endDate>2015-06-01</endDate> 
    </period>    
  </context>   
  <context id="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-06-01</startDate>     
      <endDate>2015-06-01</endDate> 
    </period>    
  </context>   
  <context id="c125_From1Jul2018To30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c126_From1Jan2018To30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c127_AsOf30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c128_AsOf30Sep2018_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:SeasideNationalBankAndTrustMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c129_AsOf31Dec2017_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:SeasideNationalBankAndTrustMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c130_AsOf31Dec2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:HuntonWilliamsNotesMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c131_AsOf30Sep2018_PowerUpLendingGroupNotesPayableMember_NotesPayableOtherPayablesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c132_AsOf31Dec2017_PowerUpLendingGroupNotesPayableMember_NotesPayableOtherPayablesMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:PowerUpLendingGroupNotesPayableMember</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c133_AsOf30Sep2018_CapitalLeaseObligationsMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c134_AsOf31Dec2017_CapitalLeaseObligationsMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c135_AsOf30Sep2018_EquipmentMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c136_AsOf31Dec2017_EquipmentMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c137_AsOf30Sep2018_OfficeEquipmentMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c138_AsOf31Dec2017_OfficeEquipmentMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c139_AsOf29Feb2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2012-02-29</instant> 
    </period>    
  </context>   
  <context id="c140_From30Mar2012To30Mar2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2012-03-30</startDate>     
      <endDate>2012-03-30</endDate> 
    </period>    
  </context>   
  <context id="c141_From21Sep2012To21Sep2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2012-09-21</startDate>     
      <endDate>2012-09-21</endDate> 
    </period>    
  </context>   
  <context id="c142_From1Oct2012To1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2012-10-01</startDate>     
      <endDate>2012-10-01</endDate> 
    </period>    
  </context>   
  <context id="c143_AsOf1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2012-10-01</instant> 
    </period>    
  </context>   
  <context id="c144_AsOf28Feb2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2013-02-28</instant> 
    </period>    
  </context>   
  <context id="c145_AsOf31Dec2012"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2012-12-31</instant> 
    </period>    
  </context>   
  <context id="c146_From1Oct2012To1Oct2012_SeriesAPreferredStockMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2012-10-01</startDate>     
      <endDate>2012-10-01</endDate> 
    </period>    
  </context>   
  <context id="c147_From1Mar2017To1Mar2017">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2017-03-01</startDate>     
      <endDate>2017-03-01</endDate> 
    </period>    
  </context>   
  <context id="c148_From1Mar2017To1Mar2017_NorthstarClaimsMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">usrm:NorthstarClaimsMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-01</startDate>     
      <endDate>2017-03-01</endDate> 
    </period>    
  </context>   
  <context id="c149_AsOf1Mar2017_NorthstarClaimsMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">usrm:NorthstarClaimsMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-03-01</instant> 
    </period>    
  </context>   
  <context id="c150_From9Mar2017To9Mar2017_StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember_NorthstarClaimsMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:EquityTransactionAxis">usrm:StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">usrm:NorthstarClaimsMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-03-09</startDate>     
      <endDate>2017-03-09</endDate> 
    </period>    
  </context>   
  <context id="c151_From1Apr2017To1Apr2017_StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember_NorthstarClaimsMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:EquityTransactionAxis">usrm:StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">usrm:NorthstarClaimsMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-04-01</startDate>     
      <endDate>2017-04-01</endDate> 
    </period>    
  </context>   
  <context id="c152_From1Jan2013To31Dec2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember_SeriesAPreferredStockMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2013-01-01</startDate>     
      <endDate>2013-12-31</endDate> 
    </period>    
  </context>   
  <context id="c153_From30Sep2013To30Sep2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2013-09-30</startDate>     
      <endDate>2013-09-30</endDate> 
    </period>    
  </context>   
  <context id="c154_From24Dec2013To24Dec2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2013-12-24</startDate>     
      <endDate>2013-12-24</endDate> 
    </period>    
  </context>   
  <context id="c155_From2Apr2014To2Apr2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2014-04-02</startDate>     
      <endDate>2014-04-02</endDate> 
    </period>    
  </context>   
  <context id="c156_From3Oct2014To3Oct2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2014-10-03</startDate>     
      <endDate>2014-10-03</endDate> 
    </period>    
  </context>   
  <context id="c157_From3Apr2015To3Apr2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-04-03</startDate>     
      <endDate>2015-04-03</endDate> 
    </period>    
  </context>   
  <context id="c158_From2Oct2015To2Oct2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2015-10-02</startDate>     
      <endDate>2015-10-02</endDate> 
    </period>    
  </context>   
  <context id="c159_From7Oct2015To7Oct2015">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2015-10-07</startDate>     
      <endDate>2015-10-07</endDate> 
    </period>    
  </context>   
  <context id="c160_From7Apr2016To7Apr2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2016-04-07</startDate>     
      <endDate>2016-04-07</endDate> 
    </period>    
  </context>   
  <context id="c161_From6Oct2016To6Oct2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:InterestMember</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2016-10-06</startDate>     
      <endDate>2016-10-06</endDate> 
    </period>    
  </context>   
  <context id="c162_From1Apr2017To1Apr2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-04-01</startDate>     
      <endDate>2017-04-01</endDate> 
    </period>    
  </context>   
  <context id="c163_From2Oct2017To2Oct2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-10-02</startDate>     
      <endDate>2017-10-02</endDate> 
    </period>    
  </context>   
  <context id="c164_AsOf30Sep2018_NotesPayableOtherPayablesMember_AffiliatedEntityMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c165_AsOf31Dec2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c166_AsOf1Jul2014_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2014-07-01</instant> 
    </period>    
  </context>   
  <context id="c167_From1Jul2014To1Jul2014_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2014-07-01</startDate>     
      <endDate>2014-07-01</endDate> 
    </period>    
  </context>   
  <context id="c168_From1Jan2018To30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c169_AsOf30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c170_AsOf31Dec2017_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c171_AsOf6Sep2016_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2016-09-06</instant> 
    </period>    
  </context>   
  <context id="c172_From1Jan2018To30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c173_AsOf30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c174_AsOf31Dec2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c175_AsOf7Aug2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-08-07</instant> 
    </period>    
  </context>   
  <context id="c176_From7Aug2017To7Aug2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-08-07</startDate>     
      <endDate>2017-08-07</endDate> 
    </period>    
  </context>   
  <context id="c177_AsOf30Sep2018_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c178_AsOf31Dec2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c179_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-05-07</instant> 
    </period>    
  </context>   
  <context id="c180_From7May2018To7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-05-07</startDate>     
      <endDate>2018-05-07</endDate> 
    </period>    
  </context>   
  <context id="c181_AsOf30Sep2018_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c182_AsOf31Dec2017_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c183_AsOf6Sep2016_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2016-09-06</instant> 
    </period>    
  </context>   
  <context id="c184_From1Jan2018To30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c185_AsOf30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c186_AsOf31Dec2017_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable1Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c187_AsOf7Aug2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-08-07</instant> 
    </period>    
  </context>   
  <context id="c188_From7Aug2017To7Aug2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-08-07</startDate>     
      <endDate>2017-08-07</endDate> 
    </period>    
  </context>   
  <context id="c189_AsOf30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c190_AsOf31Dec2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable2Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c191_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-05-07</instant> 
    </period>    
  </context>   
  <context id="c192_From7May2018To7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-05-07</startDate>     
      <endDate>2018-05-07</endDate> 
    </period>    
  </context>   
  <context id="c193_AsOf30Sep2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c194_AsOf30Sep2018_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c195_AsOf31Dec2017_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c196_From1May2016To1May2016_AffiliatedEntityMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2016-05-01</startDate>     
      <endDate>2016-05-01</endDate> 
    </period>    
  </context>   
  <context id="c197_From1Jul2018To30Sep2018_AffiliatedEntityMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c198_From1Jan2018To30Sep2018_AffiliatedEntityMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c199_AsOf30Sep2018_AffiliatedEntityMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c200_AsOf31Dec2017_AffiliatedEntityMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>     
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c201_From3Apr2017To3Apr2017_GACPStemCellBankLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">usrm:GACPStemCellBankLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-04-03</startDate>     
      <endDate>2017-04-03</endDate> 
    </period>    
  </context>   
  <context id="c202_From1Jan2018To30Sep2018_GACPStemCellBankLLCMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">usrm:GACPStemCellBankLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c203_From1May2017To1May2017_GACPStemCellBankLLCMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">usrm:GACPStemCellBankLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-05-01</startDate>     
      <endDate>2017-05-01</endDate> 
    </period>    
  </context>   
  <context id="c204_AsOf30Sep2018_GACPStemCellBankLLCMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">usrm:GACPStemCellBankLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c205_AsOf31Dec2017_GACPStemCellBankLLCMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">usrm:GACPStemCellBankLLCMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c206_AsOf30Sep2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c207_AsOf31Dec2017_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable4Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c208_AsOf30Sep2018_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c209_AsOf31Dec2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usrm:NotePayable3Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">usrm:ChiefScientificOfficerMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2017-12-31</instant> 
    </period>    
  </context>   
  <context id="c210_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAndAccruedExpensesMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">usrm:CommonStockIssuedInSettlementOfAccountsPayableAndAccruedExpensesMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c211_AsOf1Apr2013_Bioheart2013OmnibusEquityCompensationPlanMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2013-04-01</instant> 
    </period>    
  </context>   
  <context id="c212_AsOf4Aug2014_Bioheart2013OmnibusEquityCompensationPlanMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2014-08-04</instant> 
    </period>    
  </context>   
  <context id="c213_AsOf2Nov2015_Bioheart2013OmnibusEquityCompensationPlanMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2015-11-02</instant> 
    </period>    
  </context>   
  <context id="c214_From16Sep2016To16Sep2016_Bioheart2013OmnibusEquityCompensationPlanMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2016-09-16</startDate>     
      <endDate>2016-09-16</endDate> 
    </period>    
  </context>   
  <context id="c215_From21Apr2017To21Apr2017_Bioheart2013OmnibusEquityCompensationPlanMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-04-21</startDate>     
      <endDate>2017-04-21</endDate> 
    </period>    
  </context>   
  <context id="c216_From7Aug2017To7Aug2017_Bioheart2013OmnibusEquityCompensationPlanMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2017-08-07</startDate>     
      <endDate>2017-08-07</endDate> 
    </period>    
  </context>   
  <context id="c217_From7May2018To7May2018_Bioheart2013OmnibusEquityCompensationPlanMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usrm:Bioheart2013OmnibusEquityCompensationPlanMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-05-07</startDate>     
      <endDate>2018-05-07</endDate> 
    </period>    
  </context>   
  <context id="c218_From7May2018To7May2018">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2018-05-07</startDate>     
      <endDate>2018-05-07</endDate> 
    </period>    
  </context>   
  <context id="c219_From8Aug2018To8Aug2018">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2018-08-08</startDate>     
      <endDate>2018-08-08</endDate> 
    </period>    
  </context>   
  <context id="c220_From1Jul2018To30Sep2018_EmployeeStockOptionMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-07-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c221_From1Jan2018To30Sep2018_EmployeeStockOptionMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c222_AsOf30Sep2018_EmployeeStockOptionMember">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c223_From27Aug2018To27Aug2018">  
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2018-08-27</startDate>     
      <endDate>2018-08-27</endDate> 
    </period>    
  </context>   
  <context id="c224_AsOf27Aug2018"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <instant>2018-08-27</instant> 
    </period>    
  </context>   
  <context id="c225_From1Jan2017To31Dec2017"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2017-01-01</startDate>     
      <endDate>2017-12-31</endDate> 
    </period>    
  </context>   
  <context id="c226_From1Jan2018To30Sep2018_Options0.0043ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0043ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c227_AsOf30Sep2018_Options0.0043ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0043ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c228_From1Jan2018To30Sep2018_Options0.0196ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0196ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c229_AsOf30Sep2018_Options0.0196ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0196ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c230_From1Jan2018To30Sep2018_Options002576ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options002576ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c231_AsOf30Sep2018_Options002576ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options002576ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c232_From1Jan2018To30Sep2018_Options0.03626ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.03626ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c233_AsOf30Sep2018_Options0.03626ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.03626ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c234_From1Jan2018To30Sep2018_Options0.03680ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.03680ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c235_AsOf30Sep2018_Options0.03680ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.03680ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c236_From1Jan2018To30Sep2018_Options0.0536ExercisPriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0536ExercisPriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c237_AsOf30Sep2018_Options0.0536ExercisPriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.0536ExercisPriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c238_From1Jan2018To30Sep2018_Options0.15402ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.15402ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c239_AsOf30Sep2018_Options0.15402ExercisePriceMember">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options0.15402ExercisePriceMember</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c240_From1Jan2018To30Sep2018_Options19.32ExercisePriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options19.32ExercisePriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c241_AsOf30Sep2018_Options19.32ExercisePriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options19.32ExercisePriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c242_From1Jan2018To30Sep2018_Options70.00ExercisePriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options70.00ExercisePriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c243_AsOf30Sep2018_Options70.00ExercisePriceMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options70.00ExercisePriceMember</xbrldi:explicitMember> 
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c244_From1Jan2018To30Sep2018_Options210.00ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options210.00ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c245_AsOf30Sep2018_Options210.00ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options210.00ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c246_From1Jan2018To30Sep2018_Options680.00ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options680.00ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c247_AsOf30Sep2018_Options680.00ExercisePriceMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">usrm:Options680.00ExercisePriceMember</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c248_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member_MinimumMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c249_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member_MaximumMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member</xbrldi:explicitMember>  
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c250_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c251_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member</xbrldi:explicitMember>  
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c252_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member_MinimumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c253_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member_MaximumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c254_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c255_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c256_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member_MinimumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c257_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member_MaximumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c258_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c259_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c260_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member_MinimumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c261_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member_MaximumMember">    
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member</xbrldi:explicitMember>   
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c262_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c263_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c264_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <instant>2018-09-30</instant> 
    </period>    
  </context>   
  <context id="c265_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member">     
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="usrm:ClassOfWarrantsOrRightsSharesAuthorizedExercisePriceRangeAxis">usrm:ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member</xbrldi:explicitMember>   
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-01-01</startDate>     
      <endDate>2018-09-30</endDate> 
    </period>    
  </context>   
  <context id="c266_From1Jan2016To31Dec2016"> 
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
    </entity>    
    <period>   
      <startDate>2016-01-01</startDate>     
      <endDate>2016-12-31</endDate> 
    </period>    
  </context>   
  <context id="c267_From1Oct2018To31Oct2018_SubsequentEventMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-10-01</startDate>     
      <endDate>2018-10-31</endDate> 
    </period>    
  </context>   
  <context id="c268_From1Oct2018To31Oct2018_DirectorMember_SubsequentEventMember">   
    <entity>   
      <identifier scheme="http://www.sec.gov/CIK">0001388319</identifier>    
      <segment> 
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:DirectorMember</xbrldi:explicitMember> 
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>    
      </segment>  
    </entity>    
    <period>   
      <startDate>2018-10-01</startDate>     
      <endDate>2018-10-31</endDate> 
    </period>    
  </context>   
  <unit id="usd">   
    <measure>iso4217:USD</measure>     
  </unit>     
  <unit id="usdPershares">  
    <divide>   
      <unitNumerator>  
        <measure>iso4217:USD</measure>    
      </unitNumerator>   
      <unitDenominator>    
        <measure>xbrli:shares</measure>     
      </unitDenominator>     
    </divide>    
  </unit>     
  <unit id="shares"> 
    <measure>xbrli:shares</measure> 
  </unit>     
  <unit id="pure">    
    <measure>xbrli:pure</measure>    
  </unit>     
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1448153</us-gaap:CashAndCashEquivalentsAtCarryingValue>  
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">986799</us-gaap:CashAndCashEquivalentsAtCarryingValue> 
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">32542</us-gaap:AccountsReceivableNetCurrent>  
  <us-gaap:AccountsReceivableNetCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">42959</us-gaap:AccountsReceivableNetCurrent>  
  <us-gaap:InventoryNet unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">72648</us-gaap:InventoryNet>     
  <us-gaap:InventoryNet unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">70364</us-gaap:InventoryNet>     
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">38128</us-gaap:PrepaidExpenseAndOtherAssetsCurrent> 
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">3128</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>     
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1591471</us-gaap:AssetsCurrent>    
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1103250</us-gaap:AssetsCurrent>    
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">294267</us-gaap:PropertyPlantAndEquipmentNet>   
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">449747</us-gaap:PropertyPlantAndEquipmentNet>   
  <us-gaap:Investments unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">170798</us-gaap:Investments>    
  <us-gaap:Investments unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">34926</us-gaap:Investments>   
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">10160</us-gaap:DepositsAssetsNoncurrent>    
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">10160</us-gaap:DepositsAssetsNoncurrent>    
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">2066696</us-gaap:Assets>     
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1598083</us-gaap:Assets>     
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1259638</us-gaap:AccountsPayableCurrent>  
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1378124</us-gaap:AccountsPayableCurrent>  
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1171123</us-gaap:AccruedLiabilitiesCurrent>   
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">929119</us-gaap:AccruedLiabilitiesCurrent>  
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">204901</us-gaap:DueToRelatedPartiesCurrent>    
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">104901</us-gaap:DueToRelatedPartiesCurrent>    
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">430330</us-gaap:DeferredRevenueCurrent> 
  <us-gaap:DeferredRevenueCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">211042</us-gaap:DeferredRevenueCurrent> 
  <us-gaap:DeferredGainOnSaleOfProperty unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">128845</us-gaap:DeferredGainOnSaleOfProperty>   
  <us-gaap:DeferredGainOnSaleOfProperty unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">128845</us-gaap:DeferredGainOnSaleOfProperty>   
  <us-gaap:DepositLiabilityCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">465286</us-gaap:DepositLiabilityCurrent>   
  <us-gaap:DepositLiabilityCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">465286</us-gaap:DepositLiabilityCurrent>   
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">2158555</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>    
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1901526</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>    
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">392470</us-gaap:NotesPayableCurrent>     
  <us-gaap:NotesPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1344594</us-gaap:NotesPayableCurrent> 
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">6211148</us-gaap:LiabilitiesCurrent>    
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">6463437</us-gaap:LiabilitiesCurrent>    
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">66250</us-gaap:DeferredRevenueNoncurrent> 
  <us-gaap:DeferredRevenueNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">68500</us-gaap:DeferredRevenueNoncurrent> 
  <us-gaap:DeferredCreditsAndOtherLiabilitiesNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">53686</us-gaap:DeferredCreditsAndOtherLiabilitiesNoncurrent>    
  <us-gaap:DeferredCreditsAndOtherLiabilitiesNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">150320</us-gaap:DeferredCreditsAndOtherLiabilitiesNoncurrent>     
  <us-gaap:Deposits unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">100000</us-gaap:Deposits>   
  <us-gaap:Deposits unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">100000</us-gaap:Deposits>   
  <us-gaap:LongTermDebtNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1280963</us-gaap:LongTermDebtNoncurrent>  
  <us-gaap:LongTermDebtNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1228690</us-gaap:LongTermDebtNoncurrent>  
  <us-gaap:LongTermNotesPayable unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1393588</us-gaap:LongTermNotesPayable>   
  <us-gaap:LongTermNotesPayable unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">687453</us-gaap:LongTermNotesPayable>  
  <us-gaap:LiabilitiesNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">2894487</us-gaap:LiabilitiesNoncurrent>     
  <us-gaap:LiabilitiesNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">2234963</us-gaap:LiabilitiesNoncurrent>     
  <us-gaap:Liabilities unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">9105635</us-gaap:Liabilities>     
  <us-gaap:Liabilities unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">8698400</us-gaap:Liabilities>     
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">0</us-gaap:CommitmentsAndContingencies> 
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">0</us-gaap:CommitmentsAndContingencies> 
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">0</us-gaap:PreferredStockValue>     
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">0</us-gaap:PreferredStockValue>     
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">368318</us-gaap:CommonStockValue>    
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">342113</us-gaap:CommonStockValue>    
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">121935624</us-gaap:AdditionalPaidInCapital> 
  <us-gaap:AdditionalPaidInCapital unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">120185821</us-gaap:AdditionalPaidInCapital> 
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">-129342881</us-gaap:RetainedEarningsAccumulatedDeficit>    
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">-127628251</us-gaap:RetainedEarningsAccumulatedDeficit>    
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">-7038939</us-gaap:StockholdersEquity>     
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">-7100317</us-gaap:StockholdersEquity>     
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">2066696</us-gaap:LiabilitiesAndStockholdersEquity>  
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1598083</us-gaap:LiabilitiesAndStockholdersEquity>  
  <us-gaap:AccountsPayableRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">130461</us-gaap:AccountsPayableRelatedPartiesCurrent>    
  <us-gaap:AccountsPayableRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">201973</us-gaap:AccountsPayableRelatedPartiesCurrent>    
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c2_AsOf30Sep2018_NoteAndCapitalLeasePayablesMember" decimals="0">58202</us-gaap:DebtInstrumentUnamortizedDiscount> 
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c3_AsOf31Dec2017_NoteAndCapitalLeasePayablesMember" decimals="0">61729</us-gaap:DebtInstrumentUnamortizedDiscount> 
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c4_AsOf30Sep2018_NotesPayableOtherPayablesMember" decimals="0">116799</us-gaap:DebtInstrumentUnamortizedDiscount>     
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c5_AsOf31Dec2017_NotesPayableOtherPayablesMember" decimals="0">169072</us-gaap:DebtInstrumentUnamortizedDiscount>     
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c6_AsOf30Sep2018_NoteAndCapitalLeasePayablesMember" decimals="0">16418</us-gaap:DebtInstrumentUnamortizedDiscount> 
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c7_AsOf31Dec2017_NoteAndCapitalLeasePayablesMember" decimals="0">33138</us-gaap:DebtInstrumentUnamortizedDiscount> 
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare> 
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare> 
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized>    
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized>    
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">0</us-gaap:PreferredStockSharesIssued>    
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">0</us-gaap:PreferredStockSharesIssued>    
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>    
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>    
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>     
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>     
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">2000000000</us-gaap:CommonStockSharesAuthorized>     
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">2000000000</us-gaap:CommonStockSharesAuthorized>     
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">368318188</us-gaap:CommonStockSharesIssued> 
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">342113098</us-gaap:CommonStockSharesIssued> 
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">368318188</us-gaap:CommonStockSharesOutstanding> 
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">342113098</us-gaap:CommonStockSharesOutstanding> 
  <us-gaap:Revenues unitRef="usd" contextRef="c8_From1Jul2018To30Sep2018_ProductMember" decimals="0">276281</us-gaap:Revenues>  
  <us-gaap:Revenues unitRef="usd" contextRef="c9_From1Jul2017To30Sep2017_ProductMember" decimals="0">527015</us-gaap:Revenues>  
  <us-gaap:Revenues unitRef="usd" contextRef="c10_From1Jan2018To30Sep2018_ProductMember" decimals="0">1414571</us-gaap:Revenues>    
  <us-gaap:Revenues unitRef="usd" contextRef="c11_From1Jan2017To30Sep2017_ProductMember" decimals="0">1523004</us-gaap:Revenues>    
  <us-gaap:Revenues unitRef="usd" contextRef="c12_From1Jul2018To30Sep2018_ServicesMember" decimals="0">1227603</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c13_From1Jul2017To30Sep2017_ServicesMember" decimals="0">979503</us-gaap:Revenues>    
  <us-gaap:Revenues unitRef="usd" contextRef="c14_From1Jan2018To30Sep2018_ServicesMember" decimals="0">3622671</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c15_From1Jan2017To30Sep2017_ServicesMember" decimals="0">2524411</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">1503884</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">1506518</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">5037242</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">4047415</us-gaap:Revenues>     
  <us-gaap:CostOfGoodsAndServicesSold unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">544398</us-gaap:CostOfGoodsAndServicesSold>     
  <us-gaap:CostOfGoodsAndServicesSold unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">534584</us-gaap:CostOfGoodsAndServicesSold>     
  <us-gaap:CostOfGoodsAndServicesSold unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">1615431</us-gaap:CostOfGoodsAndServicesSold> 
  <us-gaap:CostOfGoodsAndServicesSold unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">1348647</us-gaap:CostOfGoodsAndServicesSold> 
  <us-gaap:GrossProfit unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">959486</us-gaap:GrossProfit>     
  <us-gaap:GrossProfit unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">971934</us-gaap:GrossProfit>     
  <us-gaap:GrossProfit unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">3421811</us-gaap:GrossProfit> 
  <us-gaap:GrossProfit unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">2698768</us-gaap:GrossProfit> 
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">599</us-gaap:ResearchAndDevelopmentExpense>   
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">3753</us-gaap:ResearchAndDevelopmentExpense>    
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">4527</us-gaap:ResearchAndDevelopmentExpense>    
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">12242</us-gaap:ResearchAndDevelopmentExpense>     
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">1177638</us-gaap:SellingGeneralAndAdministrativeExpense>     
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">2023986</us-gaap:SellingGeneralAndAdministrativeExpense>     
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">4468121</us-gaap:SellingGeneralAndAdministrativeExpense>     
  <us-gaap:SellingGeneralAndAdministrativeExpense unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">3638705</us-gaap:SellingGeneralAndAdministrativeExpense>     
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">0</us-gaap:DepreciationAndAmortization>  
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">1230</us-gaap:DepreciationAndAmortization>     
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">524</us-gaap:DepreciationAndAmortization>    
  <us-gaap:DepreciationAndAmortization unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">4463</us-gaap:DepreciationAndAmortization>     
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">1178237</us-gaap:OperatingExpenses>   
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">2028969</us-gaap:OperatingExpenses>   
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">4473172</us-gaap:OperatingExpenses>   
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">3655410</us-gaap:OperatingExpenses>   
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">-218751</us-gaap:OperatingIncomeLoss>  
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">-1057035</us-gaap:OperatingIncomeLoss>   
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-1051361</us-gaap:OperatingIncomeLoss>   
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-956642</us-gaap:OperatingIncomeLoss>  
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">80200</us-gaap:GainsLossesOnExtinguishmentOfDebt>   
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">245662</us-gaap:GainsLossesOnExtinguishmentOfDebt>    
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">45013</us-gaap:GainsLossesOnExtinguishmentOfDebt>   
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-137198</us-gaap:GainsLossesOnExtinguishmentOfDebt>     
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">32211</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>   
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">32212</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>   
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">96634</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>   
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">75160</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>   
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>   
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>   
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>   
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-1891205</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>     
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">160216</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">39400</us-gaap:IncomeLossFromEquityMethodInvestments> 
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">263322</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">178409</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:GainLossRelatedToLitigationSettlement unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">0</us-gaap:GainLossRelatedToLitigationSettlement>  
  <us-gaap:GainLossRelatedToLitigationSettlement unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">0</us-gaap:GainLossRelatedToLitigationSettlement>  
  <us-gaap:GainLossRelatedToLitigationSettlement unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:GainLossRelatedToLitigationSettlement>  
  <us-gaap:GainLossRelatedToLitigationSettlement unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-316800</us-gaap:GainLossRelatedToLitigationSettlement>   
  <us-gaap:InterestExpense unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">384813</us-gaap:InterestExpense>   
  <us-gaap:InterestExpense unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">191933</us-gaap:InterestExpense>   
  <us-gaap:InterestExpense unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">1068238</us-gaap:InterestExpense>    
  <us-gaap:InterestExpense unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">780092</us-gaap:InterestExpense>   
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">-112186</us-gaap:NonoperatingIncomeExpense>    
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">125341</us-gaap:NonoperatingIncomeExpense>   
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-663269</us-gaap:NonoperatingIncomeExpense>    
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-2871726</us-gaap:NonoperatingIncomeExpense>     
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">-330937</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> 
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">-931694</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest> 
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-1714630</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>  
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-3828368</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>  
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>    
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>    
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>    
  <us-gaap:IncomeTaxExpenseBenefit unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>    
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">-330938</us-gaap:NetIncomeLoss>     
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">-931694</us-gaap:NetIncomeLoss>     
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-1714630</us-gaap:NetIncomeLoss> 
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-3828368</us-gaap:NetIncomeLoss> 
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c16_From1Jul2018To30Sep2018" decimals="2">0.00</us-gaap:EarningsPerShareBasicAndDiluted>  
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c17_From1Jul2017To30Sep2017" decimals="2">0.00</us-gaap:EarningsPerShareBasicAndDiluted>  
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="2">0.00</us-gaap:EarningsPerShareBasicAndDiluted>  
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c19_From1Jan2017To30Sep2017" decimals="2">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>   
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c16_From1Jul2018To30Sep2018" decimals="INF">368188089</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>    
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c17_From1Jul2017To30Sep2017" decimals="INF">337417859</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>    
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">362461973</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>    
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c19_From1Jan2017To30Sep2017" decimals="INF">298041880</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>    
  <us-gaap:SharesOutstanding unitRef="shares" contextRef="c20_AsOf31Dec2017_CommonStockMember" decimals="INF">342113098</us-gaap:SharesOutstanding>   
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c20_AsOf31Dec2017_CommonStockMember" decimals="0">342113</us-gaap:StockholdersEquity>  
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c21_AsOf31Dec2017_AdditionalPaidInCapitalMember" decimals="0">120185821</us-gaap:StockholdersEquity>  
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c22_AsOf31Dec2017_RetainedEarningsMember" decimals="0">-127628251</us-gaap:StockholdersEquity> 
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="INF">8988508</us-gaap:StockIssuedDuringPeriodSharesOther>     
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">8988</us-gaap:StockIssuedDuringPeriodValueOther>     
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">397111</us-gaap:StockIssuedDuringPeriodValueOther>    
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueOther>  
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">406099</us-gaap:StockIssuedDuringPeriodValueOther>    
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="INF">7866274</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>    
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">7866</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>    
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">391665</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>   
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices> 
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">399531</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>   
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="-6">24986000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>  
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="-6">24986000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>  
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="INF">9350508</us-gaap:StockIssuedDuringPeriodSharesNewIssues>   
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">9351</us-gaap:StockIssuedDuringPeriodValueNewIssues>   
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">358349</us-gaap:StockIssuedDuringPeriodValueNewIssues>  
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>     
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">367700</us-gaap:StockIssuedDuringPeriodValueNewIssues>  
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>   
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">189909</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>     
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>   
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">189909</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>     
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>   
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">387783</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>     
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>   
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">387783</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>     
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c23_From1Jan2018To30Sep2018_CommonStockMember" decimals="0">0</us-gaap:NetIncomeLoss>  
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c24_From1Jan2018To30Sep2018_AdditionalPaidInCapitalMember" decimals="0">0</us-gaap:NetIncomeLoss>    
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c25_From1Jan2018To30Sep2018_RetainedEarningsMember" decimals="0">-1714630</us-gaap:NetIncomeLoss>    
  <us-gaap:SharesOutstanding unitRef="shares" contextRef="c26_AsOf30Sep2018_CommonStockMember" decimals="INF">368318388</us-gaap:SharesOutstanding>   
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c26_AsOf30Sep2018_CommonStockMember" decimals="0">368318</us-gaap:StockholdersEquity>  
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c27_AsOf30Sep2018_AdditionalPaidInCapitalMember" decimals="0">121935624</us-gaap:StockholdersEquity>  
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c28_AsOf30Sep2018_RetainedEarningsMember" decimals="0">-129342881</us-gaap:StockholdersEquity> 
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">155480</us-gaap:DepreciationDepletionAndAmortization>     
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">124984</us-gaap:DepreciationDepletionAndAmortization>     
  <us-gaap:ProvisionForDoubtfulAccounts unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">32546</us-gaap:ProvisionForDoubtfulAccounts>   
  <us-gaap:ProvisionForDoubtfulAccounts unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-1327</us-gaap:ProvisionForDoubtfulAccounts>   
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">164312</us-gaap:AmortizationOfDebtDiscountPremium>    
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">341306</us-gaap:AmortizationOfDebtDiscountPremium>    
  <us-gaap:CostsAndExpensesRelatedParty unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">800000</us-gaap:CostsAndExpensesRelatedParty>    
  <us-gaap:CostsAndExpensesRelatedParty unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">800000</us-gaap:CostsAndExpensesRelatedParty>    
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">812300</us-gaap:ShareBasedCompensation>  
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">562928</us-gaap:ShareBasedCompensation>  
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">22129</us-gaap:IncreaseDecreaseInReceivables>     
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">97639</us-gaap:IncreaseDecreaseInReceivables>     
  <us-gaap:IncreaseDecreaseInInventories unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">2284</us-gaap:IncreaseDecreaseInInventories>    
  <us-gaap:IncreaseDecreaseInInventories unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">16774</us-gaap:IncreaseDecreaseInInventories>     
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">35000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>     
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> 
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">332577</us-gaap:IncreaseDecreaseInAccountsPayable>    
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">519352</us-gaap:IncreaseDecreaseInAccountsPayable>    
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">242004</us-gaap:IncreaseDecreaseInAccruedLiabilities>     
  <us-gaap:IncreaseDecreaseInAccruedLiabilities unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">372360</us-gaap:IncreaseDecreaseInAccruedLiabilities>     
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">217038</us-gaap:IncreaseDecreaseInDeferredRevenue>    
  <us-gaap:IncreaseDecreaseInDeferredRevenue unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">157673</us-gaap:IncreaseDecreaseInDeferredRevenue>    
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">577245</us-gaap:NetCashProvidedByUsedInOperatingActivities>  
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">1026129</us-gaap:NetCashProvidedByUsedInOperatingActivities>   
  <us-gaap:PaymentsForProceedsFromInvestments unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-214200</us-gaap:PaymentsForProceedsFromInvestments>  
  <us-gaap:PaymentsForProceedsFromInvestments unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-190000</us-gaap:PaymentsForProceedsFromInvestments>  
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>    
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">400000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>    
  <us-gaap:ProceedsFromOtherDeposits unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:ProceedsFromOtherDeposits>   
  <us-gaap:ProceedsFromOtherDeposits unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">100000</us-gaap:ProceedsFromOtherDeposits>   
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>  
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">1162</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>     
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">214200</us-gaap:NetCashProvidedByUsedInInvestingActivities>  
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">688838</us-gaap:NetCashProvidedByUsedInInvestingActivities>  
  <us-gaap:ProceedsFromNotesPayable unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">126402</us-gaap:ProceedsFromNotesPayable> 
  <us-gaap:ProceedsFromNotesPayable unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">154785</us-gaap:ProceedsFromNotesPayable> 
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">367700</us-gaap:ProceedsFromIssuanceOfCommonStock>    
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>    
  <us-gaap:ProceedsFromRelatedPartyDebt unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">100000</us-gaap:ProceedsFromRelatedPartyDebt>    
  <us-gaap:ProceedsFromRelatedPartyDebt unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:ProceedsFromRelatedPartyDebt>    
  <us-gaap:ProceedsFromContributedCapital unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">103159</us-gaap:ProceedsFromContributedCapital>   
  <us-gaap:ProceedsFromContributedCapital unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:ProceedsFromContributedCapital>   
  <us-gaap:RepaymentsOfRelatedPartyDebt unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">542971</us-gaap:RepaymentsOfRelatedPartyDebt>    
  <us-gaap:RepaymentsOfRelatedPartyDebt unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">1083559</us-gaap:RepaymentsOfRelatedPartyDebt>     
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">484381</us-gaap:RepaymentsOfNotesPayable> 
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">350298</us-gaap:RepaymentsOfNotesPayable> 
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">-330091</us-gaap:NetCashProvidedByUsedInFinancingActivities>   
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">-1029072</us-gaap:NetCashProvidedByUsedInFinancingActivities>    
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">461354</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease> 
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">685895</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease> 
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c29_AsOf31Dec2016" decimals="0">270720</us-gaap:CashAndCashEquivalentsAtCarryingValue>  
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c30_AsOf30Sep2017" decimals="0">956615</us-gaap:CashAndCashEquivalentsAtCarryingValue>  
  <us-gaap:InterestPaidNet unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">808243</us-gaap:InterestPaidNet>   
  <us-gaap:InterestPaidNet unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">151228</us-gaap:InterestPaidNet>   
  <us-gaap:IncomeTaxesPaid unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:IncomeTaxesPaid>   
  <us-gaap:IncomeTaxesPaid unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:IncomeTaxesPaid>   
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c31_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfNotesPayableMember" decimals="0">0</us-gaap:StockIssued1>  
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c32_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfNotesPayableMember" decimals="0">111972</us-gaap:StockIssued1>  
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c33_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableMember" decimals="0">406099</us-gaap:StockIssued1>     
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c34_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfAccountsPayableMember" decimals="0">692431</us-gaap:StockIssued1>     
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c35_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember" decimals="0">0</us-gaap:StockIssued1>     
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c36_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfRelatedPartyNotesAndAdvancesPayableMember" decimals="0">58601</us-gaap:StockIssued1>    
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c37_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfGuarantorFeesMember" decimals="0">0</us-gaap:StockIssued1>   
  <us-gaap:StockIssued1 unitRef="usd" contextRef="c38_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfGuarantorFeesMember" decimals="0">316800</us-gaap:StockIssued1>   
  <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges unitRef="usd" contextRef="c39_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfLegalFeesMember" decimals="0">0</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>   
  <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges unitRef="usd" contextRef="c40_From1Jan2017To30Sep2017_CommonStockIssuedInSettlementOfLegalFeesMember" decimals="0">619825</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>   
  <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity> 
  <us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">185505</us-gaap:EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity> 
  <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1 unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">86750</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1>   
  <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1 unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1>    
  <dei:EntityRegistrantName contextRef="c18_From1Jan2018To30Sep2018">U.S. STEM CELL, INC.</dei:EntityRegistrantName>  
  <dei:DocumentType contextRef="c18_From1Jan2018To30Sep2018">10-Q</dei:DocumentType>     
  <dei:CurrentFiscalYearEndDate contextRef="c18_From1Jan2018To30Sep2018">--12-31</dei:CurrentFiscalYearEndDate>  
  <dei:EntitySmallBusiness contextRef="c18_From1Jan2018To30Sep2018">true</dei:EntitySmallBusiness>    
  <dei:EntityEmergingGrowthCompany contextRef="c18_From1Jan2018To30Sep2018">false</dei:EntityEmergingGrowthCompany> 
  <dei:EntityExTransitionPeriod contextRef="c18_From1Jan2018To30Sep2018">false</dei:EntityExTransitionPeriod>     
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c41_AsOf7Nov2018" decimals="INF">374576977</dei:EntityCommonStockSharesOutstanding>     
  <dei:AmendmentFlag contextRef="c18_From1Jan2018To30Sep2018">false</dei:AmendmentFlag>   
  <dei:EntityCentralIndexKey contextRef="c18_From1Jan2018To30Sep2018">0001388319</dei:EntityCentralIndexKey>    
  <dei:EntityCurrentReportingStatus contextRef="c18_From1Jan2018To30Sep2018">Yes</dei:EntityCurrentReportingStatus> 
  <dei:EntityFilerCategory contextRef="c18_From1Jan2018To30Sep2018">Non-accelerated Filer</dei:EntityFilerCategory> 
  <dei:DocumentFiscalYearFocus contextRef="c18_From1Jan2018To30Sep2018">2018</dei:DocumentFiscalYearFocus>  
  <dei:DocumentFiscalPeriodFocus contextRef="c18_From1Jan2018To30Sep2018">Q3</dei:DocumentFiscalPeriodFocus>    
  <dei:DocumentPeriodEndDate contextRef="c18_From1Jan2018To30Sep2018">2018-09-30</dei:DocumentPeriodEndDate>    
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;NOTE 1 &amp;#x2014; SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;A summary of the significant accounting policies applied in the presentation of the accompanying unaudited condensed financial statements follows:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;General&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The accompanying unaudited condensed financial statements of U.S. Stem Cell, Inc. (the &amp;#x201c;Company&amp;#x201d;) have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the &amp;#x201c;SEC&amp;#x201d;) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results from operations for the three and nine month periods ended September 30, 2018 are not necessarily indicative of the results that may be expected for the year ended December 31, 2018. The unaudited condensed financial statements should be read in conjunction with the December 31, 2017 audited financial statements and notes thereto included in the Company&amp;#x2019;s Annual Report on Form 10-K.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Basis and business presentation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;U.S. Stem Cell, Inc. was incorporated under the laws of the State of Florida in August, 1999. The Company is in the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The primary business includes the development of proprietary cell therapy products as well as revenue generating physician and patient based regenerative medicine/cell therapy training services, revenues realized from an Asset Sale and Lease Agreement related to the segment of the Company business involving collecting, growing and banking cell cultures and treatment kits for humans and animals, and the operation of a cell therapy clinic. To date, the Company has not generated significant sales revenues in that they remain less than their total operating expenses, has incurred expenses, and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a research and development business enterprise.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Effective January 1, 2018, the Company recognizes revenue in accordance with Accounting Standards Codification 2014-09,&amp;#xa0;Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific revenue recognition guidance throughout the Industry Topics of the Accounting Standards Codification. The updated guidance states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also provides for additional disclosures with respect to revenues and cash flows arising from contracts with customers.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At the time of each transaction, management assesses whether the fee associated with the transaction is fixed or determinable and whether or not collection is reasonably assured. The assessment of whether the fee is fixed or determinable is based upon the payment terms of the transaction. Collectability is assessed based on a number of factors, including past transaction history with the client and the creditworthiness of the client.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s primary sources of revenue are from the sale of test kits and equipment, training services, patient treatments, laboratory services and cell banking.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Revenues for kits and equipment sold are not recorded until kits and equipment are received by the customer. Revenues from in-person trainings are recognized when the training occurs and revenues from on demand online trainings are recognized when the customer purchases the rights to the training course. Any cash received as a deposit for trainings are recorded by the Company as a liability.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Patient treatments and laboratory services revenue are recognized when those services have been completed or satisfied.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Revenues for cell banking sales are accounted for as multiple performance obligations as described in ASC 606 and addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets. Because the Company sells its services separately, on more than a limited basis and at a price within a narrow range, the Company was able to allocate revenue based on stand-alone pricing. The multiple performance obligations include stem cell banking, dose retrieval and yearly storage fees. Revenues for stem cell banking and dose retrieval is recognized at the point of service and revenues for the yearly storage fees is recognized over the term of the banking contract, which is typically one year with annual renewals.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, the Company had deferred revenues of $496,580 and $279,542, respectively, which includes $69,250 and $71,500, respectively, to the Intellectual Property Licensing Agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Use of Estimates&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&amp;#x2019;s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Accounts Receivable&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Trade receivables are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis; thus trade receivables do not bear interest. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Allowance for Doubtful Accounts&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Any charges to the allowance for doubtful&amp;#xa0;accounts on accounts receivable are charged to operations in amounts sufficient to maintain the allowance for uncollectible accounts at a level management believes is adequate to cover any probable losses. Management determines the adequacy of the allowance based on historical write-off percentages and the current status of accounts receivable. Accounts receivable are charged off against the allowance when collectability is determined to be permanently impaired. As of September 30, 2018 and December 31, 2017, allowance for doubtful accounts was $1,147 and $12,298, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Inventories&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Inventories are stated at the lower of cost or market with cost being determined on a first-in, first-out (FIFO) basis. The Company writes down its inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. During the periods presented, there were no inventory write-downs.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Investments&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 323-10, Investments-Equity Methods and Joint Ventures (&amp;#x201c;ASC 323-10) which requires the accounting for investments where the Company can exert significant influence, but not control of a joint venture or equity investment. The Company accounted for its 33 percent member interest ownerships of U.S. Stem Cell Clinic, LLC and Regenerative Wellness Clinic, LLC respectively and its 49 percent member interest ownership of U.S. Stem Cell Clinic of the Villages utilizing the equity method of accounting (See Note 3).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Property and Equipment&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 15 years. Equipment under capital leases are recorded at the estimated present value of the minimum lease payments. Equipment under capital leases are amortized over the term of the lease, which is three years.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Based Compensation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Net Loss per Common Share, basic and diluted&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share (&amp;#x201c;ASC 260-10&amp;#x201d;). Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year.&amp;#xa0;&amp;#xa0;Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the &amp;#x201c;treasury stock&amp;#x201d; and/or &amp;#x201c;if converted&amp;#x201d; methods as applicable.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The computation of basic and diluted income (loss) per share as of September 30, 2018 and 2017 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1717&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1718&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1719&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1720&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1721&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1722&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options to purchase common stock&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1723&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1724&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1725&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;103,970,693&lt;/td&gt; 
			&lt;td id=&quot;new_id-1726&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1727&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1728&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1729&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,630,770&lt;/td&gt;     
			&lt;td id=&quot;new_id-1730&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Warrants to purchase common stock&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1731&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1732&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1733&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;1,118,019&lt;/td&gt;   
			&lt;td id=&quot;new_id-1734&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1735&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1736&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1737&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;135,996&lt;/td&gt; 
			&lt;td id=&quot;new_id-1738&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Totals&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1739&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1740&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1741&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;105,088,712&lt;/td&gt;    
			&lt;td id=&quot;new_id-1742&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1743&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1744&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1745&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,766,766&lt;/td&gt;   
			&lt;td id=&quot;new_id-1746&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Concentrations of Credit Risk&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Generally, the Company&amp;#x2019;s cash and cash equivalents in interest-bearing accounts does not exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018, three customers represented 35%, 25% and 11%, respectively, representing an aggregate of 71% of the Company&amp;#x2019;s accounts receivable. As of December 31, 2017, three customers represented 27%, 15% and 13% respectively, representing an aggregate of 55% of the Company&amp;#x2019;s accounts receivable.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;For the three months ended September 30, 2018, the Company&amp;#x2019;s revenues earned from sale of products and services were $1,503,884, of which two customers represented 12% and 10%, respectively, one of which is a related party (US Stem Cell Clinic LLC, a partly owned investment in which the Company holds a 33% interest) represented 12% of Company&amp;#x2019;s revenue.&amp;#xa0;&amp;#xa0;For the three months ended September 30, 2017, the Company&amp;#x2019;s revenues earned from the sale of products and services were $1,506,518, of which one customer represented 10%, of which is a related party (US Stem Cell Clinic LLC).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;For the nine months ended September 30, 2018, the Company&amp;#x2019;s revenues earned from sale of products and services were $5,037,242, of which two customers represented 11% and 8% respectively, of Company&amp;#x2019;s revenue, one of which is a related party (US Stem Cell Clinic LLC, a partly owned investment in which the Company holds a 33% interest) represented 11%.&amp;#xa0;&amp;#xa0;&amp;#xa0;For the nine months ended September 30, 2017, the Company&amp;#x2019;s revenues earned from the sale of products and services were $4,047,415, of which two customers represented 11% and 10% respectively, of Company&amp;#x2019;s revenue, one of which is a related party (US Stem Cell Clinic LLC), represented 11% of the Company&amp;#x2019;s revenues.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Research and Development&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (&amp;#x201c;ASC 730-10&amp;#x201d;). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $599 and $4,527 for the three and nine months ended September 30, 2018, respectively; and $3,753 and $12,242 for the three and nine months ended September 30, 2017, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#x201c;ASC 825-10&amp;#x201d;) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&amp;#x201c;ASC 820-10&amp;#x201d;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#x201c;ASC 825-10&amp;#x201d;), which permits entities to choose to measure many financial instruments and certain other items at fair value.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Long Term Deposits&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Long term deposits are comprised of the following:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into a customer purchase agreement with General American Capital Partners (GACP), whereby the Company agreed to sell, for $50,000, the first 5,000 customers of the cell banking business after the effective date of the equipment sale/leaseback agreement with rights to purchase additional customers at a price of $20 per customer.&amp;#xa0; There is no reduction in the selling price should the new customers be fewer than 5,000.&amp;#xa0; The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction (See Notes 4 and 6).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into an asset purchase agreement of intellectual property with GACP whereby the Company agreed to sell all of the Company&amp;#x2019;s worldwide rights, title or interest in certain intellectual and other property (as defined) associated with the cell banking business for $50,000. The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction (See Notes 4, 6, and 7).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Income Taxes&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes (&amp;#x201c;ASC 740-10&amp;#x201d;) for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate.&amp;#xa0;&amp;#xa0;Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In May 2014, the Financial Accounting Standards Board (the &amp;#x201c;FASB&amp;#x201d;) issued Accounting Standards Update (&amp;#x201c;ASU&amp;#x201d;) 2014-09 &amp;#x201c;Revenue from Contracts with Customers&amp;#x201d; to supersede previous revenue recognition guidance under current U.S. GAAP. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. The Company adopted ASU 2014-09 using the modified retrospective transition method in the first quarter of 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In February 2016, the FASB issued ASU 2016-02&amp;#x2014;Leases (Topic 842), requiring lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases except for short-term leases. For lessees, leases will continue to be classified as either operating or finance leases in the income statement. The effective date of the new standard for public companies is for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented. The Company is evaluating the effect that the updated standard will have on its financial statements and related disclosures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In August 2016, the FASB issued ASU 2016-15&amp;#x2014;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for eight specific cash flow issues with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice.&amp;#xa0;The effective date for ASU 2016-15 is for annual periods beginning after December 15, 2017 and interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2016-15 in the first quarter of 2018 and such adoption did not have a material impact on the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles &amp;#x2013; Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company adopted ASU 2017-01 in the first quarter of 2018 and such adoption did not have a material impact on the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#x2019;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value because of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt&amp;#x2014;Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The Company is currently reviewing the impact of adoption of ASU 2017-11 on its financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company&amp;#x2019;s financial position, results of operations or cash flows.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Subsequent Events&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued.&amp;#xa0; Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>  
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Basis and business presentation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;U.S. Stem Cell, Inc. was incorporated under the laws of the State of Florida in August, 1999. The Company is in the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The primary business includes the development of proprietary cell therapy products as well as revenue generating physician and patient based regenerative medicine/cell therapy training services, revenues realized from an Asset Sale and Lease Agreement related to the segment of the Company business involving collecting, growing and banking cell cultures and treatment kits for humans and animals, and the operation of a cell therapy clinic. To date, the Company has not generated significant sales revenues in that they remain less than their total operating expenses, has incurred expenses, and has sustained losses. Consequently, its operations are subject to all the risks inherent in the establishment of a research and development business enterprise.&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>     
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Revenue Recognition&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Effective January 1, 2018, the Company recognizes revenue in accordance with Accounting Standards Codification 2014-09,&amp;#xa0;Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific revenue recognition guidance throughout the Industry Topics of the Accounting Standards Codification. The updated guidance states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also provides for additional disclosures with respect to revenues and cash flows arising from contracts with customers.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At the time of each transaction, management assesses whether the fee associated with the transaction is fixed or determinable and whether or not collection is reasonably assured. The assessment of whether the fee is fixed or determinable is based upon the payment terms of the transaction. Collectability is assessed based on a number of factors, including past transaction history with the client and the creditworthiness of the client.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s primary sources of revenue are from the sale of test kits and equipment, training services, patient treatments, laboratory services and cell banking.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Revenues for kits and equipment sold are not recorded until kits and equipment are received by the customer. Revenues from in-person trainings are recognized when the training occurs and revenues from on demand online trainings are recognized when the customer purchases the rights to the training course. Any cash received as a deposit for trainings are recorded by the Company as a liability.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Patient treatments and laboratory services revenue are recognized when those services have been completed or satisfied.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Revenues for cell banking sales are accounted for as multiple performance obligations as described in ASC 606 and addresses accounting for arrangements that may involve the delivery or performance of multiple products, services and/or rights to use assets. Because the Company sells its services separately, on more than a limited basis and at a price within a narrow range, the Company was able to allocate revenue based on stand-alone pricing. The multiple performance obligations include stem cell banking, dose retrieval and yearly storage fees. Revenues for stem cell banking and dose retrieval is recognized at the point of service and revenues for the yearly storage fees is recognized over the term of the banking contract, which is typically one year with annual renewals.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, the Company had deferred revenues of $496,580 and $279,542, respectively, which includes $69,250 and $71,500, respectively, to the Intellectual Property Licensing Agreement.&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>    
  <us-gaap:DeferredRevenue unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">496580</us-gaap:DeferredRevenue>  
  <us-gaap:DeferredRevenue unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">279542</us-gaap:DeferredRevenue>  
  <us-gaap:DeferredRevenue unitRef="usd" contextRef="c42_AsOf30Sep2018_RoyaltyArrangementMember" decimals="0">69250</us-gaap:DeferredRevenue>  
  <us-gaap:DeferredRevenue unitRef="usd" contextRef="c43_AsOf31Dec2017_RoyaltyArrangementMember" decimals="0">71500</us-gaap:DeferredRevenue>  
  <us-gaap:UseOfEstimates contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Use of Estimates&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company&amp;#x2019;s stock, stock-based compensation, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates> 
  <us-gaap:ReceivablesPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Accounts Receivable&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Trade receivables are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis; thus trade receivables do not bear interest. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition.&lt;/p&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>     
  <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Allowance for Doubtful Accounts&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Any charges to the allowance for doubtful&amp;#xa0;accounts on accounts receivable are charged to operations in amounts sufficient to maintain the allowance for uncollectible accounts at a level management believes is adequate to cover any probable losses. Management determines the adequacy of the allowance based on historical write-off percentages and the current status of accounts receivable. Accounts receivable are charged off against the allowance when collectability is determined to be permanently impaired. As of September 30, 2018 and December 31, 2017, allowance for doubtful accounts was $1,147 and $12,298, respectively.&lt;/p&gt;&lt;/div&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>     
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1147</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>     
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">12298</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent> 
  <us-gaap:InventoryPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Inventories&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Inventories are stated at the lower of cost or market with cost being determined on a first-in, first-out (FIFO) basis. The Company writes down its inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. During the periods presented, there were no inventory write-downs.&lt;/p&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>    
  <us-gaap:EquityMethodInvestmentsPolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Investments&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 323-10, Investments-Equity Methods and Joint Ventures (&amp;#x201c;ASC 323-10) which requires the accounting for investments where the Company can exert significant influence, but not control of a joint venture or equity investment. The Company accounted for its 33 percent member interest ownerships of U.S. Stem Cell Clinic, LLC and Regenerative Wellness Clinic, LLC respectively and its 49 percent member interest ownership of U.S. Stem Cell Clinic of the Villages utilizing the equity method of accounting (See Note 3).&lt;/p&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>    
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c44_AsOf30Sep2018_USStemCellClinicLLCMember" decimals="2">0.33</us-gaap:EquityMethodInvestmentOwnershipPercentage>     
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c45_AsOf30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="2">0.33</us-gaap:EquityMethodInvestmentOwnershipPercentage>     
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c46_AsOf30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="2">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>   
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;  
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Property and Equipment&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 15 years. Equipment under capital leases are recorded at the estimated present value of the minimum lease payments. Equipment under capital leases are amortized over the term of the lease, which is three years.&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>  
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c47_From1Jan2018To30Sep2018_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>  
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c48_From1Jan2018To30Sep2018_MaximumMember">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>   
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c49_From1Jan2018To30Sep2018_AssetsHeldUnderCapitalLeasesMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>   
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Stock Based Compensation&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>   
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uvRsJTXMeMewLyH9HKj6I6pbvcDxjLAL/YwjWBVzRmYufv9rxBO+flxzvADFbai79xrg/NdCZeVW/kNMDoz4/lAqfPb0HvyHg93pRRPlguf/Jp/y+OfpeVh3ZBdza2NzDPXXKjTNX0Pc34M3Zf568SFMPrOjxqBkpP6pkka//uJnQ/c3zB0X/2r9yuXmmsqiTuT1xtKs2O2Dr69oqa9nF] CSR-->  
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Net Loss per Common Share, basic and diluted&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company computes earnings (loss) per share under Accounting Standards Codification subtopic 260-10, Earnings Per Share (&amp;#x201c;ASC 260-10&amp;#x201d;). Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the year.&amp;#xa0;&amp;#xa0;Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the &amp;#x201c;treasury stock&amp;#x201d; and/or &amp;#x201c;if converted&amp;#x201d; methods as applicable.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The computation of basic and diluted income (loss) per share as of September 30, 2018 and 2017 excludes potentially dilutive securities when their inclusion would be anti-dilutive, or if their exercise prices were greater than the average market price of the common stock during the period.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1717&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1718&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1719&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1720&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1721&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1722&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options to purchase common stock&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1723&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1724&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1725&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;103,970,693&lt;/td&gt; 
			&lt;td id=&quot;new_id-1726&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1727&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1728&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1729&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,630,770&lt;/td&gt;     
			&lt;td id=&quot;new_id-1730&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Warrants to purchase common stock&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1731&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1732&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1733&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;1,118,019&lt;/td&gt;   
			&lt;td id=&quot;new_id-1734&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1735&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1736&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1737&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;135,996&lt;/td&gt; 
			&lt;td id=&quot;new_id-1738&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Totals&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1739&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1740&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1741&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;105,088,712&lt;/td&gt;    
			&lt;td id=&quot;new_id-1742&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1743&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1744&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1745&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,766,766&lt;/td&gt;   
			&lt;td id=&quot;new_id-1746&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>    
  <us-gaap:ConcentrationRiskCreditRisk contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Concentrations of Credit Risk&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Generally, the Company&amp;#x2019;s cash and cash equivalents in interest-bearing accounts does not exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018, three customers represented 35%, 25% and 11%, respectively, representing an aggregate of 71% of the Company&amp;#x2019;s accounts receivable. As of December 31, 2017, three customers represented 27%, 15% and 13% respectively, representing an aggregate of 55% of the Company&amp;#x2019;s accounts receivable.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;For the three months ended September 30, 2018, the Company&amp;#x2019;s revenues earned from sale of products and services were $1,503,884, of which two customers represented 12% and 10%, respectively, one of which is a related party (US Stem Cell Clinic LLC, a partly owned investment in which the Company holds a 33% interest) represented 12% of Company&amp;#x2019;s revenue.&amp;#xa0;&amp;#xa0;For the three months ended September 30, 2017, the Company&amp;#x2019;s revenues earned from the sale of products and services were $1,506,518, of which one customer represented 10%, of which is a related party (US Stem Cell Clinic LLC).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;For the nine months ended September 30, 2018, the Company&amp;#x2019;s revenues earned from sale of products and services were $5,037,242, of which two customers represented 11% and 8% respectively, of Company&amp;#x2019;s revenue, one of which is a related party (US Stem Cell Clinic LLC, a partly owned investment in which the Company holds a 33% interest) represented 11%.&amp;#xa0;&amp;#xa0;&amp;#xa0;For the nine months ended September 30, 2017, the Company&amp;#x2019;s revenues earned from the sale of products and services were $4,047,415, of which two customers represented 11% and 10% respectively, of Company&amp;#x2019;s revenue, one of which is a related party (US Stem Cell Clinic LLC), represented 11% of the Company&amp;#x2019;s revenues.&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>   
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c50_From1Jan2018To30Sep2018_CustomerOneMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.35</us-gaap:ConcentrationRiskPercentage1> 
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c51_From1Jan2018To30Sep2018_CustomerTwoMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.25</us-gaap:ConcentrationRiskPercentage1> 
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c52_From1Jan2018To30Sep2018_CustomerThreeMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>   
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c53_From1Jan2018To30Sep2018_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.71</us-gaap:ConcentrationRiskPercentage1>   
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c54_From1Jan2017To31Dec2017_CustomerOneMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1> 
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c55_From1Jan2017To31Dec2017_CustomerTwoMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.15</us-gaap:ConcentrationRiskPercentage1> 
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c56_From1Jan2017To31Dec2017_CustomerThreeMember_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.13</us-gaap:ConcentrationRiskPercentage1>   
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c57_From1Jan2017To31Dec2017_AccountsReceivableMember_CreditConcentrationRiskMember" decimals="2">0.55</us-gaap:ConcentrationRiskPercentage1>   
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c58_From1Jul2018To30Sep2018_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.12</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c59_From1Jul2018To30Sep2018_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c60_From1Jul2018To30Sep2018_CustomerThreeMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.12</us-gaap:ConcentrationRiskPercentage1>  
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c61_From1Jul2017To30Sep2017_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c62_From1Jan2018To30Sep2018_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c63_From1Jan2018To30Sep2018_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.08</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c64_From1Jan2017To30Sep2017_CustomerTwoMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c65_From1Jan2017To30Sep2017_CustomerOneMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>     
  <us-gaap:ConcentrationRiskPercentage1 unitRef="pure" contextRef="c66_From1Jan2017To30Sep2017_CustomerThreeMember_SalesRevenueGoodsNetMember_CustomerConcentrationRiskMember" decimals="2">0.11</us-gaap:ConcentrationRiskPercentage1>  
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;  
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Research and Development&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (&amp;#x201c;ASC 730-10&amp;#x201d;). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved as defined under the applicable agreement. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $599 and $4,527 for the three and nine months ended September 30, 2018, respectively; and $3,753 and $12,242 for the three and nine months ended September 30, 2017, respectively.&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>     
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#x201c;ASC 825-10&amp;#x201d;) requires disclosure of the fair value of certain financial instruments. The carrying value of cash and cash equivalents, accounts payable and accrued liabilities, and short-term borrowings, as reflected in the balance sheets, approximate fair value because of the short-term maturity of these instruments. All other significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practicable the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 820-10, Fair Value Measurements and Disclosures (&amp;#x201c;ASC 820-10&amp;#x201d;) and Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#x201c;ASC 825-10&amp;#x201d;), which permits entities to choose to measure many financial instruments and certain other items at fair value.&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>    
  <us-gaap:DepositContractsPolicy contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Long Term Deposits&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Long term deposits are comprised of the following:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into a customer purchase agreement with General American Capital Partners (GACP), whereby the Company agreed to sell, for $50,000, the first 5,000 customers of the cell banking business after the effective date of the equipment sale/leaseback agreement with rights to purchase additional customers at a price of $20 per customer.&amp;#xa0; There is no reduction in the selling price should the new customers be fewer than 5,000.&amp;#xa0; The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction (See Notes 4 and 6).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into an asset purchase agreement of intellectual property with GACP whereby the Company agreed to sell all of the Company&amp;#x2019;s worldwide rights, title or interest in certain intellectual and other property (as defined) associated with the cell banking business for $50,000. The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction (See Notes 4, 6, and 7).&lt;/p&gt;&lt;/div&gt;</us-gaap:DepositContractsPolicy>   
  <us-gaap:ProceedsFromSaleOfMachineryAndEquipment unitRef="usd" contextRef="c67_From3Mar2017To3Mar2017" decimals="0">50000</us-gaap:ProceedsFromSaleOfMachineryAndEquipment>    
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Income Taxes&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company follows Accounting Standards Codification subtopic 740-10, Income Taxes (&amp;#x201c;ASC 740-10&amp;#x201d;) for recording the provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expenses or benefits are based on the changes in the asset or liability during each period. If available evidence suggests that it is more likely than not that some portion or all of the deferred tax assets will not be realized, a valuation allowance is required to reduce the deferred tax assets to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income taxes in the period of change. Deferred income taxes may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate.&amp;#xa0;&amp;#xa0;Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse and are considered immaterial.&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>   
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In May 2014, the Financial Accounting Standards Board (the &amp;#x201c;FASB&amp;#x201d;) issued Accounting Standards Update (&amp;#x201c;ASU&amp;#x201d;) 2014-09 &amp;#x201c;Revenue from Contracts with Customers&amp;#x201d; to supersede previous revenue recognition guidance under current U.S. GAAP. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. The Company adopted ASU 2014-09 using the modified retrospective transition method in the first quarter of 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In February 2016, the FASB issued ASU 2016-02&amp;#x2014;Leases (Topic 842), requiring lessees to recognize a right-of-use asset and a lease liability on the balance sheet for all leases except for short-term leases. For lessees, leases will continue to be classified as either operating or finance leases in the income statement. The effective date of the new standard for public companies is for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Early adoption is permitted. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented. The Company is evaluating the effect that the updated standard will have on its financial statements and related disclosures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In August 2016, the FASB issued ASU 2016-15&amp;#x2014;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 provides guidance for eight specific cash flow issues with respect to how cash receipts and cash payments are classified in the statements of cash flows, with the objective of reducing diversity in practice.&amp;#xa0;The effective date for ASU 2016-15 is for annual periods beginning after December 15, 2017 and interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2016-15 in the first quarter of 2018 and such adoption did not have a material impact on the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles &amp;#x2013; Goodwill and Other (Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on our financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company adopted ASU 2017-01 in the first quarter of 2018 and such adoption did not have a material impact on the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#x2019;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value because of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt&amp;#x2014;Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The Company is currently reviewing the impact of adoption of ASU 2017-11 on its financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company&amp;#x2019;s financial position, results of operations or cash flows.&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>  
  <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Subsequent Events&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued.&amp;#xa0; Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, except as disclosed.&lt;/p&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock> 
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;    
Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1717&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1718&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1719&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1720&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1721&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1722&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options to purchase common stock&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1723&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1724&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1725&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;103,970,693&lt;/td&gt; 
			&lt;td id=&quot;new_id-1726&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1727&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1728&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1729&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,630,770&lt;/td&gt;     
			&lt;td id=&quot;new_id-1730&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Warrants to purchase common stock&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1731&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1732&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1733&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;1,118,019&lt;/td&gt;   
			&lt;td id=&quot;new_id-1734&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1735&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-1736&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1737&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;135,996&lt;/td&gt; 
			&lt;td id=&quot;new_id-1738&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Totals&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1739&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1740&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1741&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;105,088,712&lt;/td&gt;    
			&lt;td id=&quot;new_id-1742&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1743&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1744&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1745&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,766,766&lt;/td&gt;   
			&lt;td id=&quot;new_id-1746&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>     
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c68_From1Jan2018To30Sep2018_EmployeeStockOptionMember" decimals="INF">103970693</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>     
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c69_From1Jan2017To30Sep2017_EmployeeStockOptionMember" decimals="INF">71630770</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>    
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c70_From1Jan2018To30Sep2018_WarrantMember" decimals="INF">1118019</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> 
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c71_From1Jan2017To30Sep2017_WarrantMember" decimals="INF">135996</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>     
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">105088712</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>    
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c19_From1Jan2017To30Sep2017" decimals="INF">71766766</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>   
  <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 2 &amp;#x2013; GOING CONCERN AND MANAGEMENT&amp;#x2019;S LIQUIDITY PLANS&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements during nine months ended September 30, 2018, the Company incurred net losses of $1,714,630 and has a working capital deficit (current liabilities in excess of current assets) of $4,619,677. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s primary source of operating funds in 2017 and 2018 has been from revenue generated from sales and cash proceeds from the sale of common stock and the issuance of convertible and other debt. The Company has experienced net losses and negative cash flows from operations since inception, but expects these conditions to improve in 2018 and beyond as it develops its business model. The Company has stockholders&amp;#x2019; deficiencies at September 30, 2018 and requires additional financing to fund future operations.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company&amp;#x2019;s existence is dependent upon management&amp;#x2019;s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company&amp;#x2019;s financing efforts or revenues realized from the Asset Sale and Lease Agreement will result in profitable operations or the resolution of the Company&amp;#x2019;s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>   
  <usrm:WorkingCapitalDeficit unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">-4619677</usrm:WorkingCapitalDeficit>     
  <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;    
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 3 &amp;#x2014; INVESTMENTS&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;U.S. Stem Cell Clinic, LLC&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The investment in U.S. Stem Cell Clinic, LLC is comprised of a 33% member interest ownership and is accounted for using the equity method of accounting. The Company&amp;#x2019;s 33% income earned by U.S. Stem Cell Clinic, LLC member interests was $82,950 and $171,740 for the three and nine months ended September 30, 2018, respectively; and $39,400 and $178,409 for the three and nine months ended September 30, 2017, respectively (inception to date income of $546,952) which was recorded as other income/expense in the Company&amp;#x2019;s Statement of Operations in the appropriate periods.&amp;#xa0; In addition, during the nine months ended September 30, 2018 and 2017, the Company received distributions totaling $154,000 and $190,000 from U.S. Stem Cell Clinic, LLC, respectively (inception to date of $554,000).&amp;#xa0; The carrying value of the investment at September 30, 2018 and December 31, 2017 is $52,666 and $34,926, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, accounts receivable for sales of product and services to U.S. Stem Cell Clinic, LLC was $30,975 and $8,449 respectively; revenues earned from sales to U.S. Stem Clinic, LLC for the three and nine months ended September 30, 2018 were $183,832 and $529,880, respectively; and for the three and nine months ended September 30, 2017 were $152,779 and $438,344, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;An affiliate of one of the Company&amp;#x2019;s officers is a minority investor in the U.S. Stem Cell Clinic, LLC.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Regenerative Wellness Clinic, LLC&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The investment in Regenerative Wellness Clinic, LLC is comprised of a 33% member interest ownership and is accounted for using the equity method of accounting. The Company has provided technical expertise, but no cash investment with Regenerative Wellness Clinic, LLC&amp;#x2019;s startup in 2017. The Company&amp;#x2019;s 33% loss incurred by Regenerative Wellness Clinic, LLC member interests was $(12,765) for year ended December 31, 2017. However the recorded other income/expense in the Company&amp;#x2019;s Statement of Operations was limited to $0.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The carrying value was $0 at December 31, 2017. For the three and nine months ended September 30, 2018, the Company&amp;#x2019;s 33% income earned by Regenerative Wellness Clinic, LLC member interests was $58,931 and $73,247 reported, after effects of 2017 loss, of $9,695. In addition, during the nine months ended September 30, 2018, the Company received distributions totaling $21,000 from Regenerative Wellness Clinic, LLC.&amp;#xa0;The carrying value of the investment at September 30, 2018 and December 31, 2017 is $52,247 and $0, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, accounts receivable for sales of products and services to Regenerative Wellness Clinic, LLC was $2,345 and $15,115, respectively; revenues earned from sales to Regenerative Wellness Clinic, LLC for the three and nine months ended September 30, 2018 was $64,945 and $149,469, respectively, and $0 for the three and nine months ended September 30, 2017.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;An affiliate of one of the Company&amp;#x2019;s officers is an investor in the Regenerative Wellness Clinic, LLC.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;U.S. Stem Cell of the Villages LLC&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On January 30, 2018, Greg Knutson, a director of the Company (&amp;#x201c;Knutson&amp;#x201d;) and the Company agreed to open and operate a regenerative medicine/cell therapy clinic providing cellular treatments for patients afflicted with neurological, autoimmune, orthopedic and degenerative diseases in Florida.&amp;#xa0; To that end,&amp;#xa0;U.S. Stem Cell Clinic of The Villages LLC (the &amp;#x201c;LLC&amp;#x201d;) was formed January 30, 2018.&amp;#xa0;Knutson provided the Company with the sum of Three Hundred Thousand Dollars ($300,000) (the &amp;#x201c;Investment&amp;#x201d;) to be utilized for the formation and initial operation of the LLC.&amp;#xa0; Currently, Knutson holds a 51% member interest in the LLC and the Company holds a 49% member interest. The Company will provide operating assistance as well as management services, the latter to be compensated at fee of five percent (5%) of the LLC net revenues.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018, upon completion of U.S. Stem Cell of the Villages LLC, the Company was credited with investment equity of $189,909 from Greg Knutson, the holder of the 51% member interest. The Company then recorded the investment equity as contributed capital by the Company. The Company&amp;#x2019;s 49% income (loss) incurred by U.S. Stem Cell of the Villages LLC member interests was $18,335 for three and nine months ended September 30, 2018. The carrying value was $65,884 at September 30, 2018.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;At September 30, 2018, accounts receivable for sales of products and services to U.S Stem Cell of the Villages LLC was $9,626; revenues earned from sales to U.S Stem Cell of the Villages LLC&amp;#xa0; for the three and nine months ended September 30, 2018 was $64,074 and $143,550, respectively.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>    
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c72_From1Jul2018To30Sep2018_USStemCellClinicLLCMember" decimals="0">82950</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c73_From1Jan2018To30Sep2018_USStemCellClinicLLCMember" decimals="0">171740</us-gaap:IncomeLossFromEquityMethodInvestments>   
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c74_From1Jul2017To30Sep2017_USStemCellClinicLLCMember" decimals="0">39400</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c75_From1Jan2017To30Sep2017_USStemCellClinicLLCMember" decimals="0">178409</us-gaap:IncomeLossFromEquityMethodInvestments>   
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c76_From1Aug1999To30Jun2018_USStemCellClinicLLCMember" decimals="0">546952</us-gaap:IncomeLossFromEquityMethodInvestments>   
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions unitRef="usd" contextRef="c73_From1Jan2018To30Sep2018_USStemCellClinicLLCMember" decimals="0">154000</us-gaap:EquityMethodInvestmentDividendsOrDistributions> 
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions unitRef="usd" contextRef="c75_From1Jan2017To30Sep2017_USStemCellClinicLLCMember" decimals="0">190000</us-gaap:EquityMethodInvestmentDividendsOrDistributions> 
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions unitRef="usd" contextRef="c77_From1Aug1999To30Sep2018_USStemCellClinicLLCMember" decimals="0">554000</us-gaap:EquityMethodInvestmentDividendsOrDistributions> 
  <us-gaap:Investments unitRef="usd" contextRef="c44_AsOf30Sep2018_USStemCellClinicLLCMember" decimals="0">52666</us-gaap:Investments>     
  <us-gaap:Investments unitRef="usd" contextRef="c78_AsOf31Dec2017_USStemCellClinicLLCMember" decimals="0">34926</us-gaap:Investments>     
  <us-gaap:AccountsReceivableNet unitRef="usd" contextRef="c44_AsOf30Sep2018_USStemCellClinicLLCMember" decimals="0">30975</us-gaap:AccountsReceivableNet>     
  <us-gaap:AccountsReceivableNet unitRef="usd" contextRef="c78_AsOf31Dec2017_USStemCellClinicLLCMember" decimals="0">8449</us-gaap:AccountsReceivableNet>    
  <us-gaap:Revenues unitRef="usd" contextRef="c72_From1Jul2018To30Sep2018_USStemCellClinicLLCMember" decimals="0">183832</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c73_From1Jan2018To30Sep2018_USStemCellClinicLLCMember" decimals="0">529880</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c74_From1Jul2017To30Sep2017_USStemCellClinicLLCMember" decimals="0">152779</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c75_From1Jan2017To30Sep2017_USStemCellClinicLLCMember" decimals="0">438344</us-gaap:Revenues>     
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c79_From1Jan2017To31Dec2017_RegenerativeWellnessClinicLLCMember" decimals="0">-12765</us-gaap:IncomeLossFromEquityMethodInvestments>   
  <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss unitRef="usd" contextRef="c79_From1Jan2017To31Dec2017_RegenerativeWellnessClinicLLCMember" decimals="0">0</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss>    
  <us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss unitRef="usd" contextRef="c80_From1Jan2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">0</us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss>  
  <us-gaap:EquityMethodInvestments unitRef="usd" contextRef="c81_AsOf31Dec2017_RegenerativeWellnessClinicLLCMember" decimals="0">0</us-gaap:EquityMethodInvestments>     
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c82_From1Jul2018To30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">58931</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c83_From1Jan2018To30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">73247</us-gaap:IncomeLossFromEquityMethodInvestments>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c84_From1Jan2017To31Dec2017_RegenerativeWellnessClinicLLCMember_OtherIncomeMember" decimals="0">-9695</us-gaap:IncomeLossFromEquityMethodInvestments>     
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions unitRef="usd" contextRef="c83_From1Jan2018To30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">21000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>     
  <us-gaap:EquityMethodInvestments unitRef="usd" contextRef="c45_AsOf30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">52247</us-gaap:EquityMethodInvestments>    
  <us-gaap:AccountsReceivableGross unitRef="usd" contextRef="c45_AsOf30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">2345</us-gaap:AccountsReceivableGross>   
  <us-gaap:AccountsReceivableGross unitRef="usd" contextRef="c81_AsOf31Dec2017_RegenerativeWellnessClinicLLCMember" decimals="0">15115</us-gaap:AccountsReceivableGross>    
  <us-gaap:Revenues unitRef="usd" contextRef="c82_From1Jul2018To30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">64945</us-gaap:Revenues>    
  <us-gaap:Revenues unitRef="usd" contextRef="c83_From1Jan2018To30Sep2018_RegenerativeWellnessClinicLLCMember" decimals="0">149469</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c85_From1Jul2017To30Sep2017_RegenerativeWellnessClinicLLCMember" decimals="0">0</us-gaap:Revenues>     
  <us-gaap:Revenues unitRef="usd" contextRef="c86_From1Jan2017To30Sep2017_RegenerativeWellnessClinicLLCMember" decimals="0">9</us-gaap:Revenues>     
  <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="c87_From30Jan2018To30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember">To that end,&amp;#xa0;U.S. Stem Cell Clinic of The Villages LLC (the &amp;#x201c;LLC&amp;#x201d;) was formed January 30, 2018.&amp;#xa0;Knutson provided the Company with the sum of Three Hundred Thousand Dollars ($300,000) (the &amp;#x201c;Investment&amp;#x201d;) to be utilized for the formation and initial operation of the LLC.&amp;#xa0; Currently, Knutson holds a 51% member interest in the LLC and the Company holds a 49% member interest. The Company will provide operating assistance as well as management services, the latter to be compensated at fee of five percent (5%) of the LLC net revenues</us-gaap:RelatedPartyTransactionDescriptionOfTransaction> 
  <us-gaap:RelatedPartyTransactionAmountsOfTransaction unitRef="usd" contextRef="c88_From30Jan2018To30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember_UtilizedForFromationOfLLCMember" decimals="0">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction> 
  <usrm:OwnershipPercentageByKnutson unitRef="pure" contextRef="c87_From30Jan2018To30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="2">0.51</usrm:OwnershipPercentageByKnutson>  
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c89_AsOf30Jan2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="2">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>   
  <us-gaap:ProceedsFromContributedCapital unitRef="usd" contextRef="c80_From1Jan2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">189909</us-gaap:ProceedsFromContributedCapital>  
  <us-gaap:IncomeLossFromEquityMethodInvestments unitRef="usd" contextRef="c80_From1Jan2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">18335</us-gaap:IncomeLossFromEquityMethodInvestments>     
  <us-gaap:EquityMethodInvestments unitRef="usd" contextRef="c46_AsOf30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">65884</us-gaap:EquityMethodInvestments>  
  <us-gaap:AccountsReceivableGross unitRef="usd" contextRef="c46_AsOf30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">9626</us-gaap:AccountsReceivableGross> 
  <us-gaap:Revenues unitRef="usd" contextRef="c90_From1Jul2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">64074</us-gaap:Revenues>  
  <us-gaap:Revenues unitRef="usd" contextRef="c80_From1Jan2018To30Sep2018_USStemCellClinicOfTheVillageLLCtheLLCMember" decimals="0">143550</us-gaap:Revenues>   
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 4 &amp;#x2014; PROPERTY AND EQUIPMENT&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Property and equipment are recorded on the basis of cost. For financial statement purposes, property, plant and equipment are depreciated using the straight-line method over their estimated useful lives.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment in accordance with the guidance for impairment of long lived assets.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Property and equipment as of September 30, 2018 and December 31, 2017 is summarized as follows:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1747&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1748&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1749&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1750&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1751&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1752&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Laboratory and medical equipment&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1753&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1754&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1755&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5,590&lt;/td&gt;     
			&lt;td id=&quot;new_id-1756&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1757&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1758&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1759&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5,590&lt;/td&gt;     
			&lt;td id=&quot;new_id-1760&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Furniture, fixtures and equipment&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1761&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1762&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1763&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;125,633&lt;/td&gt;  
			&lt;td id=&quot;new_id-1764&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1765&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1766&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1767&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;125,633&lt;/td&gt;  
			&lt;td id=&quot;new_id-1768&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Computer equipment&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1769&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1770&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1771&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;49,951&lt;/td&gt; 
			&lt;td id=&quot;new_id-1772&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1773&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1774&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1775&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;49,951&lt;/td&gt; 
			&lt;td id=&quot;new_id-1776&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Equipment under capital lease&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1777&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1778&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1779&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;624,602&lt;/td&gt;  
			&lt;td id=&quot;new_id-1780&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1781&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1782&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1783&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;624,602&lt;/td&gt;  
			&lt;td id=&quot;new_id-1784&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Leasehold improvements&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1785&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1786&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1787&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;362,046&lt;/td&gt; 
			&lt;td id=&quot;new_id-1788&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1789&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1790&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1791&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;362,046&lt;/td&gt; 
			&lt;td id=&quot;new_id-1792&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1793&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1794&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1795&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,167,822&lt;/td&gt;  
			&lt;td id=&quot;new_id-1796&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1797&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1798&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1799&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,167,822&lt;/td&gt;  
			&lt;td id=&quot;new_id-1800&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&amp;#xa0;Less accumulated depreciation and amortization&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1801&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1802&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1803&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(873,555&lt;/td&gt;  
			&lt;td id=&quot;new_id-1804&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1805&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1806&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1807&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(718,075&lt;/td&gt;  
			&lt;td id=&quot;new_id-1808&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1809&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1810&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1811&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;294,267&lt;/td&gt;  
			&lt;td id=&quot;new_id-1812&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1813&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1814&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1815&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;449,747&lt;/td&gt;  
			&lt;td id=&quot;new_id-1816&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into an asset sale and lease agreement (sale/leaseback transaction, the &amp;#x201c;Asset Sale and Lease Agreement&amp;#x201d;) with GACP, whereby the Company sold certain lab, medical and other equipment relating to the cell banking business for $400,000 and leased back the sold equipment over a three year term.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company determined that the transaction was a capitalized lease and accordingly recorded the leased assets and liability based on the estimated present value of the minimum lease payments.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Included in net property are assets under capital leases of $624,602, less accumulated depreciation of $327,130 as of September 30, 2018 and $624,602, less accumulated depreciation of $174,120 December 31, 2017, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In connection with the sale of the lab, medical and other equipment, the Company realized a gain on sale of equipment of $386,535.&amp;#xa0; The gain is recognized ratably over the term of the lease to operations. During the three and nine months ended September 30, 2018, the Company recognized $32,211 and $96,634; and $32,212 and $75,160 for the three and nine months ended September 30, 2017, as the gain on sale of equipment, respectively.&amp;#xa0; As of September 30, 2018 and December 31, 2017, deferred gain on sale of equipment was $182,531 and $279,165, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Property and equipment are recorded on the basis of cost. For financial statement purposes, property, plant and equipment are depreciated using the straight-line method over their estimated useful lives.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Depreciation expense was $51,652 and $155,480 of which $51,652 and $154,956 were included in cost of sales for the three and nine months ended September 30, 2018, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Depreciation expense was $52,882 and $124,984 of which $51,652 and $120,521 were included in cost of sales for the three and nine months ended September 30, 2017, respectively.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock> 
  <us-gaap:SaleLeasebackTransactionNetBookValue unitRef="usd" contextRef="c91_AsOf3Mar2017" decimals="0">400000</us-gaap:SaleLeasebackTransactionNetBookValue>    
  <us-gaap:SaleLeasebackTransactionLeaseTerms contextRef="c67_From3Mar2017To3Mar2017">leased back the sold equipment over a three year term</us-gaap:SaleLeasebackTransactionLeaseTerms>     
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c92_AsOf30Sep2018_AssetsHeldUnderCapitalLeasesMember" decimals="0">624602</us-gaap:CapitalLeasedAssetsGross> 
  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation unitRef="usd" contextRef="c92_AsOf30Sep2018_AssetsHeldUnderCapitalLeasesMember" decimals="0">327130</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>     
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c93_AsOf31Dec2017_AssetsHeldUnderCapitalLeasesMember" decimals="0">624602</us-gaap:CapitalLeasedAssetsGross> 
  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation unitRef="usd" contextRef="c93_AsOf31Dec2017_AssetsHeldUnderCapitalLeasesMember" decimals="0">174120</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>     
  <us-gaap:SaleLeasebackTransactionDeferredGainGross unitRef="usd" contextRef="c91_AsOf3Mar2017" decimals="0">386535</us-gaap:SaleLeasebackTransactionDeferredGainGross>    
  <us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">32211</us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized>    
  <us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">96634</us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized>    
  <us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">32212</us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized>    
  <us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">75160</us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized>    
  <us-gaap:SaleLeasebackTransactionDeferredGainNet unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">182531</us-gaap:SaleLeasebackTransactionDeferredGainNet>     
  <us-gaap:SaleLeasebackTransactionDeferredGainNet unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">279165</us-gaap:SaleLeasebackTransactionDeferredGainNet>     
  <us-gaap:Depreciation unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">51652</us-gaap:Depreciation> 
  <us-gaap:Depreciation unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">155480</us-gaap:Depreciation>  
  <us-gaap:CostOfGoodsAndServicesSoldDepreciation unitRef="usd" contextRef="c16_From1Jul2018To30Sep2018" decimals="0">51652</us-gaap:CostOfGoodsAndServicesSoldDepreciation>   
  <us-gaap:CostOfGoodsAndServicesSoldDepreciation unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">154956</us-gaap:CostOfGoodsAndServicesSoldDepreciation>    
  <us-gaap:Depreciation unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">52882</us-gaap:Depreciation> 
  <us-gaap:Depreciation unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">124984</us-gaap:Depreciation>  
  <us-gaap:CostOfGoodsAndServicesSoldDepreciation unitRef="usd" contextRef="c17_From1Jul2017To30Sep2017" decimals="0">51652</us-gaap:CostOfGoodsAndServicesSoldDepreciation>   
  <us-gaap:CostOfGoodsAndServicesSoldDepreciation unitRef="usd" contextRef="c19_From1Jan2017To30Sep2017" decimals="0">120521</us-gaap:CostOfGoodsAndServicesSoldDepreciation>    
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt; 
Property and equipment as of September 30, 2018 and December 31, 2017 is summarized as follows:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1747&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1748&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1749&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1750&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1751&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1752&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Laboratory and medical equipment&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1753&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1754&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1755&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5,590&lt;/td&gt;     
			&lt;td id=&quot;new_id-1756&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1757&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1758&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1759&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5,590&lt;/td&gt;     
			&lt;td id=&quot;new_id-1760&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Furniture, fixtures and equipment&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1761&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1762&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1763&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;125,633&lt;/td&gt;  
			&lt;td id=&quot;new_id-1764&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1765&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1766&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1767&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;125,633&lt;/td&gt;  
			&lt;td id=&quot;new_id-1768&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Computer equipment&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1769&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1770&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1771&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;49,951&lt;/td&gt; 
			&lt;td id=&quot;new_id-1772&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1773&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1774&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1775&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;49,951&lt;/td&gt; 
			&lt;td id=&quot;new_id-1776&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Equipment under capital lease&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1777&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1778&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1779&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;624,602&lt;/td&gt;  
			&lt;td id=&quot;new_id-1780&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1781&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1782&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1783&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;624,602&lt;/td&gt;  
			&lt;td id=&quot;new_id-1784&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Leasehold improvements&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1785&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1786&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1787&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;362,046&lt;/td&gt; 
			&lt;td id=&quot;new_id-1788&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1789&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1790&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1791&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;362,046&lt;/td&gt; 
			&lt;td id=&quot;new_id-1792&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1793&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1794&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1795&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,167,822&lt;/td&gt;  
			&lt;td id=&quot;new_id-1796&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1797&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1798&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1799&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,167,822&lt;/td&gt;  
			&lt;td id=&quot;new_id-1800&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&amp;#xa0;Less accumulated depreciation and amortization&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1801&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1802&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1803&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(873,555&lt;/td&gt;  
			&lt;td id=&quot;new_id-1804&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1805&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1806&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1807&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(718,075&lt;/td&gt;  
			&lt;td id=&quot;new_id-1808&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1809&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1810&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1811&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;294,267&lt;/td&gt;  
			&lt;td id=&quot;new_id-1812&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1813&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1814&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1815&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;449,747&lt;/td&gt;  
			&lt;td id=&quot;new_id-1816&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>  
  <us-gaap:MachineryAndEquipmentGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">5590</us-gaap:MachineryAndEquipmentGross>  
  <us-gaap:MachineryAndEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">5590</us-gaap:MachineryAndEquipmentGross>  
  <us-gaap:FurnitureAndFixturesGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">125633</us-gaap:FurnitureAndFixturesGross>  
  <us-gaap:FurnitureAndFixturesGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">125633</us-gaap:FurnitureAndFixturesGross>  
  <us-gaap:CapitalizedComputerSoftwareGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">49951</us-gaap:CapitalizedComputerSoftwareGross>     
  <us-gaap:CapitalizedComputerSoftwareGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">49951</us-gaap:CapitalizedComputerSoftwareGross>     
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">624602</us-gaap:CapitalLeasedAssetsGross>     
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">624602</us-gaap:CapitalLeasedAssetsGross>     
  <us-gaap:LeaseholdImprovementsGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">362046</us-gaap:LeaseholdImprovementsGross>    
  <us-gaap:LeaseholdImprovementsGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">362046</us-gaap:LeaseholdImprovementsGross>    
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1167822</us-gaap:PropertyPlantAndEquipmentGross>   
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1167822</us-gaap:PropertyPlantAndEquipmentGross>   
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">873555</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> 
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">718075</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> 
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;  
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 5 &amp;#x2014; ACCRUED EXPENSES&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Accrued expenses consisted of the following as of September 30, 2018 and December 31, 2017:&amp;#xa0;&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1817&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1818&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September &lt;/b&gt;&lt;b&gt;30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1819&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1820&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;6&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Interest and fees payable to the Guarantors of the Company&amp;#x2019;s loan agreement with Seaside Bank&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1821&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1822&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1823&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;313,579&lt;/td&gt;  
			&lt;td id=&quot;new_id-1824&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1825&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1826&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1827&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;248,746&lt;/td&gt;  
			&lt;td id=&quot;new_id-1828&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Interest payable on notes payable-related party (See Note 7)&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1829&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1830&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1831&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;478,774&lt;/td&gt;  
			&lt;td id=&quot;new_id-1832&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1833&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1834&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1835&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;381,667&lt;/td&gt;  
			&lt;td id=&quot;new_id-1836&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Vendor accruals and other&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1837&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1838&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1839&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;146,420&lt;/td&gt;  
			&lt;td id=&quot;new_id-1840&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1841&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1842&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1843&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;146,421&lt;/td&gt;  
			&lt;td id=&quot;new_id-1844&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Marketing obligation&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1845&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1846&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1847&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;193,700&lt;/td&gt;  
			&lt;td id=&quot;new_id-1848&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1849&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1850&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1851&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;141,560&lt;/td&gt;  
			&lt;td id=&quot;new_id-1852&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Employee commissions, compensation, etc.&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1853&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1854&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1855&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;38,650&lt;/td&gt;     
			&lt;td id=&quot;new_id-1856&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1857&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1858&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1859&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;10,725&lt;/td&gt;     
			&lt;td id=&quot;new_id-1860&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1861&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1862&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1863&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,171,123&lt;/td&gt;    
			&lt;td id=&quot;new_id-1864&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1865&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1866&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1867&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;929,119&lt;/td&gt;  
			&lt;td id=&quot;new_id-1868&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;During the nine months ended September 30, 2018, the Company issued an aggregate of 8,988,508 shares of its common stock in settlement of outstanding accounts payable and accrued expenses. In connection with the issuance, the Company incurred a $14,625 net loss in settlement of debt.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock> 
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c94_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAccruedExpensesAndAccruedInterestMember" decimals="INF">8988508</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>  
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c94_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAccruedExpensesAndAccruedInterestMember" decimals="0">-14625</us-gaap:GainsLossesOnExtinguishmentOfDebt>     
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;    
Accrued expenses consisted of the following as of September 30, 2018 and December 31, 2017:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;     
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1817&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1818&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September &lt;/b&gt;&lt;b&gt;30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1819&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1820&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;6&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Interest and fees payable to the Guarantors of the Company&amp;#x2019;s loan agreement with Seaside Bank&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1821&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1822&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1823&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;313,579&lt;/td&gt;  
			&lt;td id=&quot;new_id-1824&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1825&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1826&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1827&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;248,746&lt;/td&gt;  
			&lt;td id=&quot;new_id-1828&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Interest payable on notes payable-related party (See Note 7)&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1829&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1830&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1831&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;478,774&lt;/td&gt;  
			&lt;td id=&quot;new_id-1832&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1833&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1834&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1835&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;381,667&lt;/td&gt;  
			&lt;td id=&quot;new_id-1836&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Vendor accruals and other&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1837&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1838&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1839&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;146,420&lt;/td&gt;  
			&lt;td id=&quot;new_id-1840&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1841&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1842&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1843&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;146,421&lt;/td&gt;  
			&lt;td id=&quot;new_id-1844&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Marketing obligation&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1845&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1846&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1847&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;193,700&lt;/td&gt;  
			&lt;td id=&quot;new_id-1848&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1849&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1850&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1851&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;141,560&lt;/td&gt;  
			&lt;td id=&quot;new_id-1852&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Employee commissions, compensation, etc.&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1853&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1854&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1855&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;38,650&lt;/td&gt;     
			&lt;td id=&quot;new_id-1856&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1857&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1858&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1859&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;10,725&lt;/td&gt;     
			&lt;td id=&quot;new_id-1860&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1861&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1862&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1863&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,171,123&lt;/td&gt;    
			&lt;td id=&quot;new_id-1864&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1865&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1866&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1867&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;929,119&lt;/td&gt;  
			&lt;td id=&quot;new_id-1868&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>     
  <us-gaap:AccruedProfessionalFeesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">313579</us-gaap:AccruedProfessionalFeesCurrent>  
  <us-gaap:AccruedProfessionalFeesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">248746</us-gaap:AccruedProfessionalFeesCurrent>  
  <us-gaap:InterestPayableCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">478774</us-gaap:InterestPayableCurrent> 
  <us-gaap:InterestPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">381667</us-gaap:InterestPayableCurrent> 
  <us-gaap:DueToAffiliateCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">146420</us-gaap:DueToAffiliateCurrent>    
  <us-gaap:DueToAffiliateCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">146421</us-gaap:DueToAffiliateCurrent>    
  <us-gaap:AccruedMarketingCostsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">193700</us-gaap:AccruedMarketingCostsCurrent>   
  <us-gaap:AccruedMarketingCostsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">141560</us-gaap:AccruedMarketingCostsCurrent>   
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">38650</us-gaap:EmployeeRelatedLiabilitiesCurrent>  
  <us-gaap:EmployeeRelatedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">10725</us-gaap:EmployeeRelatedLiabilitiesCurrent>  
  <us-gaap:DebtDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 6 &amp;#x2014; NOTES AND CAPITAL LEASE PAYABLE&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Notes and capital lease payable were comprised of the following as of September 30, 2018 and December 31, 2017:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1869&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1870&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1871&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1872&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1873&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1874&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Seaside Bank note payable.&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1875&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1876&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1877&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;980,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1878&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1879&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1880&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1881&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;980,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1882&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Hunton &amp;amp; Williams note(s) payable&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1883&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1884&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1885&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;484,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1886&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1887&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1888&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1889&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;584,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1890&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Power Up Lending Group notes payable&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1891&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1892&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1893&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;79,123&lt;/td&gt; 
			&lt;td id=&quot;new_id-1894&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1895&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1896&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1897&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;94,448&lt;/td&gt; 
			&lt;td id=&quot;new_id-1898&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Lab and medical equipment capitalized leases&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1899&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1900&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1901&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;317,555&lt;/td&gt; 
			&lt;td id=&quot;new_id-1902&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1903&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1904&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1905&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;468,465&lt;/td&gt; 
			&lt;td id=&quot;new_id-1906&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total notes payable&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1907&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1908&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1909&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,860,678&lt;/td&gt;  
			&lt;td id=&quot;new_id-1910&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1911&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1912&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1913&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,126,913&lt;/td&gt;  
			&lt;td id=&quot;new_id-1914&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less unamortized debt discount&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1915&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1916&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1917&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(74,620&lt;/td&gt; 
			&lt;td id=&quot;new_id-1918&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1919&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1920&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1921&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(94,866&lt;/td&gt; 
			&lt;td id=&quot;new_id-1922&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total notes payable net of unamortized debt discount&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1923&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1924&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1925&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,786,058&lt;/td&gt;  
			&lt;td id=&quot;new_id-1926&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1927&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1928&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1929&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,032,047&lt;/td&gt;  
			&lt;td id=&quot;new_id-1930&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less current portion&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1931&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1932&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1933&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(392,470&lt;/td&gt;  
			&lt;td id=&quot;new_id-1934&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1935&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1936&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1937&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(1,344,594&lt;/td&gt;    
			&lt;td id=&quot;new_id-1938&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Long term portion&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1939&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1940&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1941&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,393,588&lt;/td&gt;    
			&lt;td id=&quot;new_id-1942&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1943&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1944&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1945&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;687,453&lt;/td&gt;  
			&lt;td id=&quot;new_id-1946&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Seaside Bank&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 25, 2010, the Company entered into a Loan Agreement with Seaside National Bank and Trust for a $980,000 loan at 4.25% per annum interest that was used to refinance the Company&amp;#x2019;s loan with Bank of America. The obligation is guaranteed by certain shareholders of the Company. The Company renewed the loan with Seaside National Bank and Trust during the first quarter of 2018 to extend the maturity date to May 18, 2020.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Hunton &amp;amp; Williams Notes&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At December 31, 2016, the Company has two outstanding notes payable with interest at 8% per annum due at maturity. The two notes, $61,150 and $323,822, are payable in one balloon payment upon the date the Noteholder provides written demand, however the Company is not obligated to make payments until the Northstar Biotech Group, LLC (or successor) Loan is paid off.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On August 31, 2017, the Company and the note holder entered into a Note Forbearance, Modification and Repayment Agreement (&amp;#x201c;Agreement&amp;#x201d;). The two notes, $61,150 and $323,822, were payable in one balloon payment upon the date of a written demand and upon certain triggering events occurring. The total of unpaid principal and accumulated interest for both notes as of August 31, 2017 was $747,680 and an accounts payable of $40,596, for an aggregate total of $788,276.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The note holder agreed to accept full payment of their obligation of over a four (4) year period in 48 monthly installments on an adjusted debt obligation in aggregate of $624,000 (reducing the outstanding balance), with such payments staggered in amounts such that the Company will pay $10,000 monthly the first year, $12,000 monthly the second year, $14,000 monthly the third year, and $16,000 monthly the final year.&amp;#xa0; In addition, the note holder agreed to suspend accrual interest on the notes commencing September 1, 2017.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Agreement remains in full force and effect provided the Company continues to make the monthly payments, there is no event of default as defined in the notes, and an agreement to a subordination agreement by Northstar Biotech Group, LLC, which has been provided.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company imputed an interest rate of 5% and discounted the note accordingly. The imputed debt discount of $69,700 is amortized to interest expense using the effective interest method. For three and nine months ended September 30, 2018, the Company amortized $6,343 and $22,426 of debt discounts to current period operations as interest expense. The unamortized debt discount at September 30, 2018 is $37,098.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;PowerUp Lending Group, Ltd&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 12, 2017, the Company entered into a revenue based factoring agreement and received an aggregate of $137,200 (less origination fees of $2,800) in exchange for $187,600 of future receipts relating to monies collected from customers or other third party payors. Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days.&amp;#xa0;&amp;#xa0;The Company received net proceeds of $103,085 along with cancellation of the previous revenue based factoring agreement issued in February 2017.&amp;#xa0;&amp;#xa0;In connection with the cancellation of the February 2017 revenue based factoring agreement, the Company incurred a gain in settlement of debt of $2,734 in 2017.&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On January 2, 2018, the Company entered into a revenue based factoring agreement and received an aggregate of $137,200 (less origination fees of $2,800) in exchange for $187,600 of future receipts relating to monies collected from customers or other third party payors. Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days.&amp;#xa0;&amp;#xa0;The Company received net proceeds of $47,907 along with cancellation of the previous revenue based factoring agreement issued in September 2017.&amp;#xa0;&amp;#xa0;In connection with the cancellation of the September 2017 revenue based factoring agreement, the Company incurred a gain in settlement of debt of $5,154 in 2018.&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 29, 2018, the Company entered into a revenue based factoring agreement and received an aggregate of $137,200 (less origination fees of $2,800) in exchange for $187,600 of future receipts relating to monies collected from customers or other third party payors. Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days.&amp;#xa0;&amp;#xa0;The Company received net proceeds of $78,495 along with cancellation of the previous revenue based factoring agreement issued in January 2018.&amp;#xa0;&amp;#xa0;In connection with the cancellation of the January 2018 revenue based factoring agreement, the Company incurred a loss in settlement of debt of $5,105 in 2018.&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The remaining principle balance of the PowerUp Lending Group promissory note payable at September 30, 2018 is $79,124, net of unamortized discount of $37,523.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Lab and Medical Equipment Capitalized Lease&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into an asset sale and lease agreement (sale/leaseback transaction; &amp;#x201c;Asset Sale and Lease Agreement&amp;#x201d;) with GACP, whereby the Company sold certain lab, medical and other equipment relating to the cell banking business for $400,000 and leased back the sold equipment over a three year term.&amp;#xa0; The Company recognized the arrangement as a capital lease.&amp;#xa0; The Company initially recorded the equipment and the capitalized lease liability at the estimated present value of the minimum lease payments of $619,825.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The lease includes a base monthly rental payment of $20,000, due the first day of each calendar month plus contingent rent equal to 2.3%, 22.5%, and 31.6% of revenues collected on deposits arising from cell banking business for years 1, 2 and 3, respectively.&amp;#xa0; The contingent rent is recognized as a period expense and as interest expense at the time of collection.&amp;#xa0; At the expiration of the lease, the Company is required to return all leased equipment and along with any maintenance records, logs, etc. in the Company&amp;#x2019;s possession to the lessor with no right of repurchase.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company determined that the present value of the minimum lease payments exceeded 90% of the estimated fair value of the equipment and therefore classified the equipment sale/lease as a capitalized lease. The effective interest rate of the capitalized lease is estimated at 10.00% based on the Company estimated incremental borrowing rate.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The following summarizes the assets under capital leases:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1947&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1948&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1949&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1950&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1951&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1952&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Classes of property&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1953&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1954&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1955&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1956&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1957&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1958&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1959&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1960&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Lab, medical and other equipment&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1961&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1962&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1963&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;619,825&lt;/td&gt;  
			&lt;td id=&quot;new_id-1964&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1965&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1966&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1967&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;619,825&lt;/td&gt;  
			&lt;td id=&quot;new_id-1968&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Office equipment&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1969&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1970&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1971&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,777&lt;/td&gt;     
			&lt;td id=&quot;new_id-1972&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1973&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1974&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1975&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,777&lt;/td&gt;     
			&lt;td id=&quot;new_id-1976&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less: accumulated depreciation&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1977&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1978&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1979&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(331,907&lt;/td&gt;  
			&lt;td id=&quot;new_id-1980&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1981&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1982&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1983&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(174,120&lt;/td&gt;  
			&lt;td id=&quot;new_id-1984&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1985&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1986&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-1987&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;292,695&lt;/td&gt;     
			&lt;td id=&quot;new_id-1988&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1989&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1990&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-1991&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;450,482&lt;/td&gt;     
			&lt;td id=&quot;new_id-1992&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The following summarizes the current and long-term portion of capital leases:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;     
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1993&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1994&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1995&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1996&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1997&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1998&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Current leases payable&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1999&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2000&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2001&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;219,549&lt;/td&gt;  
			&lt;td id=&quot;new_id-2002&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2003&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2004&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2005&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;203,875&lt;/td&gt;  
			&lt;td id=&quot;new_id-2006&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Long-term leases payable&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2007&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2008&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2009&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;98,006&lt;/td&gt;     
			&lt;td id=&quot;new_id-2010&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2011&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2012&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2013&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;264,590&lt;/td&gt; 
			&lt;td id=&quot;new_id-2014&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2015&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2016&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-2017&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;317,555&lt;/td&gt;     
			&lt;td id=&quot;new_id-2018&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2019&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2020&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-2021&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;468,465&lt;/td&gt;     
			&lt;td id=&quot;new_id-2022&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The following summarizes total future minimum lease payments at September 30, 2018:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;Period ending December 31,&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2023&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2024&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2025&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2026&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Three months ended December 31, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2027&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2028&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2029&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60,349&lt;/td&gt; 
			&lt;td id=&quot;new_id-2030&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;2019&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2031&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2032&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2033&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;241,396&lt;/td&gt;  
			&lt;td id=&quot;new_id-2034&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;2020&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2035&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2036&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2037&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;60,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2038&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total minimum lease payments&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2039&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2040&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2041&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;361,745&lt;/td&gt;  
			&lt;td id=&quot;new_id-2042&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Amount representing interest&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2043&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2044&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2045&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(44,190&lt;/td&gt; 
			&lt;td id=&quot;new_id-2046&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Present value of minimum lease payments&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2047&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2048&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2049&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;317,555&lt;/td&gt;  
			&lt;td id=&quot;new_id-2050&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Current portion of capital lease obligations&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2051&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2052&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2053&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;219,549&lt;/td&gt; 
			&lt;td id=&quot;new_id-2054&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Capital lease obligation, less current portion&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2055&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2056&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2057&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;98,006&lt;/td&gt; 
			&lt;td id=&quot;new_id-2058&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Promissory note&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On June 1, 2015, the Company issued an amended and restated promissory note of $1,697,762 in settlement of the $1,500,000 outstanding subordinated debt, related accrued interest of $373,469 and accumulated and unpaid guarantor fees of $624,737.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The note is unsecured and non-interest bearing with four semi-annual payments of $75,000 beginning on December 31, 2015 with the remaining unpaid balance due June 1, 2020.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company imputed an interest rate of 5% and discounted the promissory note accordingly. The imputed debt discount of $368,615 is amortized to interest expense using the effective interest method. For the three and nine months ended September 30, 2018, the Company amortized $17,616 and $52,273 of debt discounts to current period operations as interest expense, respectively.&amp;#xa0;&amp;#xa0;The unamortized debt discount at September 30, 2018 is $116,799.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;As of September 30, 2018, the remaining principle due was $1,397,762.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>   
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c95_AsOf25Oct2010_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember" decimals="0">980000</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c95_AsOf25Oct2010_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember" decimals="4">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>   
  <us-gaap:DebtInstrumentMaturityDate contextRef="c96_From1Jan2018To31Mar2018_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember">2020-05-18</us-gaap:DebtInstrumentMaturityDate>  
  <usrm:NumberOfOutstandingNotesPayable unitRef="pure" contextRef="c97_AsOf31Dec2016_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">2</usrm:NumberOfOutstandingNotesPayable>   
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c97_AsOf31Dec2016_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="2">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>    
  <us-gaap:NotesPayable unitRef="usd" contextRef="c98_AsOf31Dec2016_HuntonWilliamsNote1Member_NotesPayableOtherPayablesMember" decimals="0">61150</us-gaap:NotesPayable>    
  <us-gaap:NotesPayable unitRef="usd" contextRef="c99_AsOf31Dec2016_HuntonWilliamsNote2Member_NotesPayableOtherPayablesMember" decimals="0">323822</us-gaap:NotesPayable>     
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c100_From1Jan2016To31Dec2016_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">payable in one balloon payment upon the date the Noteholder provides written demand, however the Company is not obligated to make payments until the Northstar Biotech Group, LLC (or successor) Loan is paid off.</us-gaap:DebtInstrumentPaymentTerms> 
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c101_From31Aug2017To31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">payable in one balloon payment upon the date of a written demand and upon certain triggering events occurring</us-gaap:DebtInstrumentPaymentTerms> 
  <us-gaap:OtherNotesPayable unitRef="usd" contextRef="c102_AsOf31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">747680</us-gaap:OtherNotesPayable> 
  <us-gaap:AccountsPayableOtherCurrent unitRef="usd" contextRef="c102_AsOf31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">40596</us-gaap:AccountsPayableOtherCurrent>     
  <us-gaap:NotesAndLoansPayable unitRef="usd" contextRef="c102_AsOf31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">788276</us-gaap:NotesAndLoansPayable>  
  <us-gaap:DebtInstrumentDescription contextRef="c101_From31Aug2017To31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember">The note holder agreed to accept full payment of their obligation of over a four (4) year period in 48 monthly installments on an adjusted debt obligation in aggregate of $624,000 (reducing the outstanding balance), with such payments staggered in amounts such that the Company will pay $10,000 monthly the first year, $12,000 monthly the second year, $14,000 monthly the third year, and $16,000 monthly the final year.&amp;#xa0; In addition, the note holder agreed to suspend accrual interest on the notes commencing September 1, 2017.</us-gaap:DebtInstrumentDescription> 
  <usrm:ImputedInterestRate unitRef="pure" contextRef="c101_From31Aug2017To31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="2">0.05</usrm:ImputedInterestRate>    
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c102_AsOf31Aug2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">69700</us-gaap:DebtInstrumentUnamortizedDiscount>  
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c103_From1Jul2018To30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">6343</us-gaap:AmortizationOfDebtDiscountPremium> 
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c104_From1Jan2018To30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">22426</us-gaap:AmortizationOfDebtDiscountPremium>  
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c105_AsOf30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">37098</us-gaap:DebtInstrumentUnamortizedDiscount>  
  <us-gaap:ProceedsFromIssuanceOfDebt unitRef="usd" contextRef="c106_From12Sep2017To12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">137200</us-gaap:ProceedsFromIssuanceOfDebt>  
  <us-gaap:DebtInstrumentFeeAmount unitRef="usd" contextRef="c107_AsOf12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">2800</us-gaap:DebtInstrumentFeeAmount>   
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c107_AsOf12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">187600</us-gaap:DebtInstrumentFaceAmount>  
  <us-gaap:ProceedsFromDebtNetOfIssuanceCosts unitRef="usd" contextRef="c106_From12Sep2017To12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">103085</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>   
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c106_From12Sep2017To12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">2734</us-gaap:GainsLossesOnExtinguishmentOfDebt>    
  <us-gaap:ProceedsFromIssuanceOfDebt unitRef="usd" contextRef="c108_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">137200</us-gaap:ProceedsFromIssuanceOfDebt>     
  <us-gaap:DebtInstrumentFeeAmount unitRef="usd" contextRef="c109_AsOf2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">2800</us-gaap:DebtInstrumentFeeAmount>  
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c109_AsOf2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">187600</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:ProceedsFromDebtNetOfIssuanceCosts unitRef="usd" contextRef="c108_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">47907</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>     
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c110_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_EmbeddedDerivativeFinancialInstrumentsMember_ConvertibleDebtMember_RevenueBasedFactoringAgreementMember" decimals="0">5154</us-gaap:GainsLossesOnExtinguishmentOfDebt>    
  <us-gaap:ProceedsFromIssuanceOfDebt unitRef="usd" contextRef="c111_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">137200</us-gaap:ProceedsFromIssuanceOfDebt>  
  <us-gaap:DebtInstrumentFeeAmount unitRef="usd" contextRef="c112_AsOf29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">2800</us-gaap:DebtInstrumentFeeAmount>   
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c112_AsOf29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">187600</us-gaap:DebtInstrumentFaceAmount>  
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c111_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days</us-gaap:DebtInstrumentPaymentTerms>     
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c106_From12Sep2017To12Sep2017_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days.</us-gaap:DebtInstrumentPaymentTerms> 
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c108_From2Jan2018To2Jan2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember">Under the terms of the factoring agreement, the Company is required to make daily payments equal&amp;#xa0;to $1,276&amp;#xa0;for 147 business days.</us-gaap:DebtInstrumentPaymentTerms>    
  <us-gaap:ProceedsFromDebtNetOfIssuanceCosts unitRef="usd" contextRef="c111_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_RevenueBasedFactoringAgreementMember" decimals="0">78495</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>  
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c113_From29May2018To29May2018_PowerUpLendingGroupNotesPayableMember_EmbeddedDerivativeFinancialInstrumentsMember_ConvertibleDebtMember_RevenueBasedFactoringAgreementMember" decimals="0">-5105</us-gaap:GainsLossesOnExtinguishmentOfDebt>  
  <us-gaap:NotesPayable unitRef="usd" contextRef="c114_AsOf30Sep2018_PowerUpLendingGroupNotesPayableMember" decimals="0">79124</us-gaap:NotesPayable>     
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c114_AsOf30Sep2018_PowerUpLendingGroupNotesPayableMember" decimals="0">37523</us-gaap:DebtInstrumentUnamortizedDiscount>  
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c115_AsOf3Mar2017_CapitalLeaseObligationsMember" decimals="0">400000</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtInstrumentTerm contextRef="c116_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember">P3Y</us-gaap:DebtInstrumentTerm>    
  <us-gaap:CapitalLeaseObligations unitRef="usd" contextRef="c115_AsOf3Mar2017_CapitalLeaseObligationsMember" decimals="0">619825</us-gaap:CapitalLeaseObligations>    
  <us-gaap:SaleLeasebackTransactionMonthlyRentalPayments unitRef="usd" contextRef="c116_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember" decimals="0">20000</us-gaap:SaleLeasebackTransactionMonthlyRentalPayments>  
  <usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid unitRef="pure" contextRef="c117_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearOneMember" decimals="3">0.023</usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid>     
  <usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid unitRef="pure" contextRef="c118_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearTwoMember" decimals="3">0.225</usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid>     
  <usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid unitRef="pure" contextRef="c119_From3Mar2017To3Mar2017_CapitalLeaseObligationsMember_RevenuePrecentageYearThreeMember" decimals="3">0.316</usrm:SaleLeasebackTransactionRateOfRevenuesToBePaid>  
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c120_AsOf1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">1697762</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c121_From1Jun2015To1Jun2015_PrincipalMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>    
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c122_From1Jun2015To1Jun2015_InterestMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">373469</us-gaap:DebtConversionConvertedInstrumentAmount1>  
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c123_From1Jun2015To1Jun2015_UnpaidGuarantorFeesMember_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">624737</us-gaap:DebtConversionConvertedInstrumentAmount1>   
  <us-gaap:DebtInstrumentInterestRateTerms contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">non-interest bearing</us-gaap:DebtInstrumentInterestRateTerms> 
  <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">four semi-annual</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>     
  <us-gaap:DebtInstrumentPeriodicPayment unitRef="usd" contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">75000</us-gaap:DebtInstrumentPeriodicPayment>    
  <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1 contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">2015-12-31</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1> 
  <us-gaap:DebtInstrumentMaturityDate contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember">2020-06-01</us-gaap:DebtInstrumentMaturityDate> 
  <usrm:ImputedInterestRate unitRef="pure" contextRef="c124_From1Jun2015To1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="2">0.05</usrm:ImputedInterestRate>   
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c120_AsOf1Jun2015_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">368615</us-gaap:DebtInstrumentUnamortizedDiscount>   
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c125_From1Jul2018To30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">17616</us-gaap:AmortizationOfDebtDiscountPremium>   
  <us-gaap:AmortizationOfDebtDiscountPremium unitRef="usd" contextRef="c126_From1Jan2018To30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">52273</us-gaap:AmortizationOfDebtDiscountPremium>   
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c127_AsOf30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">116799</us-gaap:DebtInstrumentUnamortizedDiscount>    
  <us-gaap:NotesPayable unitRef="usd" contextRef="c127_AsOf30Sep2018_NotePayableSettlementOfSubordinatedDebtAccruedInterestAndGuarantorFeesMember_NotesPayableOtherPayablesMember" decimals="0">1397762</us-gaap:NotesPayable>   
  <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;     
Notes and capital lease payable were comprised of the following as of September 30, 2018 and December 31, 2017:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;     
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1869&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1870&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1871&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1872&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1873&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1874&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Seaside Bank note payable.&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1875&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1876&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1877&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;980,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1878&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1879&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1880&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1881&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;980,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1882&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Hunton &amp;amp; Williams note(s) payable&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1883&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1884&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1885&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;484,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1886&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1887&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1888&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1889&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;584,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-1890&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Power Up Lending Group notes payable&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1891&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1892&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1893&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;79,123&lt;/td&gt; 
			&lt;td id=&quot;new_id-1894&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1895&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1896&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1897&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;94,448&lt;/td&gt; 
			&lt;td id=&quot;new_id-1898&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Lab and medical equipment capitalized leases&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1899&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1900&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1901&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;317,555&lt;/td&gt; 
			&lt;td id=&quot;new_id-1902&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1903&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1904&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1905&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;468,465&lt;/td&gt; 
			&lt;td id=&quot;new_id-1906&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total notes payable&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1907&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1908&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1909&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,860,678&lt;/td&gt;  
			&lt;td id=&quot;new_id-1910&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1911&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1912&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1913&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,126,913&lt;/td&gt;  
			&lt;td id=&quot;new_id-1914&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less unamortized debt discount&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1915&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1916&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1917&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(74,620&lt;/td&gt; 
			&lt;td id=&quot;new_id-1918&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1919&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1920&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1921&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(94,866&lt;/td&gt; 
			&lt;td id=&quot;new_id-1922&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total notes payable net of unamortized debt discount&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1923&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1924&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1925&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,786,058&lt;/td&gt;  
			&lt;td id=&quot;new_id-1926&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1927&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1928&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1929&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,032,047&lt;/td&gt;  
			&lt;td id=&quot;new_id-1930&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less current portion&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1931&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1932&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1933&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(392,470&lt;/td&gt;  
			&lt;td id=&quot;new_id-1934&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1935&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1936&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1937&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(1,344,594&lt;/td&gt;    
			&lt;td id=&quot;new_id-1938&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Long term portion&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1939&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1940&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1941&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,393,588&lt;/td&gt;    
			&lt;td id=&quot;new_id-1942&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1943&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1944&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1945&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;687,453&lt;/td&gt;  
			&lt;td id=&quot;new_id-1946&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock> 
  <us-gaap:NotesPayable unitRef="usd" contextRef="c128_AsOf30Sep2018_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember" decimals="0">980000</us-gaap:NotesPayable>   
  <us-gaap:NotesPayable unitRef="usd" contextRef="c129_AsOf31Dec2017_SeasideNationalBankAndTrustMember_NotesPayableToBanksMember" decimals="0">980000</us-gaap:NotesPayable>   
  <us-gaap:NotesPayable unitRef="usd" contextRef="c105_AsOf30Sep2018_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">484000</us-gaap:NotesPayable> 
  <us-gaap:NotesPayable unitRef="usd" contextRef="c130_AsOf31Dec2017_HuntonWilliamsNotesMember_NotesPayableOtherPayablesMember" decimals="0">584000</us-gaap:NotesPayable> 
  <us-gaap:NotesPayable unitRef="usd" contextRef="c131_AsOf30Sep2018_PowerUpLendingGroupNotesPayableMember_NotesPayableOtherPayablesMember" decimals="0">79123</us-gaap:NotesPayable>  
  <us-gaap:NotesPayable unitRef="usd" contextRef="c132_AsOf31Dec2017_PowerUpLendingGroupNotesPayableMember_NotesPayableOtherPayablesMember" decimals="0">94448</us-gaap:NotesPayable>  
  <us-gaap:NotesPayable unitRef="usd" contextRef="c133_AsOf30Sep2018_CapitalLeaseObligationsMember" decimals="0">317555</us-gaap:NotesPayable>   
  <us-gaap:NotesPayable unitRef="usd" contextRef="c134_AsOf31Dec2017_CapitalLeaseObligationsMember" decimals="0">468465</us-gaap:NotesPayable>   
  <us-gaap:NotesPayable unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1860678</us-gaap:NotesPayable>  
  <us-gaap:NotesPayable unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">2126913</us-gaap:NotesPayable>  
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">74620</us-gaap:DebtInstrumentUnamortizedDiscount>  
  <us-gaap:DebtInstrumentUnamortizedDiscount unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">94866</us-gaap:DebtInstrumentUnamortizedDiscount>  
  <usrm:NotesPayableNetOfUnamortizedDebtDiscount unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1786058</usrm:NotesPayableNetOfUnamortizedDebtDiscount>  
  <usrm:NotesPayableNetOfUnamortizedDebtDiscount unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">2032047</usrm:NotesPayableNetOfUnamortizedDebtDiscount>  
  <us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt; 
The following summarizes the assets under capital leases:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1947&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1948&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1949&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1950&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1951&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1952&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Classes of property&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1953&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1954&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1955&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1956&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1957&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1958&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1959&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1960&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Lab, medical and other equipment&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1961&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1962&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1963&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;619,825&lt;/td&gt;  
			&lt;td id=&quot;new_id-1964&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1965&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1966&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-1967&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;619,825&lt;/td&gt;  
			&lt;td id=&quot;new_id-1968&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Office equipment&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1969&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1970&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1971&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,777&lt;/td&gt;     
			&lt;td id=&quot;new_id-1972&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1973&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1974&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1975&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,777&lt;/td&gt;     
			&lt;td id=&quot;new_id-1976&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Less: accumulated depreciation&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1977&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1978&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1979&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(331,907&lt;/td&gt;  
			&lt;td id=&quot;new_id-1980&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1981&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1982&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-1983&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(174,120&lt;/td&gt;  
			&lt;td id=&quot;new_id-1984&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1985&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1986&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-1987&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;292,695&lt;/td&gt;     
			&lt;td id=&quot;new_id-1988&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1989&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-1990&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-1991&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;450,482&lt;/td&gt;     
			&lt;td id=&quot;new_id-1992&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-1993&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1994&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September&lt;/b&gt;&lt;b&gt; 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1995&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-1996&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-1997&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1998&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Current leases payable&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-1999&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2000&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2001&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;219,549&lt;/td&gt;  
			&lt;td id=&quot;new_id-2002&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2003&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2004&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2005&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;203,875&lt;/td&gt;  
			&lt;td id=&quot;new_id-2006&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Long-term leases payable&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2007&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2008&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2009&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;98,006&lt;/td&gt;     
			&lt;td id=&quot;new_id-2010&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2011&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2012&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2013&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;264,590&lt;/td&gt; 
			&lt;td id=&quot;new_id-2014&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2015&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2016&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-2017&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;317,555&lt;/td&gt;     
			&lt;td id=&quot;new_id-2018&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2019&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2020&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt;    
			&lt;td id=&quot;new_id-2021&quot; style=&quot;width: 16%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;468,465&lt;/td&gt;     
			&lt;td id=&quot;new_id-2022&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock>  
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c135_AsOf30Sep2018_EquipmentMember" decimals="0">619825</us-gaap:CapitalLeasedAssetsGross>   
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c136_AsOf31Dec2017_EquipmentMember" decimals="0">619825</us-gaap:CapitalLeasedAssetsGross>   
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c137_AsOf30Sep2018_OfficeEquipmentMember" decimals="0">4777</us-gaap:CapitalLeasedAssetsGross>  
  <us-gaap:CapitalLeasedAssetsGross unitRef="usd" contextRef="c138_AsOf31Dec2017_OfficeEquipmentMember" decimals="0">4777</us-gaap:CapitalLeasedAssetsGross>  
  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">331907</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>    
  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">174120</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>    
  <us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">292695</us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet>    
  <us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">450482</us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet>    
  <us-gaap:CapitalLeaseObligationsCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">219549</us-gaap:CapitalLeaseObligationsCurrent>  
  <us-gaap:CapitalLeaseObligationsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">203875</us-gaap:CapitalLeaseObligationsCurrent>  
  <us-gaap:CapitalLeaseObligationsNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">98006</us-gaap:CapitalLeaseObligationsNoncurrent>  
  <us-gaap:CapitalLeaseObligationsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">264590</us-gaap:CapitalLeaseObligationsNoncurrent>   
  <us-gaap:CapitalLeaseObligations unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">317555</us-gaap:CapitalLeaseObligations>   
  <us-gaap:CapitalLeaseObligations unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">468465</us-gaap:CapitalLeaseObligations>   
  <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;   
The following summarizes total future minimum lease payments at September 30, 2018:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;Period ending December 31,&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2023&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2024&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2025&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2026&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&lt;b&gt;&amp;#xa0;&lt;/b&gt;&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Three months ended December 31, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2027&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2028&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2029&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60,349&lt;/td&gt; 
			&lt;td id=&quot;new_id-2030&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;2019&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2031&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2032&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2033&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;241,396&lt;/td&gt;  
			&lt;td id=&quot;new_id-2034&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;2020&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2035&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2036&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2037&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;60,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2038&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total minimum lease payments&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2039&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2040&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2041&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;361,745&lt;/td&gt;  
			&lt;td id=&quot;new_id-2042&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Amount representing interest&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2043&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2044&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2045&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(44,190&lt;/td&gt; 
			&lt;td id=&quot;new_id-2046&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Present value of minimum lease payments&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2047&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2048&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2049&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;317,555&lt;/td&gt;  
			&lt;td id=&quot;new_id-2050&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Current portion of capital lease obligations&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2051&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2052&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2053&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;219,549&lt;/td&gt; 
			&lt;td id=&quot;new_id-2054&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;1&quot; style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 81%;&quot;&gt;   
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Capital lease obligation, less current portion&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2055&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2056&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2057&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;98,006&lt;/td&gt; 
			&lt;td id=&quot;new_id-2058&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>    
  <us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">60349</us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear> 
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">241396</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears> 
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">60000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>    
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDue unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">361745</us-gaap:CapitalLeasesFutureMinimumPaymentsDue> 
  <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">44190</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments> 
  <us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">317555</us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments>    
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;     
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;NOTE 7 &amp;#x2014; RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Advances&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018 and December 31, 2017, the Company&amp;#x2019;s officers and directors have provided advances in the aggregate of $204,901 and $104,901 respectively, for working capital purposes. The advances are unsecured, due on demand, and non-interest bearing.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;font style=&quot;text-decoration:underline&quot;&gt;Notes payable-related party&lt;/font&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Northstar Biotechnology Group, LLC&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On February 29, 2012, a promissory note issued to BlueCrest Master Fund Limited was assigned to Northstar Biotechnology Group, LLC (&amp;#x201c;Northstar&amp;#x201d;), owned partly by certain directors and existing shareholders of the Company at the time, including Dr. William P. Murphy Jr., Dr. Samuel Ahn and Charles Hart. At the date of the assignment, the principal amount of the BlueCrest note was $544,267 the (&amp;#x201c;Note&amp;#x201d;).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 30, 2012, the Company and Northstar agreed to extend until May 1, 2012 the initial payment date for any and all required monthly under the Note, such that the first of the four monthly payments required under the Note will be due and payable on May, 2012 and all subsequent payments will be due on a monthly basis thereafter commencing on June 1, 2012, and to waive any and all defaults and/or events of default under the Note with respect to such payments. The Company did not make the required payment, and as a result, was in default of the revised agreement. The Company renegotiated the terms of the Note and Northstar agreed to suspend the requirement of principal payments by the Company and allow payment of interest-only in common stock.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 21, 2012, the Company issued 5,000 common stock purchase warrants to Northstar that was treated as additional interest expense upon issuance.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 1, 2012, the Company and Northstar entered into a limited waiver and forbearance agreement providing a recapitalized new note balance comprised of all sums due Northstar with a maturity date extended perpetually. The Company agreed to issue 5,000,000 shares of Series A Convertible Preferred Stock and 10,000 shares of common stock in exchange for $210,000 as payment towards outstanding debt, default interest, penalties, professional fees outstanding and due Northstar. In addition, the Company executed a security agreement granting Northstar a lien on all patents, patent applications, trademarks, service marks, copyrights and intellectual property rights of any nature, as well as the results of all clinical trials, know-how for preparing Myoblasts, old and new clinical data, existing approved trials, all right and title to Myoblasts, clinical trial protocols and other property rights.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In addition, the Company granted Northstar a perpetual license on products as described for resale, relicensing, and commercialization outside the United States. In connection with the granted license, Northstar shall pay the Company a royalty of up to 8% on revenues generated.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Effective October 1, 2012, the effective interest rate was 12.85% per annum. The parties agreed, as of February 28, 2013, to reduce the interest rate to 7% per annum.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In connection with the consideration paid, Northstar waived, from the effective date through the earlier of termination or expiration of the agreement, satisfaction of the obligations as described in the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In 2012, 5,000,000 shares of Series A Convertible Preferred Stock were approved to be issued, which was subsequently increased to 20,000,000 shares of preferred stock as Series A Convertible Preferred Stock. In addition, the Company was obligated to issue additional preferred stock equal in lieu of payment of cash of accrued and unpaid interest on each six month anniversary of the effective date (October 1, 2012). In lieu of the initial two payments in preferred stock, the parties agreed to modify the voting rights of the subsequently cancelled Series A Convertible Preferred Stock from 20 votes per share on matters to be voted on by the common stock holders to 25 votes per share on matters to be voted on by the common stock holders and all prior and subsequent payments of interest will be in common stock. The Company is required to issue additional shares of its common stock (as amended), in lieu of cash, each six month anniversary of the effective date for any accrued and unpaid interest.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 1, 2017, Northstar and the Company entered into a settlement agreement (&amp;#x201c;Settlement Agreement &amp;#x201c;) related to then pending litigation (See Note 11). Pursuant to the terms and conditions of the Settlement Agreement, Northstar converted its outstanding Series A Convertible preferred stock, into twenty million (20,000,000) shares of common stock according to the original conversion terms. In addition, and separate and apart from the conversion, Northstar&amp;#xa0;received Eleven Million (11,000,000) shares of the Company&amp;#x2019;s common stock. Northstar will receive ten percent (10%) of all Company international sales (based on a gross sales basis). There was no effect of the 10% obligation as there were no international sales in 2017 or, to date, in 2018 Furthermore, a Northstar designee, Greg Knutson, was appointed as a member of the Board of Directors of the Company and two Company directors, Michael Tomas and Kristin Comella, each exercised their prior Northstar options to each receive a Five percent (5%) Member Interest in Northstar.&amp;#xa0; The parties agreed to a mutual release and Northstar agreed to terminate any UCC lien on the Company assets previously filed for the benefit of Northstar. On March 9, 2017 and April 1, 2017, the Company issued 30,000,000 and 1,000,000 shares of its common stock, respectively, as described above. In connection with the settlement, the Company recorded a loss on litigation settlement of $316,800.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 30, 2013, the Company issued 8,772 shares of its common stock as payment of $100,000 towards cash advances.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On December 24, 2013, the Company issued 3,916 shares of its common stock as payment of accrued interest through June 30, 2013 of $85,447.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 2, 2014, the Company issued 275 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,635 due April 1, 2014 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 17, 2014, the limited waiver and forbearance agreement entered into on October 1, 2012 to provide that the perpetual license on products as described for resale, relicensing and commercialization outside the United States was amended as such on the condition that Northstar provide certain financing, which financing the Company, in its sole discretion, could decline and retain the license.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 3, 2014, the Company issued 515 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,705 due October 1, 2014 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 3, 2015, the Company issued 1,363 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,635 due April 1, 2015 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 2, 2015, the Company issued 4,156 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,705 due October 1, 2015 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 7, 2015, the Company issued 34,522 shares of its common stock in settlement of $100,000 principal payment towards the outstanding debt.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 7, 2016, the Company issued 57,778 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,705 due April 1, 2016 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 6, 2016, the Company issued 848,490 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,705 due October 1, 2016 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 1, 2017, the Company issued 286,315 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,703 due October 1, 2016 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On October 2, 2017, the Company issued 559,187 shares of its common stock in lieu of payment in cash of accrued and unpaid interest of $12,705 due October 1, 2016 per the forbearance agreement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018 and December 31, 2017, the principal of this note was $262,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;&lt;b&gt;Officer and Director Notes&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2059&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2060&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2061&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2062&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2063&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2064&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2065&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2066&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2067&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2068&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2069&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2070&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2071&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;101,729&lt;/td&gt;  
			&lt;td id=&quot;new_id-2072&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2073&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2074&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2075&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;143,260&lt;/td&gt;  
			&lt;td id=&quot;new_id-2076&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2077&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2078&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2079&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2080&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2081&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2082&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2083&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2084&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2085&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2086&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2087&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2088&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2089&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2090&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2091&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2092&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2093&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2094&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2095&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2096&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2097&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2098&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2099&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;153,295&lt;/td&gt;  
			&lt;td id=&quot;new_id-2100&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2101&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2102&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2103&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;237,797&lt;/td&gt;  
			&lt;td id=&quot;new_id-2104&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2105&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2106&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2107&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;300,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2108&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2109&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2110&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2111&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;300,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2112&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2113&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2114&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2115&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;300,000&lt;/td&gt; 
			&lt;td id=&quot;new_id-2116&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2117&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2118&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2119&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;-&lt;/td&gt;     
			&lt;td id=&quot;new_id-2120&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2121&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2122&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2123&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,896,555&lt;/td&gt;    
			&lt;td id=&quot;new_id-2124&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2125&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2126&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2127&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,639,526&lt;/td&gt;    
			&lt;td id=&quot;new_id-2128&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Notes payable, Mr. Tomas&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On July 1, 2014, the Company issued a $500,000 promissory note in settlement of compensation earned. The promissory note bears interest of 5% per annum and was due on January 1, 2015. During the nine months ended September 30, 2018, the Company paid off $101,729 of the outstanding promissory note. The principal outstanding balance of this note as of September 30, 2018 and December 31, 2017 is $0 and $101,729, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 6, 2016, the Company issued a $500,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and is due upon demand. During the nine months ended September 30, 2018, the Company paid off $356,740 of the outstanding promissory note. The principal outstanding balance of this note as of September 30, 2018 and December 31, 2017 is $143,260 and $500,000, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On August 7, 2017, the Company issued a $500,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and is due one year from date of issuance. The principal outstanding balance of this note as of September 30, 2018 and December 31, 2017 is $500,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 7, 2018, the Company issued a $500,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and is due six months from date of issuance. The principal outstanding balance of this note as of September 30, 2018 is $500,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, the Company has recorded accrued interest on the outstanding and past notes to Mr. Tomas in the amount of $325,601 and $281,903, respectively, which is included in the accrued expenses on the balance sheet.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;&lt;b&gt;Notes payable, Dr. Comella&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 6, 2016, the Company issued a $300,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and was due upon demand. During the nine months ended September 30, 2018, the Company paid off $84,502 of the outstanding promissory note. The principal outstanding balance of this note as of September 30, 2018 and December 31, 2017 is $153,295 and $237,797, respectively.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On August 7, 2017, the Company issued a $300,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and is due one year from date of issuance. The principal outstanding balance of this note as of September 30, 2018 and December 31, 2017 is $300,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 7, 2018, the Company issued a $300,000 promissory note in exchange for compensation earned. The promissory note bears interest of 5% per annum and is due six months from date of issuance. The principal outstanding balance of this note as of September 30, 2018 is $300,000.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At September 30, 2018 and December 31, 2017, the Company has recorded accrued interest on the outstanding notes to Dr. Comella in the amount of $93,480 and $69,108, respectively, which is included in the accrued expenses on the balance sheet.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Transactions with Pavillion&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 1, 2016, the Company entered into a consulting agreement with Pavillion, Inc., whose owner is related to an officer of the Company.&amp;#xa0; The agreement is for 12 months and renewable for 6 month periods.&amp;#xa0; Compensation is at $250 per hour or, at the Company&amp;#x2019;s discretion, in shares of the Company&amp;#x2019;s common stock. For the three and nine months ended September 30, 2018, the Company has incurred $30,000 and $90,000 of expense under the agreement, respectively. As of September 30, 2018 and December 31, 2017, the Company had $116,909 and $187,409, respectively, in accounts payable owed to Pavillion.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;&lt;b&gt;Transactions with GACP&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company entered into an asset sale and lease agreement (sale/leaseback transaction, the &amp;#x201c;Asset Sale and Lease Agreement&amp;#x201d;) with GACP, whereby the Company sold certain lab, medical and other equipment relating to the cell banking business for $400,000 and leased back the sold equipment over a three year term&amp;#xa0;(See &amp;#x201c;&lt;i&gt;Lab and Medical Equipment Capitalized Lease&lt;/i&gt;&amp;#x201d; below). The Company determined that the transaction was a capitalized lease and accordingly recorded the leased assets and liability based on the estimated present value of the minimum lease payments (see Notes 4 and 6).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In connection with the asset sale and lease agreement, the Company is obligated to accrue 10% of banking revenue as for marketing, offset by any incurred costs of the Company.&amp;#xa0; At September 30, 2018 and December 31, 2017, the outstanding accrued marketing obligation is $193,700 and $141,560, respectively (see Note 5).&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company also entered into a customer purchase agreement with GACP, whereby the Company agreed to sell, for $50,000, the first 5,000 customers of the cell banking business after the effective date of the equipment sale/leaseback agreement with rights to purchase additional customers at a price of $20 per customer.&amp;#xa0; There is no reduction in the selling price should the new customers be fewer than 5,000.&amp;#xa0; The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On March 3, 2017, the Company also entered into an asset purchase agreement of intellectual property with GACP whereby the Company agreed to sell all of the Company&amp;#x2019;s worldwide rights, title or interest in certain intellectual and other property (as defined) associated with the cell banking business for $50,000. The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In connection with the March 3, 2017 asset purchase agreement, the CEO and CSO of U.S. Stem Cell, Inc.&amp;#xa0;were&amp;#xa0;also retained as CEO and CSO of American Stem Cell Centers of Excellence, which is owned by General American Capital Partners (GACP), to&amp;#xa0;help with scientific and successful operational deployment of clinics.&amp;#xa0;Subsequently, the CSO of U.S. Stem Cell, Inc. has vacated her position but retained her positions with U.S. Stem Cell, Inc. and subsidiaries.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 3, 2017, U.S. Stem Cell received a commitment to invest up to $5,000,000 from GACP with the intent for GACP to receive up to 63,873,275 shares of common stock.&amp;#xa0; To date, GACP has invested, pursuant to this commitment, $250,000 in return for 858,281 shares. Subsequent to this investment, GACP has informed the Company that they will make no further investments pursuant to this agreement and has entered into a new agreement to invest $3,000,000 to open their own clinics (branded American Stem Cell) using the US Stem Cell Inc. protocols, procedures, products and technologies. As of September 30, 2018 (effective May 9, 2018), pursuant to an Amendment to Asset Sale and Lease Agreement, dated June 18, 2018, GACP has suspended their obligation to open additional clinics (tolling such obligation to a mutually agreeable date in the future) and has suspended the monthly aggregate number of stem cell kits set forth for purchase in a given month arising from such clinics. All other terms and conditions of the agreements between U.S. Stem Cell, Inc. and GACP remain in full force and effect. As of September 30, 2018 and December 31, 2017, GACP owns 4,021,945 shares of the Company&amp;#x2019;s common stock.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>     
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c139_AsOf29Feb2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">544267</us-gaap:DebtInstrumentFaceAmount>  
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c140_From30Mar2012To30Mar2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">agreed to extend until May 1, 2012 the initial payment date for any and all required monthly under the Note, such that the first of the four monthly payments required under the Note will be due and payable on May, 2012 and all subsequent payments will be due on a monthly basis thereafter commencing on June 1, 2012, and to waive any and all defaults and/or events of default under the Note with respect to such payments. The Company did not make the required payment, and as a result, was in default of the revised agreement. The Company renegotiated the terms of the Note and Northstar agreed to suspend the requirement of principal payments by the Company and allow payment of interest-only in common stock.</us-gaap:DebtInstrumentPaymentTerms>    
  <usrm:ClassOfWarrantOrRightsGranted unitRef="shares" contextRef="c141_From21Sep2012To21Sep2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">5000</usrm:ClassOfWarrantOrRightsGranted>     
  <us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault contextRef="c142_From1Oct2012To1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">entered into a limited waiver and forbearance agreement providing a recapitalized new note balance comprised of all sums due Northstar with a maturity date extended perpetually. The Company agreed to issue 5,000,000 shares of Series A Convertible Preferred Stock and 10,000 shares of common stock in exchange for $210,000 as payment towards outstanding debt, default interest, penalties, professional fees outstanding and due Northstar. In addition, the Company executed a security agreement granting Northstar a lien on all patents, patent applications, trademarks, service marks, copyrights and intellectual property rights of any nature, as well as the results of all clinical trials, know-how for preparing Myoblasts, old and new clinical data, existing approved trials, all right and title to Myoblasts, clinical trial protocols and other property rights.In addition, the Company granted Northstar a perpetual license on products as described for resale, relicensing, and commercialization outside the United States. In connection with the granted license, Northstar shall pay the Company a royalty of up to 8% on revenues generated.</us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault>  
  <usrm:PercentageOfRevenuesToBeReceivedAsRoyalty unitRef="pure" contextRef="c142_From1Oct2012To1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="2">0.08</usrm:PercentageOfRevenuesToBeReceivedAsRoyalty>   
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c143_AsOf1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="4">0.1285</us-gaap:DebtInstrumentInterestRateStatedPercentage>   
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c144_AsOf28Feb2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="2">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>  
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c145_AsOf31Dec2012" decimals="INF">20000000</us-gaap:PreferredStockSharesAuthorized> 
  <us-gaap:DebtInstrumentPaymentTerms contextRef="c142_From1Oct2012To1Oct2012_NotesPayableOtherPayablesMember_AffiliatedEntityMember">Company was obligated to issue additional preferred stock equal in lieu of payment of cash of accrued and unpaid interest on each six month anniversary of the effective date (October 1, 2012).</us-gaap:DebtInstrumentPaymentTerms>    
  <us-gaap:PreferredStockVotingRights contextRef="c146_From1Oct2012To1Oct2012_SeriesAPreferredStockMember">modify the voting rights of the subsequently cancelled Series A Convertible Preferred Stock from 20 votes per share on matters to be voted on by the common stock holders to 25 votes per share on matters to be voted on by the common stock holders and all prior and subsequent payments of interest will be in common stock</us-gaap:PreferredStockVotingRights>    
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c147_From1Mar2017To1Mar2017" decimals="-6">20000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1> 
  <us-gaap:StockholdersEquityOtherShares unitRef="shares" contextRef="c148_From1Mar2017To1Mar2017_NorthstarClaimsMember" decimals="-6">11000000</us-gaap:StockholdersEquityOtherShares>    
  <usrm:PercentageOfRevenuesToBeReceivedAsRoyalty unitRef="pure" contextRef="c148_From1Mar2017To1Mar2017_NorthstarClaimsMember" decimals="2">0.10</usrm:PercentageOfRevenuesToBeReceivedAsRoyalty>     
  <usrm:NumberOfDirectors unitRef="pure" contextRef="c148_From1Mar2017To1Mar2017_NorthstarClaimsMember" decimals="0">2</usrm:NumberOfDirectors>    
  <us-gaap:EquityMethodInvestmentOwnershipPercentage unitRef="pure" contextRef="c149_AsOf1Mar2017_NorthstarClaimsMember" decimals="2">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage> 
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c150_From9Mar2017To9Mar2017_StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember_NorthstarClaimsMember" decimals="INF">30000000</us-gaap:StockIssuedDuringPeriodSharesOther> 
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c151_From1Apr2017To1Apr2017_StockIssuedForConversionOfSeriesAPreferredStockAndLitigationCaseMember_NorthstarClaimsMember" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesOther>     
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c152_From1Jan2013To31Dec2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember_SeriesAPreferredStockMember" decimals="0">316800</us-gaap:StockIssuedDuringPeriodValueOther>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c153_From30Sep2013To30Sep2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">8772</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>     
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c153_From30Sep2013To30Sep2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">100000</us-gaap:DebtConversionOriginalDebtAmount1> 
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c154_From24Dec2013To24Dec2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">3916</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>     
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c154_From24Dec2013To24Dec2013_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">85447</us-gaap:DebtConversionOriginalDebtAmount1>     
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c155_From2Apr2014To2Apr2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">275</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>  
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c155_From2Apr2014To2Apr2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12635</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c156_From3Oct2014To3Oct2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">515</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>  
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c156_From3Oct2014To3Oct2014_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12705</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c157_From3Apr2015To3Apr2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">1363</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>   
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c157_From3Apr2015To3Apr2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12635</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c158_From2Oct2015To2Oct2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">4156</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>   
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c158_From2Oct2015To2Oct2015_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12705</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c159_From7Oct2015To7Oct2015" decimals="INF">34522</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>    
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c159_From7Oct2015To7Oct2015" decimals="0">100000</us-gaap:DebtConversionOriginalDebtAmount1>    
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c160_From7Apr2016To7Apr2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">57778</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>    
  <us-gaap:DebtConversionConvertedInstrumentAmount1 unitRef="usd" contextRef="c160_From7Apr2016To7Apr2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12705</us-gaap:DebtConversionConvertedInstrumentAmount1>  
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c161_From6Oct2016To6Oct2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">848490</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>     
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c161_From6Oct2016To6Oct2016_InterestMember_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12705</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c162_From1Apr2017To1Apr2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">286315</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>     
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c162_From1Apr2017To1Apr2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12703</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c163_From2Oct2017To2Oct2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="INF">559187</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>     
  <us-gaap:DebtConversionOriginalDebtAmount1 unitRef="usd" contextRef="c163_From2Oct2017To2Oct2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">12705</us-gaap:DebtConversionOriginalDebtAmount1>   
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c164_AsOf30Sep2018_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">262000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c165_AsOf31Dec2017_NotesPayableOtherPayablesMember_AffiliatedEntityMember" decimals="0">262000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c166_AsOf1Jul2014_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:DebtInstrumentFaceAmount>     
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c166_AsOf1Jul2014_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>     
  <us-gaap:DebtInstrumentMaturityDate contextRef="c167_From1Jul2014To1Jul2014_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">2015-01-01</us-gaap:DebtInstrumentMaturityDate>  
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c168_From1Jan2018To30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">101729</us-gaap:RepaymentsOfNotesPayable> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c169_AsOf30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c170_AsOf31Dec2017_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">101729</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c171_AsOf6Sep2016_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:DebtInstrumentFaceAmount>     
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c171_AsOf6Sep2016_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>     
  <us-gaap:RepaymentsOfNotesPayable unitRef="usd" contextRef="c172_From1Jan2018To30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">356740</us-gaap:RepaymentsOfNotesPayable> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c173_AsOf30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">143260</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent unitRef="usd" contextRef="c174_AsOf31Dec2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>    
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c175_AsOf7Aug2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:DebtInstrumentFaceAmount>     
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c175_AsOf7Aug2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>     
  <us-gaap:DebtInstrumentTerm contextRef="c176_From7Aug2017To7Aug2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">P1Y</us-gaap:DebtInstrumentTerm>   
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c177_AsOf30Sep2018_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c178_AsOf31Dec2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c179_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:DebtInstrumentFaceAmount>     
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c179_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>     
  <us-gaap:DebtInstrumentTerm contextRef="c180_From7May2018To7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember">P6M</us-gaap:DebtInstrumentTerm>   
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c179_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>    
  <us-gaap:InterestPayableCurrentAndNoncurrent unitRef="usd" contextRef="c181_AsOf30Sep2018_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">325601</us-gaap:InterestPayableCurrentAndNoncurrent>    
  <us-gaap:InterestPayableCurrentAndNoncurrent unitRef="usd" contextRef="c182_AsOf31Dec2017_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">281903</us-gaap:InterestPayableCurrentAndNoncurrent>    
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c183_AsOf6Sep2016_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c183_AsOf6Sep2016_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage> 
  <us-gaap:RepaymentsOfRelatedPartyDebt unitRef="usd" contextRef="c184_From1Jan2018To30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">84502</us-gaap:RepaymentsOfRelatedPartyDebt>    
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c185_AsOf30Sep2018_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">153295</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c186_AsOf31Dec2017_NotePayable1Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">237797</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c187_AsOf7Aug2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c187_AsOf7Aug2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage> 
  <us-gaap:DebtInstrumentTerm contextRef="c188_From7Aug2017To7Aug2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">P1Y</us-gaap:DebtInstrumentTerm>    
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c189_AsOf30Sep2018_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c190_AsOf31Dec2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:DebtInstrumentFaceAmount unitRef="usd" contextRef="c191_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:DebtInstrumentFaceAmount> 
  <us-gaap:DebtInstrumentInterestRateStatedPercentage unitRef="pure" contextRef="c191_AsOf7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="2">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage> 
  <us-gaap:DebtInstrumentTerm contextRef="c192_From7May2018To7May2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember">P6M</us-gaap:DebtInstrumentTerm>    
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c193_AsOf30Sep2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:InterestPayableCurrentAndNoncurrent unitRef="usd" contextRef="c194_AsOf30Sep2018_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">93480</us-gaap:InterestPayableCurrentAndNoncurrent>    
  <us-gaap:InterestPayableCurrentAndNoncurrent unitRef="usd" contextRef="c195_AsOf31Dec2017_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">69108</us-gaap:InterestPayableCurrentAndNoncurrent>    
  <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="c196_From1May2016To1May2016_AffiliatedEntityMember">The agreement is for 12 months and renewable for 6 month periods.&amp;#xa0; Compensation is at $250 per hour or, at the Company&amp;#x2019;s discretion, in shares of the Company&amp;#x2019;s common stock</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>     
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c197_From1Jul2018To30Sep2018_AffiliatedEntityMember" decimals="0">30000</us-gaap:ProfessionalFees>   
  <us-gaap:ProfessionalFees unitRef="usd" contextRef="c198_From1Jan2018To30Sep2018_AffiliatedEntityMember" decimals="0">90000</us-gaap:ProfessionalFees>   
  <us-gaap:AccountsPayableRelatedPartiesCurrent unitRef="usd" contextRef="c199_AsOf30Sep2018_AffiliatedEntityMember" decimals="0">116909</us-gaap:AccountsPayableRelatedPartiesCurrent>    
  <us-gaap:AccountsPayableRelatedPartiesCurrent unitRef="usd" contextRef="c200_AsOf31Dec2017_AffiliatedEntityMember" decimals="0">187409</us-gaap:AccountsPayableRelatedPartiesCurrent>    
  <usrm:PercentageOfRenenueAccruedForMarketing unitRef="pure" contextRef="c67_From3Mar2017To3Mar2017" decimals="2">0.10</usrm:PercentageOfRenenueAccruedForMarketing> 
  <us-gaap:SaleLeasebackTransactionDescription contextRef="c67_From3Mar2017To3Mar2017">Company agreed to sell, for $50,000, the first 5,000 customers of the cell banking business after the effective date of the equipment sale/leaseback agreement with rights to purchase additional customers at a price of $20 per customer.&amp;#xa0; There is no reduction in the selling price should the new customers be fewer than 5,000.&amp;#xa0; The effective date of the sale is upon the expiry or early termination of the related equipment lease transaction</us-gaap:SaleLeasebackTransactionDescription>  
  <usrm:InvestmentAgreementValue unitRef="usd" contextRef="c201_From3Apr2017To3Apr2017_GACPStemCellBankLLCMember" decimals="0">5000000</usrm:InvestmentAgreementValue>  
  <usrm:InvestmentAgreementNumberOfShares unitRef="shares" contextRef="c201_From3Apr2017To3Apr2017_GACPStemCellBankLLCMember" decimals="INF">63873275</usrm:InvestmentAgreementNumberOfShares> 
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity unitRef="usd" contextRef="c202_From1Jan2018To30Sep2018_GACPStemCellBankLLCMember" decimals="0">250000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>   
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c202_From1Jan2018To30Sep2018_GACPStemCellBankLLCMember" decimals="INF">858281</us-gaap:StockIssuedDuringPeriodSharesNewIssues> 
  <usrm:InvestmentAgreementValue unitRef="usd" contextRef="c203_From1May2017To1May2017_GACPStemCellBankLLCMember" decimals="0">3000000</usrm:InvestmentAgreementValue>  
  <usrm:SharesHeldByAffiliate unitRef="shares" contextRef="c204_AsOf30Sep2018_GACPStemCellBankLLCMember" decimals="INF">4021945</usrm:SharesHeldByAffiliate>  
  <usrm:SharesHeldByAffiliate unitRef="shares" contextRef="c205_AsOf31Dec2017_GACPStemCellBankLLCMember" decimals="INF">4021945</usrm:SharesHeldByAffiliate>  
  <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;     
Officer and Director Notes&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;     
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2059&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2060&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2061&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2062&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2063&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2064&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2065&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2066&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2067&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2068&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2069&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2070&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2071&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;101,729&lt;/td&gt;  
			&lt;td id=&quot;new_id-2072&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2073&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2074&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2075&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;143,260&lt;/td&gt;  
			&lt;td id=&quot;new_id-2076&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2077&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2078&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2079&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2080&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2081&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2082&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2083&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2084&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2085&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2086&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2087&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2088&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Mr. Tomas&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2089&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2090&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2091&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;500,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2092&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2093&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2094&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2095&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2096&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2097&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2098&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2099&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;153,295&lt;/td&gt;  
			&lt;td id=&quot;new_id-2100&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2101&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2102&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2103&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;237,797&lt;/td&gt;  
			&lt;td id=&quot;new_id-2104&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2105&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2106&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2107&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;300,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2108&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2109&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2110&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2111&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;300,000&lt;/td&gt;  
			&lt;td id=&quot;new_id-2112&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Note payable, Dr. Comella&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2113&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2114&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2115&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;300,000&lt;/td&gt; 
			&lt;td id=&quot;new_id-2116&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2117&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2118&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2119&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;-&lt;/td&gt;     
			&lt;td id=&quot;new_id-2120&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Total&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2121&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2122&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2123&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,896,555&lt;/td&gt;    
			&lt;td id=&quot;new_id-2124&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2125&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2126&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2127&quot; style=&quot;width: 16%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;1,639,526&lt;/td&gt;    
			&lt;td id=&quot;new_id-2128&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c174_AsOf31Dec2017_NotePayable2Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c206_AsOf30Sep2018_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c207_AsOf31Dec2017_NotePayable4Member_NotesPayableOtherPayablesMember_ChiefExecutiveOfficerMember" decimals="0">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c208_AsOf30Sep2018_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c209_AsOf31Dec2017_NotePayable3Member_NotesPayableOtherPayablesMember_ChiefScientificOfficerMember" decimals="0">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent> 
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">1896555</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">1639526</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>     
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;NOTE 8 &amp;#x2014; STOCKHOLDERS&amp;#x2019; EQUITY&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;During the nine months ended September 30, 2018, the Company issued an aggregate of 8,988,508 shares of its common stock in settlement of outstanding accounts payable and accrued expenses. In connection with the issuance, the Company incurred a $14,625 net loss in settlement of debt.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;During the nine months ended September 30, 2018, the Company issued an aggregate of 7,866,274 shares of its common stock for services.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;During the nine months ended September 30, 2018, the Company issued an aggregate of 9,350,508 shares of its common stock for $367,700.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In December 1999, the Board of Directors and shareholders adopted the 1999 Officers and Employees Stock Option Plan, or the Employee Plan, and the 1999 Directors and Consultants Stock Option Plan, or the Director Plan. The Employee Plan and the Director Plan are collectively referred to herein as the &amp;#x201c;Plans&amp;#x201d; The Plans are administered by the Board of Directors and the Compensation Committee. The objectives of the Plans include attracting and retaining key personnel by encouraging stock ownership in the Company by such persons. In February 2010, the Directors &amp;amp; Consultants Plan was amended to extend the termination date of the Plan to December 1, 2011.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On April 1, 2013, the Board of Directors approved, subject to subsequently received shareholder approval, the establishment of the Bioheart 2013 Omnibus Equity Compensation Plan, or the &amp;#x201c;2013 Omnibus Plan&amp;#x201d;. The 2013 Omnibus Plan initially reserved up to fifty thousand (50,000) shares of common stock for issuance. On August 4, 2014, the Board of Directors approved to set the reserve to one hundred thousand (100,000) shares of common stock for issuance and to close the 1999 Officers and Employees Stock Option Plan. On February 2, 2015, at the annual meeting of shareholders, the majority of shareholders approved the 2013 Omnibus Equity Compensation Plan. On November 2, 2015, the Board of Directors approved the increase of the reserve under the 2013 Omnibus Plan to&amp;#xa0;five hundred million (500,000,000) shares of common stock for issuance, effective September 16, 2016, approved an addition of twenty five million (25,000,000) shares of common stock to the reserve, effective April 21, 2017, approved an addition of twenty five million (25,000,000) shares of common stock to the reserve, effective August 7, 2017, approved an addition of thirty million (30,000,000) shares of common stock to the reserve and effective May 7, 2018, approved an addition of one hundred million (100,000,000) shares of common stock to reserve.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;A summary of options at September 30, 2018 and activity during the nine months then ended is presented below:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2129&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2130&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2131&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2132&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2133&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2134&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2135&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2136&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term (in years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2137&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2138&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2139&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2140&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2141&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2142&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2143&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2144&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2145&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2146&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2147&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2148&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2149&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 55%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options outstanding at January 1, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2150&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2151&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2152&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,630,763&lt;/td&gt;     
			&lt;td id=&quot;new_id-2153&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2154&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2155&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2156&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0280&lt;/td&gt; 
			&lt;td id=&quot;new_id-2157&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2158&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2159&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2160&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.2&lt;/td&gt;   
			&lt;td id=&quot;new_id-2161&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Granted&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2162&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2163&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2164&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;32,340,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2165&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2166&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2167&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2168&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03598&lt;/td&gt;  
			&lt;td id=&quot;new_id-2169&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2170&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2171&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2172&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10.0&lt;/td&gt;    
			&lt;td id=&quot;new_id-2173&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercised&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2174&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2175&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2176&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;&amp;#x2014;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2177&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2178&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2179&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2180&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2181&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2182&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2183&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2184&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2185&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Forfeited/Expired&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2186&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2187&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2188&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(70&lt;/td&gt;  
			&lt;td id=&quot;new_id-2189&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2190&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2191&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2192&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,625.080&lt;/td&gt;    
			&lt;td id=&quot;new_id-2193&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2194&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2195&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2196&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2197&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options outstanding at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2198&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2199&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2200&quot; style=&quot;width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;103,970,693&lt;/td&gt;    
			&lt;td id=&quot;new_id-2201&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2202&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2203&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2204&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03362&lt;/td&gt;  
			&lt;td id=&quot;new_id-2205&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2206&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2207&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2208&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2209&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options exercisable at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2210&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2211&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2212&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;34,085,519&lt;/td&gt;     
			&lt;td id=&quot;new_id-2213&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2214&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2215&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2216&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02842&lt;/td&gt;  
			&lt;td id=&quot;new_id-2217&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2218&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2219&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2220&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2221&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Available for grant at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2222&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2223&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2224&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;84,068,070&lt;/td&gt;    
			&lt;td id=&quot;new_id-2225&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2226&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2227&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2228&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2229&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2230&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2231&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2232&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2233&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;The following information applies to options outstanding and exercisable at September 30, 2018:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2234&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;br /&gt;   
			Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2235&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2236&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2237&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Number&lt;br /&gt; 
			Outstanding&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2238&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2239&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2240&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Option Outstanding Options Average Remaining Contractual Life (years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2241&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2242&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2243&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted Average&lt;br /&gt; 
			Exercise price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2244&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2245&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2246&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Number&lt;br /&gt; 
			Exercisable&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2247&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2248&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2249&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Options Exercisable Weighted Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2250&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2251&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2252&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2253&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2254&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2255&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2256&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;16,200,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2257&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2258&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2259&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2260&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.36&lt;/td&gt;    
			&lt;td id=&quot;new_id-2261&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2262&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2263&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2264&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2265&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2266&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2267&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2268&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,050,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2269&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2270&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2271&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2272&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2273&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2274&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2275&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2276&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2277&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2278&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2279&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;22,850,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2280&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2281&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2282&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2283&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;7.98&lt;/td&gt;    
			&lt;td id=&quot;new_id-2284&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2285&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2286&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2287&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2288&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2289&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2290&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2291&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;15,350,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2292&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2293&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2294&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2295&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2296&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2297&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2298&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2299&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2300&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2301&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2302&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,340,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2303&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2304&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2305&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2306&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2307&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2308&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2309&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2310&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2311&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2312&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2313&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2314&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2315&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2316&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2317&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2318&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2319&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2320&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2321&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2322&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2323&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2324&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2325&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;31,865,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2326&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2327&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2328&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2329&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2330&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2331&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2332&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2333&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2334&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2335&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2336&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2337&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14,060,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2338&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2339&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2340&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2341&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2342&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2343&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2344&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2345&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2346&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2347&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2348&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10,000&lt;/td&gt; 
			&lt;td id=&quot;new_id-2349&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2350&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2351&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2352&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2353&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2354&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2355&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2356&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2357&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2358&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2359&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2360&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,500&lt;/td&gt;     
			&lt;td id=&quot;new_id-2361&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2362&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2363&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2364&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2365&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2366&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2367&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2368&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2369&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2370&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2371&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;30,000,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2372&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2373&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2374&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2375&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.61&lt;/td&gt;    
			&lt;td id=&quot;new_id-2376&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2377&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2378&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2379&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2380&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2381&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2382&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2383&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2384&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2385&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2386&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2387&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2388&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2389&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2390&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2391&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2392&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2393&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2394&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;705,363&lt;/td&gt;  
			&lt;td id=&quot;new_id-2395&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2396&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2397&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2398&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;7.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2399&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2400&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2401&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2402&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2403&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2404&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2405&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2406&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;622,726&lt;/td&gt;  
			&lt;td id=&quot;new_id-2407&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2408&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2409&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2410&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2411&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2412&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2413&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2414&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2415&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2416&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2417&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;150&lt;/td&gt;   
			&lt;td id=&quot;new_id-2418&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2419&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2420&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2421&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;6.10&lt;/td&gt;    
			&lt;td id=&quot;new_id-2422&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2423&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2424&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2425&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2426&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2427&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2428&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2429&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;113&lt;/td&gt;   
			&lt;td id=&quot;new_id-2430&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2431&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2432&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2433&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2434&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2435&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2436&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2437&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2438&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2439&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2440&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;100&lt;/td&gt;   
			&lt;td id=&quot;new_id-2441&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2442&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2443&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2444&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.92&lt;/td&gt;    
			&lt;td id=&quot;new_id-2445&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2446&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2447&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2448&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2449&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2450&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2451&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2452&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;100&lt;/td&gt;   
			&lt;td id=&quot;new_id-2453&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2454&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2455&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2456&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2457&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2458&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2459&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2460&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2461&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2462&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2463&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40&lt;/td&gt;  
			&lt;td id=&quot;new_id-2464&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2465&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2466&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2467&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.87&lt;/td&gt;    
			&lt;td id=&quot;new_id-2468&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2469&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2470&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2471&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2472&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2473&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2474&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2475&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40&lt;/td&gt;  
			&lt;td id=&quot;new_id-2476&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2477&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2478&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2479&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2480&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2481&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2482&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2483&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2484&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2485&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2486&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;40&lt;/td&gt; 
			&lt;td id=&quot;new_id-2487&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2488&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2489&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2490&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1.36&lt;/td&gt;    
			&lt;td id=&quot;new_id-2491&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2492&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2493&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2494&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2495&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2496&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2497&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2498&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;40&lt;/td&gt; 
			&lt;td id=&quot;new_id-2499&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2500&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2501&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2502&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2503&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2504&quot; style=&quot;text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;&quot;&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Total&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2505&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2506&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2507&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2508&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;103,970,693&lt;/td&gt; 
			&lt;td id=&quot;new_id-2509&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2510&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2511&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2512&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2513&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2514&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2515&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2516&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03362&lt;/td&gt;  
			&lt;td id=&quot;new_id-2517&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2518&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2519&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2520&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;34,085,519&lt;/td&gt;     
			&lt;td id=&quot;new_id-2521&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2522&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2523&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2524&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02842&lt;/td&gt;  
			&lt;td id=&quot;new_id-2525&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The aggregate intrinsic value of the issued and exercisable options of $519,037 and $195,825, respectively, represents the total pretax intrinsic value, based on options with an exercise price less than the Company&amp;#x2019;s stock price of $0.0265 as of September 30, 2018, which would have been received by the option holders had those option holders exercised their options as of that date.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 7, 2018, the Company granted an aggregate 30,000,000 options to purchase the Company&amp;#x2019;s common stock at $0.0536 per share to key employees, vesting over 4 years, at grant date anniversary and exercisable over 10 years. The aggregate fair value of $1,438,473, determined using the Black Scholes option pricing model with the following assumptions: Dividend yield: 0%; Volatility: 261.13% and Risk free rate: 2.90%.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On August 8, 2018, the Company granted an aggregate 2,340,000 options to purchase the Company&amp;#x2019;s common stock at $0.02576 per share to key employees, vesting over 4 years, at grant date anniversary and exercisable over 10 years. The aggregate fair value of $91,988, determined using the Black Scholes option pricing model with the following assumptions: Dividend yield: 0%; Volatility: 217.72% and Risk free rate: 2.83%.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The fair value of all options vesting during the three and nine months ended September 30, 2018 of $168,159 and $387,783, respectively, was charged to current period operations.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018, the Company had approximately $2,142,697 of total unrecognized compensation cost related to non-vested awards granted under the 2013 Omnibus Plan, which the Company expects to recognize over a weighted average period of 1.76 years.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;A summary of common stock purchase warrants at September 30, 2018 and activity during the nine months ended September 30, 2018 is presented below:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;   
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2526&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2527&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2528&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2529&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2530&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2531&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2532&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2533&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term (in years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2534&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 55%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Outstanding at January 1, 2018&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2535&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2536&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2537&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;133,591&lt;/td&gt;  
			&lt;td id=&quot;new_id-2538&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2539&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2540&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2541&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;126.26&lt;/td&gt; 
			&lt;td id=&quot;new_id-2542&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2543&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2544&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2545&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.7&lt;/td&gt;   
			&lt;td id=&quot;new_id-2546&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Issued&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2547&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2548&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2549&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,000,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2550&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2551&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2552&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2553&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02713&lt;/td&gt;  
			&lt;td id=&quot;new_id-2554&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2555&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2556&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2557&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10.0&lt;/td&gt;    
			&lt;td id=&quot;new_id-2558&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercised&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2559&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2560&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2561&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2562&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2563&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2564&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2565&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2566&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2567&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2568&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2569&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2570&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Expired&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2571&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2572&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2573&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(15,572&lt;/td&gt; 
			&lt;td id=&quot;new_id-2574&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2575&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2576&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2577&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;26.72&lt;/td&gt;     
			&lt;td id=&quot;new_id-2578&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2579&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2580&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2581&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2582&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Outstanding at September 30, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2583&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2584&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2585&quot; style=&quot;width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,118,019&lt;/td&gt;  
			&lt;td id=&quot;new_id-2586&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2587&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2588&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2589&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14.739&lt;/td&gt; 
			&lt;td id=&quot;new_id-2590&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2591&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2592&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2593&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.3&lt;/td&gt;   
			&lt;td id=&quot;new_id-2594&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercisable at September 30, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2595&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2596&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2597&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;116,474&lt;/td&gt;  
			&lt;td id=&quot;new_id-2598&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2599&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2600&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2601&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;39.24&lt;/td&gt;     
			&lt;td id=&quot;new_id-2602&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2603&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2604&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2605&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2606&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The following information applies to common stock purchase warrants outstanding and exercisable at September 30, 2018:&lt;/p&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;     
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td id=&quot;new_id-2607&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;10&quot; id=&quot;new_id-2608&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Warrants Outstanding&lt;/b&gt;&amp;#xa0;&lt;b&gt;&amp;#xa0;&amp;#xa0;&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2609&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2610&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;6&quot; id=&quot;new_id-2611&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Warrants Exercisable&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2612&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td id=&quot;new_id-2613&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2614&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;br /&gt;   
			Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2615&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2616&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2617&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2618&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2619&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2620&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2621&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2622&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2623&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2624&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2625&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2626&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2627&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2628&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2629&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2630&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2631&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2632&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2633&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.01 &amp;#x2013; 20.00&lt;/td&gt;   
			&lt;td id=&quot;new_id-2634&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2635&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2636&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2637&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,090,536&lt;/td&gt;    
			&lt;td id=&quot;new_id-2638&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2639&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2640&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2641&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.5&lt;/td&gt;   
			&lt;td id=&quot;new_id-2642&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2643&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2644&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2645&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1.312&lt;/td&gt;     
			&lt;td id=&quot;new_id-2646&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2647&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2648&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2649&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;90,536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2650&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2651&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2652&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2653&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;15.60&lt;/td&gt;     
			&lt;td id=&quot;new_id-2654&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2655&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2656&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2657&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;20.01 &amp;#x2013; 30.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2658&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2659&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2660&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2661&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19,543&lt;/td&gt; 
			&lt;td id=&quot;new_id-2662&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2663&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2664&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2665&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2666&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2667&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2668&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2669&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;25.06&lt;/td&gt;     
			&lt;td id=&quot;new_id-2670&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2671&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2672&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2673&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19,543&lt;/td&gt; 
			&lt;td id=&quot;new_id-2674&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2675&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2676&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2677&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;25.06&lt;/td&gt;     
			&lt;td id=&quot;new_id-2678&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2679&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2680&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2681&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40.01 - 50.00&lt;/td&gt;   
			&lt;td id=&quot;new_id-2682&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2683&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2684&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2685&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,253&lt;/td&gt;     
			&lt;td id=&quot;new_id-2686&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2687&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2688&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2689&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.0&lt;/td&gt;   
			&lt;td id=&quot;new_id-2690&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2691&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2692&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2693&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;48.83&lt;/td&gt;     
			&lt;td id=&quot;new_id-2694&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2695&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2696&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2697&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,253&lt;/td&gt;     
			&lt;td id=&quot;new_id-2698&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2699&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2700&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2701&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;48.83&lt;/td&gt;     
			&lt;td id=&quot;new_id-2702&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2703&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2704&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2705&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;50.01 &amp;#x2013; 60.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2706&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2707&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2708&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2709&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;543&lt;/td&gt;   
			&lt;td id=&quot;new_id-2710&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2711&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2712&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2713&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2714&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2715&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2716&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2717&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2718&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2719&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2720&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2721&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;543&lt;/td&gt;   
			&lt;td id=&quot;new_id-2722&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2723&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2724&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2725&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2726&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2727&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2728&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:right;&quot;&gt;&amp;gt; $60.00&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2729&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2730&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2731&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt;     
			&lt;td id=&quot;new_id-2732&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;5,144&lt;/td&gt;    
			&lt;td id=&quot;new_id-2733&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2734&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2735&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2736&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;3.0&lt;/td&gt;   
			&lt;td id=&quot;new_id-2737&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2738&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2739&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2740&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,800.69&lt;/td&gt;   
			&lt;td id=&quot;new_id-2741&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2742&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2743&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2744&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;3,599&lt;/td&gt;    
			&lt;td id=&quot;new_id-2745&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2746&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2747&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2748&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;701.78&lt;/td&gt; 
			&lt;td id=&quot;new_id-2749&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2750&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2751&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2752&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2753&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2754&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2755&quot; style=&quot;width: 1%; border-bottom: 3px double rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2756&quot; style=&quot;width: 13%; border-bottom: 3px double rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,118,019&lt;/td&gt;    
			&lt;td id=&quot;new_id-2757&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2758&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2759&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2760&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.3&lt;/td&gt;   
			&lt;td id=&quot;new_id-2761&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2762&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2763&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2764&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14.74&lt;/td&gt;     
			&lt;td id=&quot;new_id-2765&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2766&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2767&quot; style=&quot;width: 1%; border-bottom: 3px double rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2768&quot; style=&quot;width: 13%; border-bottom: 3px double rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;116,474&lt;/td&gt;  
			&lt;td id=&quot;new_id-2769&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2770&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2771&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2772&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;39.240&lt;/td&gt; 
			&lt;td id=&quot;new_id-2773&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On August 27, 2018, the Company issued 1,000,000 warrants to purchase the Company&amp;#x2019;s common stock at $0.02713 per share for services rendered, vesting 6 months from issuance and exercisable over 10 years. The aggregate fair value of $24,986, determined using the Black Scholes option pricing model with the following assumptions: Dividend yield: 0%; Volatility: 217.01% and Risk free rate: 2.85%.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The aggregate intrinsic value of the issued and exercisable warrants of $-0- represents the total pretax intrinsic value, based on warrants with an exercise price less than the Company&amp;#x2019;s stock price of $0.0265 as of September 30, 2018, which would have been received by the warrant holders had those warrants holders exercised their warrants as of that date.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock> 
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 unitRef="shares" contextRef="c210_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAndAccruedExpensesMember" decimals="INF">8988508</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>   
  <us-gaap:GainsLossesOnExtinguishmentOfDebt unitRef="usd" contextRef="c210_From1Jan2018To30Sep2018_CommonStockIssuedInSettlementOfAccountsPayableAndAccruedExpensesMember" decimals="0">-14625</us-gaap:GainsLossesOnExtinguishmentOfDebt> 
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">7866274</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices> 
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">9350508</us-gaap:StockIssuedDuringPeriodSharesNewIssues>     
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c211_AsOf1Apr2013_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-3">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c212_AsOf4Aug2014_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-3">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c213_AsOf2Nov2015_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-6">500000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>     
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized unitRef="shares" contextRef="c214_From16Sep2016To16Sep2016_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-6">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized unitRef="shares" contextRef="c215_From21Apr2017To21Apr2017_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-6">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized unitRef="shares" contextRef="c216_From7Aug2017To7Aug2017_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-6">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>    
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized unitRef="shares" contextRef="c217_From7May2018To7May2018_Bioheart2013OmnibusEquityCompensationPlanMember" decimals="-6">100000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>     
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">519037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>    
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">195825</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>  
  <us-gaap:SharePrice unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="4">0.0265</us-gaap:SharePrice> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c218_From7May2018To7May2018" decimals="INF">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> 
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c218_From7May2018To7May2018" decimals="4">0.0536</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c218_From7May2018To7May2018">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>     
  <usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm contextRef="c218_From7May2018To7May2018">P10Y</usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c218_From7May2018To7May2018" decimals="0">1438473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>     
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c218_From7May2018To7May2018" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c218_From7May2018To7May2018" decimals="4">2.6113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c218_From7May2018To7May2018" decimals="4">0.0290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>   
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c219_From8Aug2018To8Aug2018" decimals="INF">2340000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>     
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c219_From8Aug2018To8Aug2018" decimals="5">0.02576</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c219_From8Aug2018To8Aug2018">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>     
  <usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm contextRef="c219_From8Aug2018To8Aug2018">P10Y</usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c219_From8Aug2018To8Aug2018" decimals="0">91988</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>   
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c219_From8Aug2018To8Aug2018" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c219_From8Aug2018To8Aug2018" decimals="4">2.1772</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c219_From8Aug2018To8Aug2018" decimals="4">0.0283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>   
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 unitRef="usd" contextRef="c220_From1Jul2018To30Sep2018_EmployeeStockOptionMember" decimals="0">168159</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1> 
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 unitRef="usd" contextRef="c221_From1Jan2018To30Sep2018_EmployeeStockOptionMember" decimals="0">387783</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1> 
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions unitRef="usd" contextRef="c222_AsOf30Sep2018_EmployeeStockOptionMember" decimals="0">2142697</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>   
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c221_From1Jan2018To30Sep2018_EmployeeStockOptionMember">P1Y277D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>    
  <usrm:ClassOfWarrantOrRightsGranted unitRef="shares" contextRef="c223_From27Aug2018To27Aug2018" decimals="INF">1000000</usrm:ClassOfWarrantOrRightsGranted>   
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c224_AsOf27Aug2018" decimals="5">0.02713</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>     
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c223_From27Aug2018To27Aug2018">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>  
  <usrm:WarrantsTerm contextRef="c223_From27Aug2018To27Aug2018">P10Y</usrm:WarrantsTerm>    
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c223_From27Aug2018To27Aug2018" decimals="0">24986</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c223_From27Aug2018To27Aug2018" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>   
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c223_From27Aug2018To27Aug2018" decimals="4">2.1701</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>    
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c223_From27Aug2018To27Aug2018" decimals="4">0.0285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>     
  <usrm:AggregateIntrinsicValueOfTheIssuedAndExercisableWarrants unitRef="usd" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</usrm:AggregateIntrinsicValueOfTheIssuedAndExercisableWarrants>    
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;   
A summary of options at September 30, 2018 and activity during the nine months then ended is presented below:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;  
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2129&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2130&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2131&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2132&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2133&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2134&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2135&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2136&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term (in years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2137&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2138&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2139&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2140&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2141&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2142&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2143&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2144&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2145&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2146&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2147&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2148&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2149&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 55%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options outstanding at January 1, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2150&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2151&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2152&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;71,630,763&lt;/td&gt;     
			&lt;td id=&quot;new_id-2153&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2154&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2155&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2156&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0280&lt;/td&gt; 
			&lt;td id=&quot;new_id-2157&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2158&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2159&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2160&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.2&lt;/td&gt;   
			&lt;td id=&quot;new_id-2161&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Granted&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2162&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2163&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2164&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;32,340,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2165&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2166&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2167&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2168&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03598&lt;/td&gt;  
			&lt;td id=&quot;new_id-2169&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2170&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2171&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2172&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10.0&lt;/td&gt;    
			&lt;td id=&quot;new_id-2173&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercised&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2174&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2175&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2176&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;&amp;#x2014;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2177&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2178&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2179&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2180&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2181&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2182&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2183&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2184&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2185&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Forfeited/Expired&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2186&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2187&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2188&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(70&lt;/td&gt;  
			&lt;td id=&quot;new_id-2189&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2190&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2191&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2192&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,625.080&lt;/td&gt;    
			&lt;td id=&quot;new_id-2193&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2194&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2195&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2196&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2197&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options outstanding at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2198&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2199&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2200&quot; style=&quot;width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;103,970,693&lt;/td&gt;    
			&lt;td id=&quot;new_id-2201&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2202&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2203&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2204&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03362&lt;/td&gt;  
			&lt;td id=&quot;new_id-2205&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2206&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2207&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2208&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2209&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Options exercisable at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2210&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2211&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2212&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;34,085,519&lt;/td&gt;     
			&lt;td id=&quot;new_id-2213&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2214&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2215&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2216&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02842&lt;/td&gt;  
			&lt;td id=&quot;new_id-2217&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2218&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2219&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2220&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2221&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Available for grant at September 30, 2018&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2222&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2223&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2224&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;84,068,070&lt;/td&gt;    
			&lt;td id=&quot;new_id-2225&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2226&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2227&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2228&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2229&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2230&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2231&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2232&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2233&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>    
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c29_AsOf31Dec2016" decimals="INF">71630763</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c29_AsOf31Dec2016" decimals="4">0.0280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>   
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c225_From1Jan2017To31Dec2017">P9Y73D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">32340000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> 
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="5">0.03598</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>  
  <usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm contextRef="c18_From1Jan2018To30Sep2018">P10Y</usrm:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm>  
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>   
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="3">2625.080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>    
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">103970693</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="5">0.03362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>   
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c18_From1Jan2018To30Sep2018">P8Y292D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">34085519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber> 
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="5">0.02842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>   
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c18_From1Jan2018To30Sep2018">P8Y146D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>  
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">84068070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>     
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;     
The following information applies to options outstanding and exercisable at September 30, 2018:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;   
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2234&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;br /&gt;   
			Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2235&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2236&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2237&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Number&lt;br /&gt; 
			Outstanding&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2238&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2239&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2240&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Option Outstanding Options Average Remaining Contractual Life (years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2241&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2242&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2243&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted Average&lt;br /&gt; 
			Exercise price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2244&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2245&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2246&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Number&lt;br /&gt; 
			Exercisable&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2247&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2248&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2249&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Options Exercisable Weighted Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2250&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2251&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2252&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2253&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2254&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2255&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2256&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;16,200,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2257&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2258&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2259&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2260&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.36&lt;/td&gt;    
			&lt;td id=&quot;new_id-2261&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2262&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2263&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2264&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2265&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2266&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2267&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2268&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4,050,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2269&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2270&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2271&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2272&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0043&lt;/td&gt; 
			&lt;td id=&quot;new_id-2273&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2274&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2275&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2276&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2277&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2278&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2279&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;22,850,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2280&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2281&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2282&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2283&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;7.98&lt;/td&gt;    
			&lt;td id=&quot;new_id-2284&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2285&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2286&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2287&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2288&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2289&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2290&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2291&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;15,350,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2292&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2293&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2294&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2295&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0196&lt;/td&gt; 
			&lt;td id=&quot;new_id-2296&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2297&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2298&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2299&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2300&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2301&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2302&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,340,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2303&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2304&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2305&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2306&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2307&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2308&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2309&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2310&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2311&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2312&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2313&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2314&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2315&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2316&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2317&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2318&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02576&lt;/td&gt;  
			&lt;td id=&quot;new_id-2319&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2320&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2321&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2322&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2323&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2324&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2325&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;31,865,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2326&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2327&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2328&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2329&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2330&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2331&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2332&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2333&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2334&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2335&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2336&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2337&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14,060,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2338&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2339&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2340&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2341&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03626&lt;/td&gt;  
			&lt;td id=&quot;new_id-2342&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2343&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2344&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2345&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2346&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2347&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2348&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10,000&lt;/td&gt; 
			&lt;td id=&quot;new_id-2349&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2350&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2351&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2352&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.86&lt;/td&gt;    
			&lt;td id=&quot;new_id-2353&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2354&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2355&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2356&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2357&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2358&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2359&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2360&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,500&lt;/td&gt;     
			&lt;td id=&quot;new_id-2361&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2362&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2363&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2364&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03680&lt;/td&gt;  
			&lt;td id=&quot;new_id-2365&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2366&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2367&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2368&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2369&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2370&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2371&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;30,000,000&lt;/td&gt;     
			&lt;td id=&quot;new_id-2372&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2373&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2374&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2375&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.61&lt;/td&gt;    
			&lt;td id=&quot;new_id-2376&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2377&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2378&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2379&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2380&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2381&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2382&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2383&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2384&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2385&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2386&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2387&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.0536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2388&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2389&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2390&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2391&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2392&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2393&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2394&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;705,363&lt;/td&gt;  
			&lt;td id=&quot;new_id-2395&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2396&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2397&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2398&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;7.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2399&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2400&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2401&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2402&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2403&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2404&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2405&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2406&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;622,726&lt;/td&gt;  
			&lt;td id=&quot;new_id-2407&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2408&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2409&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2410&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.15402&lt;/td&gt;  
			&lt;td id=&quot;new_id-2411&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2412&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2413&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2414&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2415&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2416&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2417&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;150&lt;/td&gt;   
			&lt;td id=&quot;new_id-2418&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2419&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2420&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2421&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;6.10&lt;/td&gt;    
			&lt;td id=&quot;new_id-2422&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2423&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2424&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2425&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2426&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2427&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2428&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2429&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;113&lt;/td&gt;   
			&lt;td id=&quot;new_id-2430&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2431&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2432&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2433&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19.32&lt;/td&gt;     
			&lt;td id=&quot;new_id-2434&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2435&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2436&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2437&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2438&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2439&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2440&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;100&lt;/td&gt;   
			&lt;td id=&quot;new_id-2441&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2442&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2443&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2444&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.92&lt;/td&gt;    
			&lt;td id=&quot;new_id-2445&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2446&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2447&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2448&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2449&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2450&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2451&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2452&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;100&lt;/td&gt;   
			&lt;td id=&quot;new_id-2453&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2454&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2455&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2456&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;70.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2457&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2458&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2459&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2460&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2461&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2462&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2463&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40&lt;/td&gt;  
			&lt;td id=&quot;new_id-2464&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2465&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2466&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2467&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.87&lt;/td&gt;    
			&lt;td id=&quot;new_id-2468&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2469&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2470&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2471&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2472&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2473&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2474&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2475&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40&lt;/td&gt;  
			&lt;td id=&quot;new_id-2476&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2477&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2478&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2479&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;210.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2480&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2481&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2482&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2483&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2484&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2485&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2486&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;40&lt;/td&gt; 
			&lt;td id=&quot;new_id-2487&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2488&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2489&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2490&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1.36&lt;/td&gt;    
			&lt;td id=&quot;new_id-2491&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2492&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2493&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2494&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2495&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2496&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2497&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2498&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;40&lt;/td&gt; 
			&lt;td id=&quot;new_id-2499&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2500&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2501&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2502&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;680.00&lt;/td&gt; 
			&lt;td id=&quot;new_id-2503&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2504&quot; style=&quot;text-align: justify; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;&quot;&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Total&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2505&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 1%;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2506&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2507&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2508&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;103,970,693&lt;/td&gt; 
			&lt;td id=&quot;new_id-2509&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2510&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2511&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2512&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;8.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2513&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2514&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2515&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2516&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.03362&lt;/td&gt;  
			&lt;td id=&quot;new_id-2517&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2518&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2519&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2520&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);&quot;&gt;34,085,519&lt;/td&gt;     
			&lt;td id=&quot;new_id-2521&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2522&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2523&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2524&quot; style=&quot;width: 14%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02842&lt;/td&gt;  
			&lt;td id=&quot;new_id-2525&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock> 
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c226_From1Jan2018To30Sep2018_Options0.0043ExercisePriceMember" decimals="4">0.0043</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>     
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c227_AsOf30Sep2018_Options0.0043ExercisePriceMember" decimals="INF">16200000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c226_From1Jan2018To30Sep2018_Options0.0043ExercisePriceMember">P8Y131D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c227_AsOf30Sep2018_Options0.0043ExercisePriceMember" decimals="4">0.0043</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> 
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c227_AsOf30Sep2018_Options0.0043ExercisePriceMember" decimals="INF">4050000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c227_AsOf30Sep2018_Options0.0043ExercisePriceMember" decimals="4">0.0043</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>    
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c228_From1Jan2018To30Sep2018_Options0.0196ExercisePriceMember" decimals="4">0.0196</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>     
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c229_AsOf30Sep2018_Options0.0196ExercisePriceMember" decimals="INF">22850000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c228_From1Jan2018To30Sep2018_Options0.0196ExercisePriceMember">P7Y357D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c229_AsOf30Sep2018_Options0.0196ExercisePriceMember" decimals="4">0.0196</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> 
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c229_AsOf30Sep2018_Options0.0196ExercisePriceMember" decimals="INF">15350000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c229_AsOf30Sep2018_Options0.0196ExercisePriceMember" decimals="4">0.0196</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>    
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c230_From1Jan2018To30Sep2018_Options002576ExercisePriceMember" decimals="5">0.02576</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice> 
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c231_AsOf30Sep2018_Options002576ExercisePriceMember" decimals="INF">2340000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c230_From1Jan2018To30Sep2018_Options002576ExercisePriceMember">P9Y313D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c231_AsOf30Sep2018_Options002576ExercisePriceMember" decimals="5">0.02576</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>  
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c231_AsOf30Sep2018_Options002576ExercisePriceMember" decimals="5">0.02576</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>     
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c232_From1Jan2018To30Sep2018_Options0.03626ExercisePriceMember" decimals="5">0.03626</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>  
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c233_AsOf30Sep2018_Options0.03626ExercisePriceMember" decimals="INF">31865000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c232_From1Jan2018To30Sep2018_Options0.03626ExercisePriceMember">P8Y313D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>  
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c233_AsOf30Sep2018_Options0.03626ExercisePriceMember" decimals="5">0.03626</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>   
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c233_AsOf30Sep2018_Options0.03626ExercisePriceMember" decimals="INF">14060000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c233_AsOf30Sep2018_Options0.03626ExercisePriceMember" decimals="5">0.03626</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> 
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c234_From1Jan2018To30Sep2018_Options0.03680ExercisePriceMember" decimals="5">0.03680</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>  
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c235_AsOf30Sep2018_Options0.03680ExercisePriceMember" decimals="INF">10000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>   
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c234_From1Jan2018To30Sep2018_Options0.03680ExercisePriceMember">P8Y313D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>  
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c235_AsOf30Sep2018_Options0.03680ExercisePriceMember" decimals="5">0.03680</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>   
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c235_AsOf30Sep2018_Options0.03680ExercisePriceMember" decimals="INF">2500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>  
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c235_AsOf30Sep2018_Options0.03680ExercisePriceMember" decimals="5">0.03680</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> 
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c236_From1Jan2018To30Sep2018_Options0.0536ExercisPriceMember" decimals="4">0.0536</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>    
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c237_AsOf30Sep2018_Options0.0536ExercisPriceMember" decimals="INF">30000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c236_From1Jan2018To30Sep2018_Options0.0536ExercisPriceMember">P9Y222D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c237_AsOf30Sep2018_Options0.0536ExercisPriceMember" decimals="4">0.0536</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>     
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c237_AsOf30Sep2018_Options0.0536ExercisPriceMember" decimals="0">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c237_AsOf30Sep2018_Options0.0536ExercisPriceMember" decimals="4">0.0536</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>   
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c238_From1Jan2018To30Sep2018_Options0.15402ExercisePriceMember" decimals="5">0.15402</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>  
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c239_AsOf30Sep2018_Options0.15402ExercisePriceMember" decimals="INF">705363</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c238_From1Jan2018To30Sep2018_Options0.15402ExercisePriceMember">P7Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>   
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c239_AsOf30Sep2018_Options0.15402ExercisePriceMember" decimals="5">0.15402</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>   
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c239_AsOf30Sep2018_Options0.15402ExercisePriceMember" decimals="INF">622726</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c239_AsOf30Sep2018_Options0.15402ExercisePriceMember" decimals="5">0.15402</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1> 
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c240_From1Jan2018To30Sep2018_Options19.32ExercisePriceMember" decimals="2">19.32</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>   
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c241_AsOf30Sep2018_Options19.32ExercisePriceMember" decimals="INF">150</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c240_From1Jan2018To30Sep2018_Options19.32ExercisePriceMember">P6Y36D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c241_AsOf30Sep2018_Options19.32ExercisePriceMember" decimals="2">19.32</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>    
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c241_AsOf30Sep2018_Options19.32ExercisePriceMember" decimals="INF">113</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c241_AsOf30Sep2018_Options19.32ExercisePriceMember" decimals="2">19.32</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>  
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c242_From1Jan2018To30Sep2018_Options70.00ExercisePriceMember" decimals="2">70.00</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>   
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c243_AsOf30Sep2018_Options70.00ExercisePriceMember" decimals="INF">100</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c242_From1Jan2018To30Sep2018_Options70.00ExercisePriceMember">P2Y335D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c243_AsOf30Sep2018_Options70.00ExercisePriceMember" decimals="2">70.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>    
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c243_AsOf30Sep2018_Options70.00ExercisePriceMember" decimals="INF">100</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c243_AsOf30Sep2018_Options70.00ExercisePriceMember" decimals="2">70.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>  
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c244_From1Jan2018To30Sep2018_Options210.00ExercisePriceMember" decimals="2">210.00</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>     
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c245_AsOf30Sep2018_Options210.00ExercisePriceMember" decimals="INF">40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c244_From1Jan2018To30Sep2018_Options210.00ExercisePriceMember">P2Y317D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c245_AsOf30Sep2018_Options210.00ExercisePriceMember" decimals="2">210.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> 
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c245_AsOf30Sep2018_Options210.00ExercisePriceMember" decimals="INF">40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c245_AsOf30Sep2018_Options210.00ExercisePriceMember" decimals="2">210.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>    
  <usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice unitRef="usdPershares" contextRef="c246_From1Jan2018To30Sep2018_Options680.00ExercisePriceMember" decimals="2">680.00</usrm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisePrice>     
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c247_AsOf30Sep2018_Options680.00ExercisePriceMember" decimals="INF">40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c246_From1Jan2018To30Sep2018_Options680.00ExercisePriceMember">P1Y131D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c247_AsOf30Sep2018_Options680.00ExercisePriceMember" decimals="2">680.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1> 
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c247_AsOf30Sep2018_Options680.00ExercisePriceMember" decimals="INF">40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>    
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c247_AsOf30Sep2018_Options680.00ExercisePriceMember" decimals="2">680.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>    
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">103970693</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions> 
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="c18_From1Jan2018To30Sep2018">P8Y292D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>  
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="5">0.03362</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>  
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">34085519</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>     
  <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="5">0.02842</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>     
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;    
A summary of common stock purchase warrants at September 30, 2018 and activity during the nine months ended September 30, 2018 is presented below:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2526&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2527&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2528&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2529&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2530&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2531&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2532&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2533&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term (in years)&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2534&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 55%;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Outstanding at January 1, 2018&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2535&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2536&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2537&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;133,591&lt;/td&gt;  
			&lt;td id=&quot;new_id-2538&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2539&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2540&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2541&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;126.26&lt;/td&gt; 
			&lt;td id=&quot;new_id-2542&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2543&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2544&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2545&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.7&lt;/td&gt;   
			&lt;td id=&quot;new_id-2546&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Issued&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2547&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2548&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2549&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,000,000&lt;/td&gt;    
			&lt;td id=&quot;new_id-2550&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2551&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2552&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2553&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.02713&lt;/td&gt;  
			&lt;td id=&quot;new_id-2554&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2555&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2556&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2557&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;10.0&lt;/td&gt;    
			&lt;td id=&quot;new_id-2558&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercised&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2559&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2560&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2561&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;-&lt;/td&gt; 
			&lt;td id=&quot;new_id-2562&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2563&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2564&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2565&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2566&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2567&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2568&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2569&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2570&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Expired&lt;/p&gt;     
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2571&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2572&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2573&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;(15,572&lt;/td&gt; 
			&lt;td id=&quot;new_id-2574&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;)&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2575&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2576&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2577&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;26.72&lt;/td&gt;     
			&lt;td id=&quot;new_id-2578&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2579&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2580&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2581&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2582&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Outstanding at September 30, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2583&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2584&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2585&quot; style=&quot;width: 12%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,118,019&lt;/td&gt;  
			&lt;td id=&quot;new_id-2586&quot; style=&quot;width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;    
			&lt;td id=&quot;new_id-2587&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2588&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2589&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14.739&lt;/td&gt; 
			&lt;td id=&quot;new_id-2590&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2591&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2592&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2593&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.3&lt;/td&gt;   
			&lt;td id=&quot;new_id-2594&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td style=&quot;text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;Exercisable at September 30, 2018&lt;/p&gt; 
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2595&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2596&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2597&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;116,474&lt;/td&gt;  
			&lt;td id=&quot;new_id-2598&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2599&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2600&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2601&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;39.24&lt;/td&gt;     
			&lt;td id=&quot;new_id-2602&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2603&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2604&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2605&quot; style=&quot;width: 12%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2606&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>     
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2017" decimals="INF">133591</us-gaap:ClassOfWarrantOrRightOutstanding> 
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c1_AsOf31Dec2017" decimals="2">126.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>  
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c225_From1Jan2017To31Dec2017">P4Y255D</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>    
  <usrm:ClassOfWarrantOrRightsGranted unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">1000000</usrm:ClassOfWarrantOrRightsGranted> 
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="5">0.02713</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted>  
  <usrm:ClassOfWarrantsOrRightsWarrantsGrantedWeightedAverageRemainingContractualTerm contextRef="c18_From1Jan2018To30Sep2018">P10Y</usrm:ClassOfWarrantsOrRightsWarrantsGrantedWeightedAverageRemainingContractualTerm>  
  <usrm:ClassOfWarrantOrRightsExercised unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="0">0</usrm:ClassOfWarrantOrRightsExercised>  
  <usrm:ClassOfWarrantOrRightsExpired unitRef="shares" contextRef="c18_From1Jan2018To30Sep2018" decimals="INF">15572</usrm:ClassOfWarrantOrRightsExpired>    
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExpired unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="2">26.72</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExpired>     
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">1118019</us-gaap:ClassOfWarrantOrRightOutstanding>  
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="3">14.739</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>  
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c18_From1Jan2018To30Sep2018">P9Y109D</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>   
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c0_AsOf30Sep2018" decimals="INF">116474</usrm:ClassOfWarrantOrRightsExercisable>  
  <usrm:ClassOfWarrantsOrRightsWarrantsExercisableWeightedAverageRemainingContractualTerm contextRef="c18_From1Jan2018To30Sep2018">P4Y146D</usrm:ClassOfWarrantsOrRightsWarrantsExercisableWeightedAverageRemainingContractualTerm>   
  <usrm:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family:  &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size:  10pt; &quot;&gt;     
The following information applies to common stock purchase warrants outstanding and exercisable at September 30, 2018:&lt;br /&gt;&lt;br /&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;finTable&quot; style=&quot;width: 100%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;&quot;&gt; 
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td id=&quot;new_id-2607&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;10&quot; id=&quot;new_id-2608&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Warrants Outstanding&lt;/b&gt;&amp;#xa0;&lt;b&gt;&amp;#xa0;&amp;#xa0;&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2609&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2610&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;6&quot; id=&quot;new_id-2611&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Warrants Exercisable&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2612&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom;&quot;&gt;     
			&lt;td id=&quot;new_id-2613&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2614&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;br /&gt;   
			Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2615&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2616&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2617&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2618&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2619&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2620&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2621&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2622&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2623&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2624&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2625&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2626&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2627&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2628&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2629&quot; style=&quot;text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;  
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;     
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/b&gt;&lt;/p&gt; 
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:center;&quot;&gt;&lt;b&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;   
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2630&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2631&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2632&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2633&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;0.01 &amp;#x2013; 20.00&lt;/td&gt;   
			&lt;td id=&quot;new_id-2634&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2635&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2636&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2637&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,090,536&lt;/td&gt;    
			&lt;td id=&quot;new_id-2638&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2639&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2640&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2641&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.5&lt;/td&gt;   
			&lt;td id=&quot;new_id-2642&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2643&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2644&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2645&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1.312&lt;/td&gt;     
			&lt;td id=&quot;new_id-2646&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2647&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2648&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2649&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;90,536&lt;/td&gt; 
			&lt;td id=&quot;new_id-2650&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2651&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2652&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2653&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;15.60&lt;/td&gt;     
			&lt;td id=&quot;new_id-2654&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2655&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2656&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2657&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;20.01 &amp;#x2013; 30.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2658&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2659&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2660&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2661&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19,543&lt;/td&gt; 
			&lt;td id=&quot;new_id-2662&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2663&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2664&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2665&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;5.4&lt;/td&gt;   
			&lt;td id=&quot;new_id-2666&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2667&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2668&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2669&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;25.06&lt;/td&gt;     
			&lt;td id=&quot;new_id-2670&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2671&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2672&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2673&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;19,543&lt;/td&gt; 
			&lt;td id=&quot;new_id-2674&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2675&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2676&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2677&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;25.06&lt;/td&gt;     
			&lt;td id=&quot;new_id-2678&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2679&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2680&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2681&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;40.01 - 50.00&lt;/td&gt;   
			&lt;td id=&quot;new_id-2682&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2683&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2684&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2685&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,253&lt;/td&gt;     
			&lt;td id=&quot;new_id-2686&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2687&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2688&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2689&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;4.0&lt;/td&gt;   
			&lt;td id=&quot;new_id-2690&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2691&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2692&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2693&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;48.83&lt;/td&gt;     
			&lt;td id=&quot;new_id-2694&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2695&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2696&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2697&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,253&lt;/td&gt;     
			&lt;td id=&quot;new_id-2698&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2699&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2700&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2701&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;48.83&lt;/td&gt;     
			&lt;td id=&quot;new_id-2702&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2703&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2704&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2705&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;50.01 &amp;#x2013; 60.00&lt;/td&gt;    
			&lt;td id=&quot;new_id-2706&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2707&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2708&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2709&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;543&lt;/td&gt;   
			&lt;td id=&quot;new_id-2710&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2711&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2712&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2713&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2.8&lt;/td&gt;   
			&lt;td id=&quot;new_id-2714&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2715&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2716&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2717&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2718&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2719&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2720&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2721&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;543&lt;/td&gt;   
			&lt;td id=&quot;new_id-2722&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2723&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2724&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2725&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;60.00&lt;/td&gt;     
			&lt;td id=&quot;new_id-2726&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(204, 238, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2727&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td colspan=&quot;2&quot; id=&quot;new_id-2728&quot; style=&quot;text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;    
			&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:right;&quot;&gt;&amp;gt; $60.00&lt;/p&gt;    
			&lt;/td&gt;     
			&lt;td id=&quot;new_id-2729&quot; style=&quot;font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2730&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2731&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;$&lt;/td&gt;     
			&lt;td id=&quot;new_id-2732&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;5,144&lt;/td&gt;    
			&lt;td id=&quot;new_id-2733&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2734&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2735&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2736&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;3.0&lt;/td&gt;   
			&lt;td id=&quot;new_id-2737&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2738&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2739&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2740&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;2,800.69&lt;/td&gt;   
			&lt;td id=&quot;new_id-2741&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2742&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2743&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2744&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);&quot;&gt;3,599&lt;/td&gt;    
			&lt;td id=&quot;new_id-2745&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2746&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2747&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2748&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;701.78&lt;/td&gt; 
			&lt;td id=&quot;new_id-2749&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
		&lt;tr style=&quot;vertical-align: bottom; background-color: rgb(255, 255, 255);&quot;&gt;   
			&lt;td id=&quot;new_id-2750&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2751&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2752&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;     
			&lt;td id=&quot;new_id-2753&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2754&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2755&quot; style=&quot;width: 1%; border-bottom: 3px double rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2756&quot; style=&quot;width: 13%; border-bottom: 3px double rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;1,118,019&lt;/td&gt;    
			&lt;td id=&quot;new_id-2757&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2758&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2759&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2760&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;9.3&lt;/td&gt;   
			&lt;td id=&quot;new_id-2761&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2762&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2763&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2764&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;14.74&lt;/td&gt;     
			&lt;td id=&quot;new_id-2765&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
			&lt;td id=&quot;new_id-2766&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;&quot;&gt;&amp;#xa0;&lt;/td&gt;   
			&lt;td id=&quot;new_id-2767&quot; style=&quot;width: 1%; border-bottom: 3px double rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2768&quot; style=&quot;width: 13%; border-bottom: 3px double rgb(0, 0, 0); text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;116,474&lt;/td&gt;  
			&lt;td id=&quot;new_id-2769&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2770&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;&quot;&gt;&amp;#xa0;&lt;/td&gt;  
			&lt;td id=&quot;new_id-2771&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;$&lt;/td&gt; 
			&lt;td id=&quot;new_id-2772&quot; style=&quot;width: 13%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt;&quot;&gt;39.240&lt;/td&gt; 
			&lt;td id=&quot;new_id-2773&quot; style=&quot;width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; white-space: nowrap;&quot;&gt;&amp;#xa0;&lt;/td&gt; 
		&lt;/tr&gt;    
&lt;/table&gt;&lt;/div&gt;</usrm:ScheduleOfWarrantsOrRightsSharesAuthorizedByExercisePriceRangeTableTextBlock> 
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c248_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member_MinimumMember" decimals="2">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>    
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c249_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member_MaximumMember" decimals="2">20.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>     
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c250_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member" decimals="INF">1090536</us-gaap:ClassOfWarrantOrRightOutstanding>  
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c251_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member">P9Y6M</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>     
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c251_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member" decimals="3">1.312</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>  
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c250_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member" decimals="INF">90536</usrm:ClassOfWarrantOrRightsExercisable> 
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c250_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange0.01_20.00Member" decimals="2">15.60</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>  
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c252_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member_MinimumMember" decimals="2">20.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c253_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member_MaximumMember" decimals="2">30.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c254_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member" decimals="INF">19543</us-gaap:ClassOfWarrantOrRightOutstanding> 
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c255_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member">P5Y146D</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>   
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c255_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member" decimals="2">25.06</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>   
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c254_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member" decimals="INF">19543</usrm:ClassOfWarrantOrRightsExercisable>  
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c254_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange20.01_30.00Member" decimals="2">25.06</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>   
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c256_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member_MinimumMember" decimals="2">40.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c257_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member_MaximumMember" decimals="2">50.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c258_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member" decimals="INF">2253</us-gaap:ClassOfWarrantOrRightOutstanding>     
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c259_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member">P4Y</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>    
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c259_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member" decimals="2">48.83</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>   
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c258_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member" decimals="INF">2253</usrm:ClassOfWarrantOrRightsExercisable> 
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c258_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange40.01_50.00Member" decimals="2">48.83</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>   
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c260_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member_MinimumMember" decimals="2">50.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c261_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member_MaximumMember" decimals="2">60.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> 
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c262_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member" decimals="INF">543</us-gaap:ClassOfWarrantOrRightOutstanding>    
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c263_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member">P2Y292D</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>   
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c263_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member" decimals="2">60.00</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>   
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c262_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member" decimals="INF">543</usrm:ClassOfWarrantOrRightsExercisable>     
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c262_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRange50.01_60.00Member" decimals="2">60.00</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>   
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 unitRef="usdPershares" contextRef="c264_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member" decimals="2">60.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>  
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c264_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member" decimals="INF">5144</us-gaap:ClassOfWarrantOrRightOutstanding>     
  <usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm contextRef="c265_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member">P3Y</usrm:ClassOfWarrantsOrRightsWarrantsOutstandingWeightedAverageRemainingContractualTerm>    
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c265_From1Jan2018To30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member" decimals="2">2800.69</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>     
  <usrm:ClassOfWarrantOrRightsExercisable unitRef="shares" contextRef="c264_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member" decimals="INF">3599</usrm:ClassOfWarrantOrRightsExercisable> 
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c264_AsOf30Sep2018_ClassOfWarrantsOrRightsExercisePriceRangeGreaterThan60.00Member" decimals="2">701.78</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>    
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding unitRef="usdPershares" contextRef="c18_From1Jan2018To30Sep2018" decimals="2">14.74</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding>   
  <usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable unitRef="usdPershares" contextRef="c0_AsOf30Sep2018" decimals="3">39.240</usrm:ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable>   
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;   
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 9 &amp;#x2014; COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;&lt;b&gt;Litigation&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On December 12, 2017, a product liability lawsuit was filed in Broward County, specifically Jeannine Mallard v. U.S. Stem Cell, Inc., US Stem Cell Clinics LLC., Regenestem, LLC., Regenestem Network, LLC., and Kristin C. Comella. The Company will continue to defend it vigorously.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On September 17, 2015, a product liability lawsuit was filed in Broward County, specifically Patsy Bade v. Bioheart, Inc. US Stem Cell Clinics LLC, Alejandro Perez, ARNP, and Shareen Greenbaum, M.D., and on November 30, 2015, a product liability lawsuit was filed in Broward County, specifically Elizabeth Noble v. Bioheart, Inc. US Stem Cell Clinics LLC, Alejandro Perez, ARNP, and Shareen Greenbaum, M.D. During the year ended December 31, 2016, both matters settled by the Company&amp;#x2019;s insurance policy with no additional cost to the Company, excluding the Company payment of&amp;#xa0;the $100,000 insurance company deductible of which $11,000 was paid in fiscal 2017. As a result of the final settlement and determination of insurance coverage, the Company recognized $100,000 of expense due to litigation for the year ended December 31, 2017, of which $89,000 is included in accrued expenses at September 30, 2018 and December 31, 2017.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company is subject at times to other legal proceedings and claims, which arise in the ordinary course of its business.&amp;#xa0;&amp;#xa0;Although occasional adverse decisions or settlements may occur, the Company believes that the final disposition of such matters should not have a material adverse effect on its financial position, results of operations or liquidity.&amp;#xa0;&amp;#xa0;There was no outstanding litigation as of September 30, 2018 other than that described above.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;i&gt;SEC Investigation&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On or about March 1, 2018, the U.S. Securities and Exchange Commission (&amp;#x201c;Commission&amp;#x201d;), Miami Regional Office (&amp;#x201c;Commission Staff&amp;#x201d;), served a subpoena upon U.S. Stem Cell, Inc., which seeks the production of certain documents and communications. The Commission Staff is conducting a formal non-public, fact-finding inquiry of U.S. Stem Cell, Inc (&amp;#x201c;Investigation&amp;#x201d;).&amp;#xa0; The Investigation is neither an allegation of wrongdoing nor a finding that any violation of law has occurred. &amp;#xa0;The Company is cooperating with, and has provided information and documents to, the Commission Staff.&amp;#xa0;&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As part of the Investigation, on or about May 14, 2018, the Commission Staff served subpoenas upon Kristin Comella and Mike Tomas, respectively, seeking the production of certain documents and communications. Ms. Comella and Mr. Tomas responded to the respective subpoenas and provided information and documents to the Commission Staff.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;At this juncture, the Company is not able to predict the duration, scope, results, or consequences of the investigation.&amp;#xa0; No further inquiry or request for documents from the Commission Staff has been received by the Company or its management since May 14, 2018. There can be no assurance that the Investigation will be resolved in a manner that is not adverse to the Company.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;i&gt;Government Claim&lt;/i&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;On May 9, 2018, the U.S. Department of Justice filed an injunctive action, specifically United States of America v. U.S. Stem Clinic, LLC, U.S. Stem Cell, Inc., Kristin C. Comella, and Theodore Gradel. The Complaint was filed at the request of the U.S. Food and Drug Administration (FDA) and&amp;#xa0;alleges that the respective defendants manufacture &amp;#x201c;stromal vascular fraction&amp;#x201d; (SVF) products from patient adipose (fat) tissue, which the companies then market as stem cell-based treatments&amp;#xa0;without first obtaining necessary FDA approvals. The Company has retained counsel to defend in this action. The Company has had discussions with the U.S. Department of Justice to explore a favorable settlement. Court ordered mediation is now set for February 20, 2019, during which the parties will explore a mutually agreeable resolution. The Company is not able to predict the duration, scope, results, or consequences of the&amp;#xa0;U.S. Department of Justice discussion or the injunctive actions.&amp;#xa0; There can be no assurance that this matter will be resolved in a manner that is not adverse to the Company.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock> 
  <us-gaap:GeneralInsuranceExpense unitRef="usd" contextRef="c266_From1Jan2016To31Dec2016" decimals="0">100000</us-gaap:GeneralInsuranceExpense>     
  <us-gaap:GeneralInsuranceExpense unitRef="usd" contextRef="c225_From1Jan2017To31Dec2017" decimals="0">11000</us-gaap:GeneralInsuranceExpense>    
  <us-gaap:LitigationSettlementExpense unitRef="usd" contextRef="c225_From1Jan2017To31Dec2017" decimals="0">100000</us-gaap:LitigationSettlementExpense>   
  <us-gaap:SettlementLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf30Sep2018" decimals="0">89000</us-gaap:SettlementLiabilitiesCurrent>  
  <us-gaap:SettlementLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2017" decimals="0">89000</us-gaap:SettlementLiabilitiesCurrent>  
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt; 
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;&lt;b&gt;NOTE 10 &amp;#x2014; FAIR VALUE MEASUREMENT&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The Company adopted the provisions of Accounting Standards Codification subtopic 825-10, Financial Instruments (&amp;#x201c;ASC 825-10&amp;#x201d;) on January 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Level 1 &amp;#x2013; Quoted prices in active markets for identical assets or liabilities.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Level 2 &amp;#x2013; Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Level 3 &amp;#x2013; Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;All items required to be recorded or measured on a recurring basis are based upon level 3 inputs.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;Upon adoption of ASC 825-10, there was no cumulative effect adjustment to beginning retained earnings and no impact on the financial statements.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;The carrying value of the Company&amp;#x2019;s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018 and December 31, 2017, the Company did not have any items that would be classified as level 1, 2 or 3 disclosures.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;As of September 30, 2018 and December 31, 2017, the Company did not have any derivative instruments that were designated as hedges.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>  
  <us-gaap:SubsequentEventsTextBlock contextRef="c18_From1Jan2018To30Sep2018">&lt;div style=&quot;font-family: &apos;Times New Roman&apos;, Times, serif; font-size: 10pt; &quot;&gt;  
&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;&lt;b&gt;NOTE 11 &amp;#x2014; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:justify;&quot;&gt;In October 2018, the Company issued an aggregate of&amp;#xa0;6,094,265 shares of common stock for services rendered.&amp;#xa0;&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;In October 2018, the Company issued&amp;#xa0;164,523 &amp;#xa0;shares of common stock as payment of $12,704 Northstar interest.&lt;/p&gt;&lt;br/&gt;&lt;p style=&quot;font-family:&apos;Times New Roman&apos;, Times, serif;font-size:10pt;margin:0pt;text-align:left;&quot;&gt;In October 2018, the Company issued 526,918 shares of common stock as payment of past director costs.&lt;/p&gt;&lt;br/&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock> 
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c267_From1Oct2018To31Oct2018_SubsequentEventMember" decimals="INF">6094265</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>    
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c267_From1Oct2018To31Oct2018_SubsequentEventMember" decimals="INF">164523</us-gaap:StockIssuedDuringPeriodSharesOther>    
  <us-gaap:PaidInKindInterest unitRef="usd" contextRef="c267_From1Oct2018To31Oct2018_SubsequentEventMember" decimals="0">12704</us-gaap:PaidInKindInterest> 
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c268_From1Oct2018To31Oct2018_DirectorMember_SubsequentEventMember" decimals="INF">526918</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>   
</xbrl>   
